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ABSTRACT OF THE DISSERTATION

CONSEQUENCES OF NON-PHYSIOLOGICAL LIGANDS BINDING TO DREAM
ON ITS SECONDARY AND TERTIARY STRUCTURES AND INTERACTIONS
WITH INTRACELLULAR PARTNERS.
by
Samiol Azam
Florida International University, 2019
Miami, Florida
Professor Jaroslava Miksovska, Major Professor
Downstream regulatory antagonist modulator (DREAM) is 29 kDa neuronal calcium
sensor (NCS) protein which is expressed in the hippocampus of the brain. The DREAM is
involved in a wide spectrum of biological processes, including regulation of potassium
current in brain, modulation of pain, presenilin-1 processing, regulation of memory and
learning. Exposure to toxic metals such as lead (Pb2+) and cadmium (Cd2+) have been
associated with different types of neurodegenerative diseases. However, how these toxic
metals induce neurotoxicity remains an active area of research. In the present study,
utilizing a combination of spectroscopic and calorimetric techniques, we demonstrated
binding of these toxic metals to DREAM. We showed that Pb2+ and Cd2+ bind to EF-hands
in DREAM and binding of these toxic metals alters DREAM secondary and tertiary
structure. Lead and cadmium association to DREAM also modulates DREAM interactions
with FITC-labeled peptides that mimic binding sites of DREAM effector proteins,
presenilin 1 and Kv channel in a similar way as Ca2+ binding. Considering the high
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sequence homology between DREAM and other NCS proteins, Pb2+ and Cd2+could bind
to other NCS proteins and interactions of Pb2+ and Cd2+ to with NCS proteins could provide
novel insight into the molecular mechanism of Pb2+ and Cd2+-induced neurotoxicity.
Lithium (Li+) has been used for the treatment of mental disorders for more than six
decades. Increasing evidences from in vivo and in vitro studies have implicated that Li+ is
a drug candidate for the treatment of neurogenerative diseases. However, the molecular
mechanism through which Li+ exerts its therapeutic action has not elucidated yet. Here we
investigated whether Li+ directly binds to DREAM and impact its structural and functional
properties. We demonstrated that Li+ binding triggers structural rearrangement of DREAM
and enhances DREAM interactions with site-1 and site-2 of the voltage-gated potassium
channel. Results from this study suggest that DREAM and probably other NCS proteins
are molecular targets of Li+ and binding of Li+ to DREAM could provide a novel insight
into the molecular mechanism of Li+ therapeutic action.
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1. INTRODUCTION
1.1 General principle of calcium signaling
Calcium (Ca2+) is a universal intracellular signaling ion that binds to a wide
spectrum of calcium-binding proteins (CaBPs) and regulate numerous cellular functions,
including muscle contraction, fertilization, gene transcription, exocytosis, energy
metabolism, neurotransmitter secretion, activity of ion channels, and signal transduction
(Gifford, Walsh et al. 2007, Berridge, Lipp et al. 2000, Carafoli, Santella et al. 2001).
Dysregulation of calcium signaling could result in cancer, manic depression, hypertension,
heart disease, and Alzheimer’s disease (Gifford, Walsh et al. 2007, Berridge, Bootman et
al. 2003). In the resting cells, intracellular Ca2+ concentration is about 100 nM, while
concertation of extracellular Ca2+ is about 2 mM (Vogel 1994, Clapham 2007). Such an
enormous difference between intracellular Ca2+ and extracellular Ca2+ (10,000 fold)
generates a chemiosmosis force that facilitates the influx of Ca2+ into the cell. The ATPdependent pump maintains intracellular Ca2+ concentration by pumping excess Ca2+ out of
the cells or into internal stores such as mitochondria, endoplasmic and sarcoplasmic
reticulum (Gifford, Walsh et al. 2007, Clapham 2007). Intracellular calcium binds to a wide
array of CaBPs that regulate a wide range of cellular processes. Consequently, the Ca2+
signal is translated into diverse biochemical responses by triggering different intracellular
pathways (Carafoli, Santella et al. 2001, Berridge, Bootman et al. 2003, Clapham 2007).
The regulation of a wide range of cellular processes by a single Ca2+ ion emphasizes
the versatility of this ion in cellular function (Berridge, Lipp et al. 2000). The question
remains how Ca2+ regulates so many cellular processes? The versatility of calcium
signaling could be explained by its wide range of spatial and temporal signals, speed and
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amplitude (Berridge, Lipp et al. 2000). The versatility is achieved through the use of an
extensive Ca2+ signaling toolkit. The calcium-signaling toolkit comprises voltage-operated
channels, receptor-operated channels, calcium pumps and exchangers, calcium buffer
proteins, Ca2+ effector proteins, receptor proteins, transducer proteins, transcriptional
factors, endoplasmic reticulum (ER), sarcoplasmic reticulum (SR), Golgi apparatus,
mitochondria, to name a few (Berridge, Lipp et al. 2000, Berridge, Bootman et al. 2003).
Each cell type utilizes distinctive components from the Ca2+-signaling toolkit and generates
Ca2+ signals with widely different spatial and temporal properties (Berridge, Bootman et
al. 2003). Thanks to the flexibility of Ca2+ as a ligand. Although Ca2+ has similar physical
properties as Mg2+, Ca2+ binding sites have significantly higher affinity for Ca2+ than Mg2+,
as the coordination chemistry of Ca2+ allows it to bind to the binding site of irregular
geometry whereas the strict requirement of Mg2+ for octahedral geometry is hard to satisfy

Figure 1.1. Components of Ca2+ signaling network. Maintenance of intracellular
Ca2+ concentration is determined by the balance between ON/OFF reaction. Adapted
from (Berridge, Lipp et al. 2000).
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within the structure of proteins (Brini, Calì et al. 2014). A common calcium signaling
network comprises four functional units, where at any moment, the level of intracellular
Ca2+ is determined by the balance between ON/OFF reaction as shown in Figure 1.1
(Berridge, Lipp et al. 2000). Calcium signaling is initiated by stimuli such as membrane
depolarization, extracellular signaling molecules, intracellular messengers, stretch, and
noxious stimuli, which generates Ca2+ mobilizing signals (Berridge, Bootman et al. 2003).
Calcium mobilizing signals activate the ON mechanism and extracellular Ca2+ enter the
cytoplasm through different channels, including voltage-operated ion channels (VOCs),
store-operated Ca2+ channels (SOCs), receptor-operated ion channels (ROCs), and
secondary messenger operated Ca2+ channels (SMOCs) (Gifford, Walsh et al. 2007,
Berridge, Bootman et al. 2003). Additionally, internal storages such as the endoplasmic
reticulum (ER) and sarcoplasmic reticulum (SR) can also release Ca2+ into the cytoplasm.
The release of Ca2+ from internal stores is controlled by different channels, including
ryanodine receptors (RYR) and inositol triphosphate receptors (InsP3R). Calcium itself is
the activator of these channels. Activation of those channels by Ca2+ is dependent on
whether stimuli bind to cell surface receptors. For instance, inositol triphosphate (InsP3)
diffuses into the cells to bind inositol triphosphate receptors (InsP3R) and release Ca2+ from
ER (Gifford, Walsh et al. 2007, Berridge, Lipp et al. 2000). The Ca2+ that enters the
cytoplasm during the ON mechanism does not remain unbound. Instead, it interacts with
different CaBPs. Most of cytoplasmic Ca2+ rapidly binds to calcium buffer proteins,
whereas a small proportion of it binds to numerous Ca2+ sensor proteins, including
calmodulin (CaM), recoverin, troponin, and neuronal Ca2+ sensor proteins (NCS) in the
brain (Gifford, Walsh et al. 2007, Berridge, Bootman et al. 2003). These calcium sensors
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transduce chemical signals of an increased Ca2+ concentration into biochemical responses
by triggering diverse signaling pathways (Gifford, Walsh et al. 2007). At last, once Ca2+
has completed its signaling functions, it is rapidly removed from the cytoplasm with
different exchangers and pumps via OFF mechanism. Na+/Ca2+ exchangers and plasma
membrane Ca2+-ATPase (PMCA) pumps extrude Ca2+ outside of the cells. Other ion
channels, including sarco-endoplasmic calcium ATPases (SERCAs), H+/Ca2+ exchangers,
and Ca2+ uniporters return Ca2+ into the internal stores, such ER, SR, and mitochondria
(Gifford, Walsh et al. 2007, Berridge, Lipp et al. 2000).
1.2 Neuronal calcium signaling
Calcium plays an important and diversified role in neuronal physiology. For
instance, Ca2+ impacts both long-term depression (LTD) and long-term potentiation forms
of synaptic plasticity by controlling the release of neurotransmitter from the presynaptic
terminal (Bolshakov, Siegelbaum 1994, Christie, Magee et al. 1996, Grover, Teyler 1990,
Impey, Mark et al. 1996). As a universal secondary messenger, Ca2+ has been demonstrated
to regulate the process of learning and the formation and consolidation of memory,
synaptogenesis, membrane excitability, and dendrite development (Brini, Calì et al. 2014,
Südhof 2004, Redmond, Ghosh 2005, Michaelsen, Lohmann 2010, Tanaka, Nakada et al.
2008). The intracellular concentration of neuronal cell is in the range 100–500 nM, whereas
extracellular concentration is 1 mM (Kawamoto, Vivar et al. 2012). Like other cells,
neuronal cells use different components from the Ca2+ signaling toolkit to generate
neuronal Ca2+ signals with a wide range of temporal and spatial properties. Neuronal life
is dependent on the correct functioning of the above processes. Since Ca2+ plays a
prominent role in the neuronal function, subtle alteration in Ca2+ homeostasis leads to
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profound functional changes (Brini, Calì et al. 2014, Kawamoto, Vivar et al. 2012). Several
lines of evidence have demonstrated that perturbation of Ca2+ homeostasis is a causative
factors of amyotrophic lateral sclerosis (ALS), Alzheimer’s, Parkinson’s, Huntington
disease, and other neurodegenerative disease (Christie, Magee et al. 1996, Kawamoto,
Vivar et al. 2012, Bezprozvanny 2009, Bezprozvanny 2007, Mattson 2007, Mattson 2004,
Rowland, Shneider 2001, von Lewinski, Keller 2005, Lim, Fedrizzi et al. 2008). Alteration
of Ca2+ homeostasis could be attributed to the decrease in Ca2+ buffering capacity of Ca2+buffer proteins, malfunction of membrane channels and mitochondrial Ca2+ controlling
system (Brini, Calì et al. 2014, Kawamoto, Vivar et al. 2012).
1.3 Classification of Ca2+ binding proteins
As it is mentioned earlier, Ca2+ that flows into the cell during the ON reaction
interacts with numerous CaBPs; the human genome encodes more than 200
CaBPs(Berridge, Bootman et al. 2003). Functionally, CaBPs are divided into two classes:
Ca2+ buffers and Ca2+ sensors (Brini, Calì et al. 2014). Calcium buffers bind Ca2+ with high
affinity but Ca2+ association does not lead significant conformational changes. Calcium
buffers proteins modulate Ca2+ signaling and help maintain Ca2+ homeostasis by releasing
Ca2+ during the ON reaction and sequestering Ca2+ during OFF reaction (Gifford, Walsh
et al. 2007, Berridge, Bootman et al. 2003). Another important purpose of Ca2+ buffer is to
regulate the transmission of Ca2+ signaling throughout the cells by limiting the amplitude
and duration of Ca2+ signaling (Braunewell, Gundelfinger 1999). Parvalbumin, calbindin
D-9k, calbindin D-28k, and calretinin are few examples of Ca2+ buffer proteins (Gifford,
Walsh et al. 2007, Berridge, Bootman et al. 2003). On the other hand, Ca2+ sensors proteins
undergo significant conformational changes upon Ca2+ association, which enables them to
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interact with binding partners to regulate a plethora of Ca2+-dependent processes (Gifford,
Walsh et al. 2007, Braunewell, Gundelfinger 1999). Recoverin, calmodulin, troponin C,
calcineurin B, and myosin light chain are well-studied examples of Ca2+ sensing proteins
(McCue, Haynes et al. 2010). Some proteins have both Ca2+ buffering and sensing
capability; CaM is one classic example of such proteins (Brini, Calì et al. 2014). All CaBPs
comprise one of the three types of Ca2+ binding structural motifs: the C2-domain, the
annexin domain and the EF-hand domain.
1.4 Ca2+ binding motif: C-2 domain.
The C2-domain is a conserved functional domain that is composed of
approximately 130 amino acid residues. Structural studies demonstrated that C2-domain
comprises eight β strands; 4 pairs of antiparallel β strands are connected through flexible
loops as shown Figure 1.2 (Essen, Perisic et al. 1996, Nalefski, Falke 1996). These flexible

Figure 1.2. Three-dimensional structure of synaptotagmin-1 with Ca2+
bound to C2B domain (PDB: 1tjx). Cartoon representation of protein is
shown as purple blue; Ca2+ is shown as red spheres.
6

loops provide Asp residues for Ca2+ coordination. Each Ca2+ is hepta-coordinated in C2domain; five of the coordinating ligands come from Asp residue of the flexible loop and
two of them are supplied by the water molecule (Nalefski, Falke 1996). It has been shown
Ca2+ binding to C2-domain facilitates C2domain-containing protein interaction with
phospholipid membranes and other proteins (Scott, White et al. 1990, Newton 1995).
Modulation of interaction between C-2 domain protein and binding partners by Ca2+ can
be explained by the exposure of hydrophobic residues as well as exposure of charged
residues which can form electrostatic interaction with phosphate groups of phospholipid
membranes (Scott, White et al. 1990, Newton 1995).
1.5 Ca2+ binding motif: annexin.
The annexin family of proteins possess a highly variable N-terminal region,
conserved core domain and C-terminal region (Figure 1.3) (Ortlund, Chai et al. 2004). The
core domain contains a characteristics annexin repeat formed by a 70-residue-long

Figure 1.3. Three-dimensional structure of Ca2+ bound annexin V (PDB: 1yii).
Protein is represented with purple blue cartoon; Ca2+ is represented with red
spheres.
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segment. Typically, four of such annexin repeats are present in the core domain of annexin
proteins. Because of the compact packing of the central core, the overall structure of the
protein looks like a disc with a slight curvature forming a convex and concave surface on
the top and bottom of the protein surface, respectively (Ortlund, Chai et al. 2004, Weng,
Luecke et al. 1993). Core domain concave side comprises the Ca2+ binding site. Annexin
has been shown to interact with phospholipid membranes in a Ca2+-dependent manner
(Weng, Luecke et al. 1993). Annexin interacts with the phospholipid membrane as follows:
convex surface faces towards the membrane and concave surface points away from the
membrane (Weng, Luecke et al. 1993). In the apo-form of the protein, the N-terminal
domain has an irregular structure that integrates into the central domain. Ca2+ association
exposes the N-terminal domain and facilitates annexin interaction with other proteins,
including S100 proteins (Weng, Luecke et al. 1993). Annexins have been implicated in the
regulation of different biological processes, such as endocytosis, exocytosis, membrane
organization, and signal transduction (Rescher, Gerke 2004, Gerke, Moss 2002, Moss,
Morgan 2004, McNeil, Rescher et al. 2006).
1.6 Ca2+ binding motif: the EF-hand.
The EF-hand is by far mostly used Ca2+ binding motif, having more than 250
proteins in the superfamily (Braunewell, Gundelfinger 1999). The EF-hand Ca2+ binding
motif was first observed in the Ca2+ buffer protein parvalbumin (Kretsinger, Nockolds
1973, Moews, Kretsinger 1975). The name EF-hand was proposed on the basis of the
observation that E and F helices of parvalbumin are oriented around the Ca2+ binding loop
in such a way that resembles the thumb and index finger of a hand. After the first discovery
on EF-hand motif in parvalbumin, this motif was found in troponin C (Collins, Potter et al.
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Figure 1.4. Single canonical EF-hand of parvalbumin (PDB: 1b8r). Entering
and exiting helices are shown as cyan; Ca2+ chelating loop is shown as
magenta; Ca2+ ion is shown as green sphere, β-sheet is shown as red.
1973), myosin light chains (Collins 1974), calmodulin (Stevens, Walsh et al. 1976) , and
recoverin (Flaherty, Zozulya et al. 1993), to mention a few. Most protein contains even
number of EF-hands, with number four being the most prevalent. The canonical EF-hand
motif comprises a helix-loop-helix structural unit, where a 9-residue entering α-helix and
an 11-residue exiting α-helix is bridged by a 9-residue Ca2+ chelating loop (Figure 1.4)
(Gifford, Walsh et al. 2007). Ca2+ is hepta-coordinated in most EF-hand protein with
pentagonal bipyramidal geometry (Grabarek 2006). Because of the geometric and space
constrain helices and sheets provide only few ligands for Ca2+ coordination. The 9-residue
long flexible loop provides five oxygen ligands for Ca2+ coordination; the rest two oxygen
ligands come from the side chain of a bidentate carboxylate ligand glutamic acid, which is
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located in the exiting helix (Gifford, Walsh et al. 2007). The coordination sphere of the
canonical EF-hand loop is shown in Figure 1.5. Most of the residues in the EF-hand loop
have individual roles for maintaining stability and folding of the loop: The first residue
defines stereochemical rearrangement of the loop through various intraloop hydrogen

Figure 1.5. Schematic diagram of the coordination sphere of
canonical EF-hand loop. Blue represents coordinating ligands,
coordinating water molecule is shown in dark blue. Light green
represents conserved glycine residue which allows bending of
the loop. Entering and exiting helices are shown in red. Figure
adapted from (Gifford, Walsh et al. 2007).
bonds. The oxygen atoms of the side chains of Asp residues at positions 1, 3, 5, and 9 and
backbone carbonyl group at position 7 provide five ligands for Ca2+ coordination. Less
sterically hindered amino acid residue glycine is conserved in the 6th position, which allows
90˚ turn of the loop that enables remaining oxygen atoms to take coordinating positions.
Hydrophobic amino acid residues are conserved in the 8th position; main chain NH and CO
groups face away from Ca2+ binding site and form a short antiparallel β-sheet in this
position. Aspartate residue in position 9 of the EF-hand loop can coordinate Ca2+ both
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directly and through bridging water. Glutamic acid, supplied by the C-terminal exiting
helix, is present at the 12th position of the canonical EF-hand loops and provides the
remaining two oxygen atoms for Ca2+ coordination (Gifford, Walsh et al. 2007). The
location of the amino acid residue at the 12th position of the loop is critical as it determines
the structure and function of the loop and specificity of the EF-hand. For instance, when
glutamic acid is present in the 12th position, it can donate two ligands to fulfill the heptacoordination of Ca2+ and EF-hand binds Ca2+ selectively. On the contrary, when aspartate
is present in the 12th position, because of its smaller size, it can provide only one ligand,
which can satisfy the hexa-coordination of Mg2+, but not the hepta coordination of Ca2+
and EF-hand binds Mg2+ preferentially. Besides coordinating the calcium ion as described
above, the EF-hand loop possesses an extensive network of hydrogen bonds between
chelating and non-chelating residues which stabilizes the loop (Gifford, Walsh et al. 2007).
1.7 EF-hand structural reorganization.
The EF-hand proteins that are Ca2+-sensors undergo structural rearrangement upon
Ca2+ binding. The question is how does Ca2+ binding trigger structural reorganization in
the EF-hand protein? As noted above, Ca2+ binding sites are located in the flexible loop
that is located between entering and exiting helices of EF-hand. Residues 1, 3, 5, 7, and 9
of the loop provide five ligands for Ca2+ coordination. The rest two ligands are provided
by the 12th position of the loop (glutamic acid) which is located in the exiting helix.
Glutamate residue at the 12th position is far away to chelate the Ca2+. To complete the
coordination sphere of Ca2+, the exiting helix is repositioned by ̴ 2 Å and consequently,
glutamic acid donates two ligands and fulfills the pentagonal bipyramidal geometry of
Ca2+. Movement of the exiting helix leads to the conformational change in that EF-hand
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which is transmitted to other parts of the protein. Ca2+ induced structural reorganization
can be exemplified by comparing the structure of ubiquitous Ca2+ binding protein
calmodulin (CaM), which contains four EF-hands, in the Ca2+ bound form and in Ca2+-free
form (Figure 1.6). In the metal-free form of the CaM, entering and exiting helices are
antiparallelly oriented (interhelical angle ̴ 140˚) and both helices experience extensive
hydrophobic contacts (Figure 1.6, left); this conformation is known as closed
conformation. Upon Ca2+ binding, helices become perpendicular and interhelical contact
between the helices is lost; this conformation is called open conformation (Figure 1.6,
right). This conformation change exposes the buried hydrophobic cavities, which enables
CaM to interact with a wide range of targets. However, the extent by which EF-hand
proteins undergo structural reorganization varies among proteins and within EF-hands of
the same protein. For example, Ca2+ binding to metal-free recoverin, a protein associated

Figure 1.6. Structural reorganization of the EF-hands of CaM. Left) EF-1 in apo
and Ca2+ bound forms are shown as firebrick color and slate colors, respectively.
Right) EF-3 in apo and Ca2+-bound forms are shown as lime green and cyan,
respectively. In both cases, Ca2+ is shown as magenta sphere. Ca2+ binding
reorganizes both EF-hands from antiparallel to perpendicular orientation. PDB
code of apo-CaM: 1cfc; PDB code of Ca2+-CaM: 1cll.
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with vision, does not lead to the pronounced structural reorganization; however, Ca2+
association leads to domain organization which exposes buried myristoylated group and
enables recoverin to associate with the membrane (Figure 1.7). EF-hand proteins that act
as calcium buffers, for example, parvalbumin and calbindin D-9k, undergo minimum
structural reorganization upon Ca2+ association.

Figure 1.7. Structural reorganization of the EF-hands of recoverin. A) EF-1 in apo and
Ca2+ bound forms are shown as firebrick and slate, respectively. B) EF-3 in apo and Ca2+bound forms are shown as lime green and cyan, respectively. In both cases, Ca2+ is shown
as magenta sphere. Ca2+ binding does not lead to significant structural reorganization in
the protein. PDB code of apo-recoverin: 1iku; PDB code of Ca2+-recoverin: 1jsa.
1.8 Binding of non-physiological metals to EF-hand proteins.
In addition to the binding of physiological ligands Ca2+ and Mg2+, EF-hand
proteins have been shown to bind non-physiological ligands. A wide spectrum of studies
has demonstrated that Pb2+ interacts with EF-hand protein CaM and modulates its
interaction with intracellular partners which might contribute to Pb2+-induced neurotoxicity
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(Gorkhali, Huang et al. 2016). For instance, Pb2+ displaces Ca2+ that is bound to EF-hands
of CaM and Pb2+:CaM complex stimulates myosin light chain kinase and
phosphodiesterase (Habermann, Crowell et al. 1983). Lead also has been shown to bind
sites other than EF-hands, which could disrupt multiple downstream activities and induce
neurotoxicity (Kern, Wisniewski et al. 2000, Goldstein, Ar 1983). Statistical analysis of
Pb2+-bound proteins that were obtained from the protein data bank (PDB) have shown that
negatively charged amino acid residues such as Asp and Glu provide ligands for Pb 2+
coordination; the geometry of Pb2+-bound EF-hands is analogous to Ca2+-bound EF-hands
as both Pb2+ and Ca2+ are coordinated by same binding ligands. Because of the
preponderance of negatively charged amino acid residues in the EF-hand loop of EF-hand
proteins, Pb2+ is a molecular target of a wide range of EF-hand proteins (Kirberger, Yang
2008).
Analogous to Pb2+ binding, Cd2+ also displaces Ca2+ from the EF-hand of
CaM (Forsén, Thulin et al. 1980, Andersson, Forsen et al. 1983) which facilitates CaM
interaction with myosin light chain kinase and phosphodiesterase (Suzuki, Chao et
al. 1985, Chao, Bu et al. 1995, Mazzei, Girard et al. 1984). It has been proposed that
competition between Cd2+ and Ca2+ for EF-hand of CaM is crucial for determining
CaM toxicity at the molecular level (Suzuki, Chao et al. 1985, Mazzei, Girard et al.
1984). Few other studies have demonstrated that Cd 2+ displaces Ca2+ from the EFhand of troponin C, a protein that regulates muscle contraction (Ellis, Strang et al.
1984, TELEMAN, DRAKENBERG et al. 1983). Cadmium shares similar properties
with Ca2+ with ionic radii of 0.97 Å and 0.99 Å and charge/radius ratio 2.06 e/Å and 2.02
e/Å, respectively (Choong, Liu et al. 2014). Computation studies have shown Cd2+ also has
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the tendency to be coordinated by negatively charged amino acid residues Asp and Glu
(Friedman 2014, Jesu Jaya Sudan, Sudandiradoss 2012). So, both similar size and tendency
of being coordinated by similar ligands support Cd2+ binding to EF-hands. In addition to
divalent metal ions binding, trivalent lanthanide ions (e.g. Tb3+, La3+, and Lu3+) have also
shown to interact with EF-hand protein (Edington, Gonzalez et al. 2018, Gonzalez, Ramos
et al. 2016). It has been demonstrated that lanthanide binding slightly distorts the geometry
of the EF-hand loop as evidenced by the fact that lanthanide-bound CaM exhibits greater
conformation flexibility and larger structural fluctuation than Ca2+-bound-CaM (Edington,
Gonzalez et al. 2018). Using fluorescence and calorimetric techniques, it was shown that
Tb3+ associates to neuronal calcium sensor (NCS) protein DREAM (Gonzalez, Ramos et
al. 2016). Binding of monovalent ions to EF-hand protein is unlikely; however, one study
has shown that monovalent ion Na+ and K+ can occupy EF-hand of parvalbumin which
attenuates Ca2+ affinity for parvalbumin (Henzl, Larson et al. 2004b).
1.9 Neuronal calcium sensor (NCS) proteins
The neuronal calcium sensor (NCS) group is a subgroup of the EF-hand
superfamily. Most members of this group are expressed in the brain and retina. The human
genome comprises 14 NCS proteins, and the amino acid sequence of those members are
highly conserved, especially in the EF-hand loop region (Ames, Lim 2012). These proteins
regulate diverse neuronal processes, such as Ca2+ channel regulation, short-term synaptic
plasticity, neuronal growth, neurotransmission regulation, light adaption (recoverin), antiapoptosis (hippocalcin), memory and learning (calsenilin, neuronal calcium sensor protein1), recycling and activation of guanylyl cyclase (visinin-like proteins 1 and 2, neurocalcinδ), potassium channels regulation (potassium channel interacting proteins (KChIP1–4),
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modulation of pain (KChIP3), and presenilin processing (KChIP 3 and 4) (Ames, Lim
2012, Burgoyne, Weiss 2001, Burgoyne 2007, Pongs, Lindemeier et al. 1993). Regulation
of diverse neuronal processes could be explained by the fact that each NCS protein
generates a unique Ca2+ signal that varies in duration, magnitude, and localization
(Burgoyne, Weiss 2001, Burgoyne 2007). Additionally, regulation of the above processes
depends on the localization of NCS proteins, the affinity of NCS proteins for Ca2+, and the
interaction of NCS proteins with interacting partners (Burgoyne 2007). All NCS family
members comprise four EF-hands and two distinct domains: EF-1 and EF-2 constitute the
N-terminal domain; EF-3 and EF-4 constitute the C-terminal domain (Figure 1.8). In all
NCS proteins, EF-hands always occur in pairs. Paired EF-hands in NCS proteins
communicate through a short antiparallel β-sheet and because of this pairing protein
display positive cooperativity for Ca2+ binding, that is, protein needs less Ca2+ to reach the

Figure 1.8. NMR structure of NCS-1 protein (PDB: 2lcp). EF-hands 1, 2, 3,
and 4 are shown as firebrick, slate, lime green, and cyan, respectively; Ca2+
ions are shown as magenta spheres; and rest of the protein is shown as orange.
EF-1 and EF-2 constitutes N terminus; EF-3 and EF-4 constitutes C-terminus.
In each terminus, paired EF-hands communicate through a short antiparallel
β-sheet.
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saturation (Ames, Lim 2012, Burgoyne, Weiss 2001). Four EF-hands of NSC proteins
have distinct metal-binding properties: EF-1 is inactive in all members of the family as the
presence of sterically hindered residue proline and cysteine in the EF-hand loop (conserved
CPxG sequence, x any residue) distort Ca2+ binding geometry; EF-2 and EF-3 binds Ca2+
with micromolar or submicromolar affinity in all members; and EF-4 is active in some
members (Gifford, Walsh et al. 2007, Braunewell, Gundelfinger 1999, Ames, Lim 2012,
Burgoyne, Weiss 2001, Haynes, Sherwood et al. 2007). Even though EF-1 of NCS proteins
does not bind any Ca2+, some members contain a buried palmitoyl or myristoyl group near
this EF-hand. Calcium binding to the C-terminus of some members has been shown to
expose the prosthetic group which facilitates membrane association of those prosthetic
groups (Figure 1.9) (Zozulya, Stryer 1992, Hughes, Brzovic et al. 1995, Ames, Tanaka et
al. 1996). Each member of the NCS family has different Ca2+ affinity which depends on

Figure 1.9. Left: NMR structure of Ca2+-free recoverin (PDB code: 1iku). Right:
NMR structure of Ca2+-bound recoverin (PDB code: 1jsa). In both cases, EF-hands
1, 2, 3, and 4 are shown as firebrick, slate, lime green, and cyan, respectively. Rest
of the protein is shown as cyan. Ca2+ ions are shown as magenta sphere. Myristoyl
group is shown as pink. Myristoyl group is buried in Ca2+-free recoverin, but Ca2+
binding exposes the myristoyl group.
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amino acid sequence variation of each EF-hand (Burgoyne 2007). The NCS proteins have
a flexible structure in the Ca2+-free form but become more ordered in Ca2+-bound form
(Burgoyne, Weiss 2001). Burgoyne et al. classified NCS proteins into five classes
(Burgoyne, Weiss 2001). Class A has only one member named frequenin. Frequenin is
alternatively known as neuronal calcium sensor protein 1 (NCS-1). The NCS-1 contains a
buried myristoyl group inside a hydrophobic moiety formed by the EF-3 and EF-4 in the
C-terminus. In most NCS proteins, Ca2+ association exposes the buried myristoyl group,
but in NCS-1, the extrusion of the myristoyl group is independent of Ca2+ association
(O'Callaghan, Ivings et al. 2002). However, it has been shown that NCS-1 associates with
lipid bilayer membrane strongly in the presence of Ca2+ (Handley, Lian et al. 2010). Class
B comprises three members, named hippocalcin, neurocalcin-δ protein, visinin-like
proteins (VILIP 1, 2, and 3). Biological properties of the members of class B are not well
known as Ca2+ affinity and interactions of these proteins with binding partners vary
(Braunewell, Szanto 2009). Class C contains only recoverin; it is first discovered NCS
protein (Dizhoor, Ray et al. 1991). Recoverin is exclusively expressed in rod
photoreceptors where it regulates vision processes through the inhibition of rhodopsin
kinase in a Ca2+-dependent manner (Calvert, Klenchin et al. 1995, Makino, Dodd et al.
2004). In contrast to NCS-1 protein, where myristoyl group is sequestered in the
hydrophobic cavity in the C-terminus, in recoverin, myristoyl group is buried inside the
hydrophobic moiety formed by EF-1 and EF-2 in the N-terminus (Tanaka, Amest et al.
1995). It has been shown that binding of one Ca2+ at EF-3 is not sufficient for exposing the
myristoyl group, but binding of two Ca2+ at EF-2 and EF-3 leads to an exposure of the
myristoyl group from the hydrophobic cavity which facilitates the association of myristoyl
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group to the membrane as shown in Figure 1.9 (Ames, Lim 2012). Class D possesses
guanylate cyclase-activating proteins (GCAPS) 1, 2, and 3. These proteins are exclusively
expressed in the photoreceptor cells and play important roles in vision processes by
activating retinal guanylate cyclase at low Ca2+ concentration and inhibiting it at high Ca2+
concentration (Ames, Lim 2012, Dizhoor, Lowe et al. 1994). In contrast to other NCS
proteins, Ca2+ association with GCPAs causes small conformational changes and therefore
does not release the buried myristoyl group (Lim, Dizhoor et al. 2014). Additionally, EF2 and EF-3 of GCAPS are capable of binding both Ca2+ and Mg2+, but EF-3 binds Ca2+
selectively (Peshenko, Dizhoor 2006). The molecular mechanism of Ca2+ and Mg2+ binding
to GCAP-1 has been resolved, but the mechanism of Ca2+ and Mg2+ binding to GCAPs 2
and 3 has not been deciphered yet. In metal-free form, GCAP-1 shows a flexible/disordered
structure and does not interact and activate retinal guanylate cyclase (Peshenko, Dizhoor
2004, Lim, Peshenko et al. 2009). Magnesium (Mg2+) binds at EF-2 of GCAP-1 and
stabilizes the tertiary structure of GCAP-1, and the stabilization enables GCAP-1 to interact
with retinal guanylate cyclase and subsequently activate it. Binding of three Ca2+ ions at
EF-2, EF-3, and EF-4 of GCAP-1 leads to a distinct conformation that allows inhibition of
retinal guanylate cyclase (Dizhoor, Lowe et al. 1994, Lim, Dizhoor et al. 2014, Peshenko,
Dizhoor 2006). Class E contains four types of potassium channel interacting proteins
(KChIPs) which are the latest member of the NCS family. These proteins are called
potassium channel interacting proteins because they have been shown to interact with
voltage-gated potassium channels (An, Bowlby et al. 2000). Each member of KChIPs has
different isomers (five for KChIP-1, nine for KChIP-2, three for KChIP-3, and five for KChIP4) (Patel, Campbell et al. 2002). Experimental results from a northern blot study have unveiled that
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KChIP-1 is expressed in the brain, KChIP-2 is expressed in brain and heart, KChIP-3 is expressed
in the brain and heart (An, Bowlby et al. 2000). The KChIP-4 was discovered from the database
search of the proteins that have high sequence similarity with the first three members of the group
(Holmqvist, Cao et al. 2002). All member of this group has high sequence homology in the Cterminus but differ each from other in the N-terminus (Patel, Campbell et al. 2002). Each member
of the family has been shown to interact with the N-terminus of voltage-gated potassium channels
(Kv channels) and control the fast ITO and ISA currents in the heart and brain, respectively. It has
been shown that KChIP-1, KChIP-2, and KChIP-3 associate with KV4 channels expressed in
xenopus oocytes which causes rise in current density, slower inactivation kinetics, and acceleration
of recovery from inactivation (An, Bowlby et al. 2000). All twenty-two isomers of the group
interact with Kv4 channels in many different combinations which lead to a wide spectrum of

Figure 1.10. Representation of the amino acid residues of KChIP1 involved in
interaction with N-terminus of Kv4.3 channel (PDB: 2nz0). N terminus of the
protein is shown in firebrick, C-terminus is shown in slate. Residues involved
in first interface is shown in cyan sticks, residues involved in the second
interface is shown in lime green sticks.
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potassium channel tuning (Bourdeau, Laplante et al. 2011, Liss, Franz et al. 2001, Kunjilwar, Qian
et al. 2013). The X-ray crystallography study has demonstrated that KChIP-1 forms an octameric
complex with Kv4.3, in which each KChIP-1 monomer interacts with two adjacent Kv4.3 Ntermini in a 4:4 manner (Pioletti, Findeisen et al. 2006, Wang, Yan et al. 2007b). Two contact
interfaces are involved in KChIP-1: Kv4.3 interaction (Wang, Yan et al. 2007b). The most
significant interaction occurs between hydrophobic cavities on the KChIP-1 surface and the
hydrophobic α-helix of the Kv4.3 channel. There are two hydrophobic cavities on the KChIP-1
surface. The N terminus residues of KChIP-1, Gly 59, Phe 60, Phe 74, Ile 77, Tyr 78, Leu94, Phe
111, Leu 115, and Leu 118, interact with Trp8 and Phe 11 of Kv4.3 channel (shown in cyan stick
on firebrick background in Figure 1.10). The C-terminus residues, Tyr 134, Ile 150, Val 151, Ile
154, Tyr155, His174, and Phe178, interact with Trp19 of Kv4.3 channel (shown in cyan stick on
slate background in Figure 1.10) (Wang, Yan et al. 2007b). The second contact interface is formed
between residues 70–78 Kv4.3 channel and entering helix of EF-1 on KChIP-1 (Wang, Yan et al.
2007b). In the interface, Leu 39, Leu 42, Leu43, Tyr57, and Phe108 of KChIP-1 interacts with
Phe73 of Kv4.3 channel through stacking interactions (shown in lime green stick on firebrick
background in Figure 1.10). Furthermore, the interaction is stabilized by two salt bridge formations
between Lys50 of KChIP-1 and Glu77 of Kv4.3 channel and between and Arg51 of KChIP-1 and
Asp78 of Kv4.3 channel (Wang, Yan et al. 2007b).
Although all members of the KChIPs interact with voltage-gated potassium channels, only
the structure of KChIP-1:Kv4 is available. On the basis of high sequence homology of KChIPs,
especially the residues involved in the formation of the complex, other KChIPs could interact with
Kv channel in an analogous manner (Liang, Wang et al. 2009).
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1.10 Calsenilin/DREAM/KChIP3
Interestingly, KChIP-3 has three different names. This protein was
discovered by three independent groups and each group named it differently. On the
basis of the fact that this protein interacts with presenilin and controls the activity of
γ- secretase complex, one research group named it calsenilin (Buxbaum, Choi et al.
1998). Later, another group named it as Downstream regulatory element antagonist
modulator (DREAM) because the protein interacts with downstream regulatory
element (DRE) and directly modulate transcription of downstream genes (Carrion,
Link et al. 1999). Finally, the protein was renamed as KChIPs as it has high sequence
similarity with KChIP-1 and KChIP-2 (An, Bowlby et al. 2000). I will use the name
DREAM throughout. The DREAM is a 29 kDa NCS protein that is expressed in the
brain and heart and has been shown to control a wide spectrum of cellular processes
(An, Bowlby et al. 2000, Buxbaum, Choi et al. 1998, Carrion, Link et al. 1999). The
DREAM is the only Ca2+ binding protein that directly binds to DNA sequence
(DRE) and represses transcription of genes (prodynorphin and c-fos genes) (Carrion,
Link et al. 1999). In the Ca2+-free state, DREAM associates with DRE of human
prodynorphin and c-fos genes and inhibit their transcription, but Ca2+ binding
induces conformation change in the protein that prevents binding of DRE and
subsequently reactivates the transcription (Carrion, Link et al. 1999, Cheng, Pitcher
et al. 2002). Prodynorphin and c-fos genes have been shown to regulate pain
modulation, cell homeostasis, and apoptosis (Dace et al. 2005, Osawa, Tong et al.
2001). The fact that DREAM represses transcription of DRE emphasize role of this
protein regulating those processes (Costigan, Woolf 2002, Fontán-Lozano, Romero-
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Granados et al. 2009). In addition to direct regulation of gene expression, DREAM
protein has been shown to indirectly regulates gene expression through interactions
with CREB and α-CREAM proteins. Interaction between DREAM and CREB enables
regulation of genes that have promoters different than DRE (Ledo, Kremer et al. 2002).
In the cytoplasm, DREAM associates with carboxy-terminal fragment (CTF) of
presenilin-1 (PS1) and presenilin-2 and stimulates the activity of γ- secretase complex in
a calcium-dependent manner and eventually overproduces Aβ42 peptide, a peptide
which has been linked to Alzheimer’s disease (Buxbaum, Choi et al. 1998, Jo, Jang
et al. 2005). The DREAM protein also interacts with the T1 domain of potassium
channels and plays a prominent role in the regulation of fast ITO and ISA current in
the heart and brain, respectively. The aforementioned interaction also facilitates the
translocation of the channel to the membrane and alters the gating properties of the
channel (An, Bowlby et al. 2000). Recently, Rashid et al. postulated that DREAM
protein could be involved in the mechanism of nicotine treatment-prevented learning
and memory impairment in REM sleep-deprived rats by altering its expression level
in the hippocampus (Abd Rashid, Hapidin et al. 2017). It was also demonstrated that
Ca2+-bound DREAM interacts with CaM and DREAM:CaM complex formation
abolishes DREAM interaction DRE sites and promotes activation of calcineurin
(Gonzalez, Arango et al. 2015, Ramachandran, Craig et al. 2012).
DREAM protein includes 256 amino acid residues. The structure of the first 77
residues of the DREAM has not been resolved yet because the poor solubility of the fulllength DREAM (residue 1-256) prevented structural determination of those residues by
NMR study (Lusin, Vanarotti et al. 2008). After deletion of the first 64 residues, the
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solution structure of Ca2+DREAM (residue 65-256) was resolved by Ames group (Lusin,
Vanarotti et al. 2008). The DREAM protein remains fully functional after deletion of Nterminal 64 residues as evidenced by the fact that DREAM (residue 65-256) interacts with
DNA, Kv.4 channel and the deletion does not impact Ca2+ induced oligomerization of the
protein (Lusin, Vanarotti et al. 2008). The three-dimensional NMR structure of Ca2+bound DREAM (residue 78-256) is shown in Figure 1.11. Like other NCS proteins, the
DREAM protein contains two domains, and each domain possesses two EF-hands. The
EF-1 (residue 90-119) and EF-2 (residue 128-157) coupled with a short N- terminus helix constitute the N–terminal domain, whereas the EF3 (residue 163-192) and EF4
(residue 211-240) and C-terminal helix that is not part of the EF-hand constitute the Cterminal domain (Lusin, Vanarotti et al. 2008). The four EF-hands of DREAM protein
differ in terms of metal binding property (Gifford, Walsh et al. 2007). The EF-hand 1 is

Figure1.11. Cartoon representation of Ca2+-bound DREAM(78-256) (PDB:
2jul). EF-hands 1, 2, 3, and 4 are shown in orange, red, green, and magenta,
respectively. Ca2+ ions are shown in cyan spheres. Rest of the protein is
shown in blue. For clariy, structure of first 77 residues were not resolved.
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not functional as the presence of sterically hindered amino acid residues in the EF-hand
loop (CPXG sequence) perturb metal-binding geometry. Because of the presence of Asp
in the 12th position of the EF-hand loop instead of glutamate, the EF-2 binds Mg2+
preferentially. It has been shown that Mg2+ binding to EF-2 stabilizes the tertiary structure
of DREAM and facilities DNA binding. The EF-hand 3 and EF-hand 4 bind Ca2+
preferentially with Kd of 1–10 µM (Gifford, Walsh et al. 2007, Lusin, Vanarotti et al.
2008, Osawa, Dace et al. 2005, Osawa, Tong et al. 2001). Research from our lab
demonstrated that EF-3 and EF-4 in DREAM bind non-physiological metal Tb3+ with
higher affinity than Ca2+ (Gonzalez, Ramos et al. 2016).
The N- and C-terminal domain is connected through a central hydrophobic patch formed
by the residues of α4 (Y130, F133, and A137), α6 (W169, L173), and α7 (I190, and M197)
(Figure 1.12). Furthermore, hydrophobic residues of EF-3 (L167, A170, M191, and L194),

Figure 1.12. The central hydrophobic patch of the DREAM that
communicate between N- and C- teriminal domain is shown in stick
(PDB: 2jul). EF-hands 1, 2, 3, and 4 are shown in diffuse firebrick, slate,
lime green, and cyan, respectively. Rest of the protein is shown in
orange. Ca2+ ions are shown in magenta spheres.
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EF-4 (F218, and M222), and α10 (M246, M249, F252, and I256) constitute another
hydrophobic patch at the C-terminal domain (Figure 1.13). The aforementioned
hydrophobic patches play a prominent role in DREAM interaction with KV4.3 channels
and hydrophobic molecules, including arachidonic acid and NS5806 (Gonzalez,
Miksovska 2014, Gonzalez, Pham et al. 2014).
In the absence of any metal, DREAM exists as a tetramer, but Ca2+ binding
triggers conformation changes in the protein that dissociates the tetramer into two dimers
if the concentration of protein is above 150 µM. When the concentration of protein is above
250 µM DREAM is tetramer in both metal-free forms and Ca2+ bound form (Osawa, Dace
et al. 2005). However, to the best of my knowledge, the molecular mechanism of DREAM
oligomerization has not been conclusively established yet. Lusin et al. proposed a model
dimer structure in which N-terminus leucine residue region (Leu 155, Leu 158, Leu 159)

Figure 1.13. The C-terminal hydrophobic patch of DREAM is shown
in stick (PDB: 2jul). EF-hands 1, 2, 3, and 4 are shown in diffuse
firebrick, slate, lime green, and cyan, respectively. Rest of the protein
is shown in orange. Ca2+ ions are shown in magenta spheres.
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of one monomer interacts with C-terminus Leu 251 of the second monomer in a head-totail fashion (Lusin, Vanarotti et al. 2008) (Figure 1.14: left panel). Docking study of our
group has demonstrated that in addition to hydrophobic interaction, dimer could be
stabilized through a salt bridge formation between positively charged amino acid residues
(Arg 200 and Arg 207) of one monomer and negatively charged amino acid residue (Glu
103) of another monomer (Figure 1.14: right panel). The study of Lusin et al. also revealed
a cluster of basic amino acid residues (Lys87, Lys90, Lys91, Arg98, Lys101, Arg160, and
Lys166) at the N-terminus of DREAM (Figure 1.15). They proposed that these amino acid
residues could be the potential DNA binding sites. The fact that many of that residue
(Lys87, Lys90, Lys91, Lys101) are not conserved in the NCS proteins that do not bind
DNA support their hypothesis. In the model dimer structure, the cluster of basic amino acid

Figure 1.14. Model structure of DREAM dimer based on the NMR structure of
DREM monomer (PDB entry 2JUL). Left panel shows hydrophobic interactions
between Leu 155, 159 and 251 and right panel show a salt bridge between Arg
200, Arg 207 (in blue) and Glu 103 (in red). The two dimers were docked
using Autodock and the initial structure of the dimer was refined in 50 ns
molecular dynamic simulation.
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residues is sterically blocked, which might explain why Ca2+ binding abolishes DREAM
interaction with DNA (Lusin, Vanarotti et al. 2008).

Figure 1.15. Cartoon representation of the N-terminus of
DREAM (PDB: 2jul). Cluster of basic amino acid residues
that are proposed to interact with DNA is shown as stick.
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1.11 Objectives
Objective 1:
Lead exposure has been associated with neurological and psychological
disorders. Especially, children and seniors are vulnerable to Pb2+ exposure because Pb2+
exposure has been implicated with cognitive deficiencies and learning difficulties. It has
been shown that Pb2+ displaces physiologically relevant ligands, such as Ca2+, Mg2+, and
Zn2+, from binding sites, which is believed to be one of the possible mechanisms of Pb2+
toxicity. Especially, Ca2+ binding proteins are molecular targets of Pb2+-induced toxicity.
Lead has been shown to displace Ca2+ from the EF-hand of ubiquitous calcium-binding
protein CaM. Displacement of physiological ligand Ca2+ by Pb2+ was suggested to interfere
with CaM interactions with downstream partners, and each interference represents a
potential mechanism of Pb2+ induced toxicity. However, the exact mechanism through
which Pb2+ induces toxicity has not been demystified yet. Statistical analysis of Pb2+- and
Ca2+- bound protein has revealed that Pb2+ and Ca2+ are coordinated by analogous binding
ligands (Asp, Glu) and Pb2+ binding does not distort the geometry of the EF-hand. Pb2+
exposure has been shown to impact the hippocampus region, the part of the brain that
regulates memory and learning processes. On the basis of the fact that DREAM protein
possesses a cluster of negatively charged amino and residues in the EF-hand regions,
DREAM protein contains four EF-hands analogous to CaM, and DREAM protein is
expressed in the hippocampus, we postulated that DREAM protein is a molecular target of
Pb2+. Using spectroscopic techniques (fluorescence, CD), we investigate whether Pb2+
addition induces the secondary and tertiary structural rearrangement of the DREAM and
alters DREAM interactions with binding partners. We determine the affinity of Pb2+ for
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DREAM using isothermal titration calorimetry and fluorescence titration. Our results
provided conclusive evidence of Pb2+ binding to DREAM. Because the DREAM protein
shares high sequence homology with NCS proteins, other NCS proteins could bind Pb2+
with high affinity and explain the causes of Pb2+-induced toxicity.
Objective 2:
Cadmium exposure has been implicated with different types of cancers,
neurodegenerative diseases. Children, pregnant women, and seniors are more susceptible
to Cd2+ intoxication. It has been proposed that Cd2+ induces toxicity through interfering
with Ca2+-and Zn2+-dependent processes, generating reactive oxygen species, inducing
apoptosis, to name a few. But the exact mechanism of Cd2+-induced toxicity remains an
active area of research. Previously, it has been shown that Cd2+ is capable of displacing
Ca2+ from the EF-hand of CaM and troponin C and Zn2+ from protein kinase C. Because
Cd2+ binds to EF-hands of CaM and troponin C and DREAM is an EF-hand protein, we
hypothesize that Cd2+ could bind to EF-hand of DREAM and displace the Ca2+. Utilizing
spectroscopic techniques and analyzing data of four different DREAM mutants, we
investigate whether Cd2+ is capable of displacing Ca2+ from the EF-hand, whether Cd2+
binding triggers structural rearrangement in the DREAM, and whether Cd2+ association
impacts DREAM interaction with intracellular partners. We employ ITC and fluorescence
titration for determining the affinity constant of Cd2+ for DREAM. Our results provide
evidence of Cd2+ binding to DREAM for the first time, which could provide insight into
Cd2+-induced toxicity. Our study could form the basis of NMR and X-ray crystallography
on Cd2+-bound NCS proteins to provide atomic-level insight into the mechanism of Cd2+
interactions with NCS proteins.

30

Objective 3:
Lithium has been used extensively for the treatment of psychological disorders
for more than six decades. Increasing evidence from in vivo and in vitro studies in humans
and rodents have implicated that Li+ is a drug candidate for the treatment of
neurogenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and
Huntington’s disease. Despite having numerous clinical applications for treating
devastating diseases, the exact mechanism through which Li+ exerts its therapeutic action
has not been resolved yet. Several mechanisms have been proposed. Among them,
inhibitions of inositol monophosphatase (IMPase) is considered the most relevant
mechanisms of action. Lithium treatment has been shown to inhibit IMPase by displacing
native cofactor Mg2+. Lithium has been shown to associates with EF-hand protein neuronal
calcium sensor-1 and alters its interaction with interacting partners. Lithium administration
has been shown to alter the expression of voltage-gated potassium channel 4.2 (Kv4.2) and
potassium channel-interacting protein (KChIP-1). Since Li+ binds to NCS-1 protein, which
is homologous to DREAM, and impact the expression of KChIP-1, we investigate whether
Li+ directly binds to DREAM. Molecular dynamics simulation from our collaborator has
identified potential Li+ binding sites on DREAM. Using fluorescence spectroscopy and
circular dichroism, we investigate whether Li+ addition triggers structural rearrangement
of DREAM, whether Li+ addition impact DREAM interactions with binding partners. Our
results provided the binding of monovalent ion to DREAM protein for the first time.
Results from the study suggest that DREAM and probably other NCS proteins are the
molecular targets of Li+.
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Objective 4:
The aMD data indicate the presence of a salt bridge between Lys87 and Asp 165 of
DREAM that couples the loop between helix-1 and helix-2 in the N- terminal domain with
the EF-3 in the C- terminal domain. We postulate that the salt bridge could be involved in
the propagation of calcium-triggered structural changes between the C- terminal and Nterminal domain. To determine the role of Lys87 to the interdomain communication Lys87
was mutated to Ala and the consequence of the mutation on DREAM secondary and tertiary
structures and DREAM interactions with interacting partners were probed.
Objective 5:
The Ca2+ binding protein DREAM binds Ca2+ at EF-3 and EF-4. We and other researchers
demonstrated that Ca2+ binding causes secondary and tertiary structural rearrangements of
the protein and consequently alters DREAM interaction with intracellular partners. But
exact mechanism of Ca2+-triggered structural rearrangements of DREAM and modulation
of interactions with binding partners remains unknown. In the present study, we mutated
glutamate residue at 12th position of EF-3 (DREAM(E186Q)) and EF-4 (DREAM(E234Q))
to glutamine for making these EF-hands Ca2+ insensitive and investigated whether
mutations impact Ca2+-induced secondary and tertiary structural rearrangements of the
protein and whether mutations impact Ca2+-induced modulation of DREAM interaction
with T-1 domain of Kv channel.
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2. MATERIALS AND METHODS
2.1 Methods used in chapter 3
2.1.1 General
The Pb(CH3COO)2.3H2O was purchased from Fisher Scientific. The Pb2+ stock
was prepared in 20 mM Tris pH 7.4 (prepared in decalcified ultrapure 18 MΩ water). The
hydrophobic fluorescent probe 1,8-ANS was purchased from Invitrogen and was used
without further purification. Peptides with sequences corresponding to the sequence of the
site-1

(FITC-AAGVAAWLPFARAAAIGWMPV)

and

site-2

((FITC-

LLGSTEKEFFFNEDTKEYFFD) of human KV4.3 were purchased from Think Peptides
and received at higher than 98% purity. The synthetic peptide derived for helix-9 of
presenilin-1 “PS1HL9” (residues 445FYFATDYLVQPFMDQLAFHQFYI467) of human
PS1-CTF with FITC covalently attached to the amino-terminus was purchased from
ProImmune (Sarasota, FL, USA). All other chemicals were obtained from Sigma-Aldrich
and Fisher Scientific unless stated otherwise.
2.1.2 Isolation and purification of DREAM(64) and DREAM (160)
Recombinant mouse DREAM(64) (residues 65–256) and DREAM(160)
(residues 161–256) with the C-terminus His-tag were expressed in E. coli BL21 (DE3)
cells and purified according to previously published procedures with minor modifications
(Osawa, Tong et al. 2001). Briefly, plasmids encoding for the his-tagged mouse
DREAM(64) and his-tagged DREAM (160) were purchased from GeneCopoeia and
transformed in E. coli BL21(DE3) competent cells and grown in TB medium at 37°C in
the presence of 100 μg/mL ampicillin until reaching an optical density of 0.8 at 600 nm.
Protein expression was induced by adding 0.5 mM IPTG. The medium was placed back in
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the shaker at 250 rpm for an additional 12 hours at room temperature followed by the
harvesting of the cells by centrifugation for 20 minutes at 5000 rpm. The cell pellet was
resuspended in lysis buffer (100 mM Tris buffer pH 8.0, 0.5 M NaCl, 1 mM CaCl2, 5 mM
MgCl2, 5 mM imidazole, 1.0 % Triton-X100, 0.5 % Tween 20, and 10% glycerol),
supplemented with 20 μg/mL DNAse, and 200 μg/mL lysozyme and sonicated in an ice
bath for 30 cycles at 30% duty cycle. The cell lysate was centrifuged at 5000 rpm for 4
hours, and the supernatant was loaded to a Ni-NTA column equilibrated with buffer A (20
mM Tris pH 7.4, 300 mM NaCl, 0.5 mM CaCl2, and 5mM imidazole). The Ni-NTA column
loaded with DREAM was washed extensively with buffer A and an increasing
concentration of imidazole (5-40 mM). Protein was eluted in buffer A and 250 mM
imidazole. Selected fractions were loaded onto a DEAE-Sepharose anion exchange column
previously equilibrated with 20 mM Tris pH 7.4, washed with 20 mM Tris pH 7.4 and 50
mM NaCl, and then eluted with 20 mM Tris pH 7.4 and 200 mM NaCl. After anion
exchange, the protein was dialyzed twice against two liters of 20mM Tris pH 7.4 for 12
hours. The purified protein was stored in 20 mM Tris pH 7.4. The purity of all protein
constructs was assessed using SDS-PAGE. The proper secondary structure and tertiary
structure of all protein constructs were confirmed by using the known far-UV CD transition
of DREAM protein as well as changes in tryptophan fluorescence upon calcium binding
(Gonzalez, Arango et al. 2015, Osawa, Dace et al. 2005, Osawa, Tong et al. 2001).
2.1.3 Sample preparation
Protein samples were prepared from stock in 20 mM Tris pH 7.4. Protein
concentrations were measured by UV-VIS spectrophotometry using ε280nm = 19,000 M-1cm1

for DREAM (64) and ε280nm = 10,544 M-1cm-1 for DREAM (160). The concentrations
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of 1,8-ANS and KV4.3(2–22) “site-1”, KV4.3(70–90) “site-2” and helix-9 of presenilin-1
“PS1HL9” were measured by using ε350nm= 4999 M−1 cm−1 and ε493nm= 75000 M−1 cm−1,
respectively. Ca2+, Pb2+, EDTA, 1,8-ANS, KV4.3(2–22) “site-2”, KV4.3(70–90) “site-2”,
and helix-9 of presenilin-1 “PS1HL9” were added to the sample to obtain the desired
concentration.
2.1.4 Steady-state emission spectra
Steady-state emission spectra were measured at room temperature (20°C) in a 0.2
x 1-cm path length quartz cuvette with excitation along the 0.2-cm path using a custom
ChronosFDspectrofluorometer (ISS, Champaign IL). For the Trp emission measurement,
samples were excited at 295 nm, whereas for 1,8-ANS emission measurement, samples
were excited at 350 nm. To determine the equilibrium dissociation constant for Pb2+
binding to apoDREAM, small aliquots of Pb2+ stock solution (500 μM Pb(CH3COO)2
dissolved in 20 mM Tris pH 7.4) was added to 20 µM DREAM(64) in the presence of
100 µM Ca2+, 20 mM Tris buffer pH 7.4. The fraction of Pb2+-bound protein (fb) was
determined from the decrease in Trp emission intensity at 329 nm using Equation 1.
fb =

(Fi - F0)
(Fmax - F0)

…………………………………………... (1)

Where Fi is the fluorescence intensity in different concentrations of Pb2+; Fo is the
fluorescence intensity in the absence of Pb2+, but in the presence of 100 μM Ca2+; and Fmax
is the saturation fluorescence intensity due to Pb2+ addition. The equilibrium dissociation
constants (Kd) were determined using single site binding model (Equation 2).
fb =

(Kd + [nPt ] + [Lt ]) -√(Kd + [nPt ] + [Lt ])2 - 4[nPt ][Lt ]
[n𝑃𝑡 ]

………………...(2)
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where Pt is total protein concentration, Lt is the total ligand concentration, and n is the
number of binding sites. For direct titration data such as 1,8-ANS binding to Pb2+DREAM(64) and peptide binding to Pb2+-DREAM(64), Kd in Equation 2 corresponds
to the equilibrium dissociation constant. In the case of displacement studies, Kd represents
Kapp for Pb2+ binding to Ca2+-DREAM(64. The reported Kapp or Kd value represents the
mean and standard deviation from three independent measurements. Based on the apparent
dissociation constant for Pb2+ binding to Ca2+ bound DREAM, the dissociation constant
(Kd) for Pb2+ binding to Ca2+ free DREAM was calculated using Equation 3 (Kirberger,
Wong et al. 2013).
Kd =

KappKdCa2+
(KdCa2+ + [Ca2+]T)

……………………………………..’. (3)

where Kd is the dissociation constant of Pb2+ binding to apoDREAM, Kapp is the apparent
dissociation constant of Pb2+

binding to Ca2+DREAM, KdCa2+ is the equilibrium

dissociation constant for Ca2+, which was reported previously to be 1 μM (Osawa, Dace et
al. 2005); [Ca2+]T is the total concentration of Ca2+, which is 100 µM.
To determine the affinity for 1,8-ANS binding to Pb2+-bound DREAM(64), 10 µM 1,8ANS was prepared in 20 mM Tris in the presence of 40 µM Pb2+. Stocks of DREAM(64)
were prepared with 40 µM Pb2+ and 10 µM 1,8-ANS. Aliquots of DREAM(64) stock
were added to 10 µM 1,8-ANS and the emission spectra were recorded. The increase in
emission intensity at the emission maximum of 466 nm was used to calculate the fraction
of 1,8-ANS bound to protein by Equation 1, and data were fitted to Equation 2 to determine
the dissociation constant for 1,8-ANS.
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2.1.5 Circular dichroism
Circular dichroism measurements were carried out using a J-810 Jasco CD
spectrometer at room temperature (20°C). For far-UV CD, 20 µM DREAM(64) in 20 mM
Tris pH 7.4 and 1 mM EDTA, 1 mM Ca2+, or 40 µM Pb2+ was placed in a quartz cuvette (1
mm x 10 mm) and data were collected through 1 mm path from 200 to 250 nm. Amount of
secondary structure content was obtained using secondary structure prediction tool K2D3
program. For near UV CD, 40 µM DREAM(64) in 5 mM phosphate pH 7.4 in the presence
of 1 mM EDTA, 1mM Ca2+, or 40 µM Pb2+ was placed in a quartz cuvette (1 mm x 10
mm) and data were recorded through 1 cm path from 250 nm to 330 nm. The baseline was
subtracted from each spectrum.
2.1.6 Fluorescence lifetime measurements
Frequency-domain fluorescence lifetime measurements were performed at room
temperature (20°C) using a ChronosFDspectrofluorometer (ISS, Champaign IL). 1,8ANS:DREAM complex was excited with the output 300 nm laser diode through 305 nm
bandpass filter and emission were collected through 400 nm long pass and 600 nm shortpass filter. For Trp lifetime measurements, samples were excited using an output of 280
nm laser diode and emission was collected through 320 nm long-pass filter. 1,4-bis(5phenyloxazol-2-yl)benzene (POPOP) in ethanol was used as a reference in lifetime
measurements(τ = 1.35 ns). For 1,8-ANS:DREAM complexes lifetime measurements,
modulation-phase data were analyzed using three discrete exponential decay component,
whereas for Trp lifetime measurements, data were fitted by using a sum of a Gaussian
distribution model and a single exponential decay model in Global software. For Trp

37

lifetime data, discrete lifetime τ2 was used as a linked variable in the Global Analysis. The
2 parameter and residuals were used as a criterion for the goodness of the fit.
2.1.7 ITC measurements
Isothermal calorimetry titrations were used to determine the thermodynamics of
displacement of Ca2+ from DREAM(64) by Pb2+. Titrations were carried out using a VPITC isothermal calorimeter (Microcal Inc. Northampton, MA). Protein solutions were
prepared in (5 mM Tris pH 7.4, 100 μM CaCl2) buffer and dialyzed overnight three times
in the same buffer. Pb2+ stock solutions were prepared in an ITC dialysate buffer. The
reaction cell was loaded with ~20 µM protein solution in 5 mM Tris pH 7.4, 100 μM CaCl2
buffer, and the protein concentration was determined spectrophotometrically prior to the
ITC experiment. The concentration of Pb2+ in the syringe was 400 µM; 30 aliquots (6 µL
each) of 400 µM Pb2+ stock were titrated into 20µM DREAM(64). The ITC experiments
were conducted three times at 25 ˚C. Thermodynamic parameters were obtained by fitting
the isotherms with the sequential model (2 sets of sites) using the Microcal ITC analysis
plug-in Origin 7.0. Overall apparent dissociation constant was obtained from individual
association constants using Equation 4 (Aravind, Chandra et al. 2008).
Kapp =

1
√K1K2

……………………………………….(4)

Where Kapp represents the overall apparent dissociation constant for Pb2+ binding to
Ca2+DREAM(64), whereas K1 and K2 represent apparent association constants of Pb2+
binding to Ca2+DREAM(64).

38

2.1.8 Steady-state polarization measurements
The

steady-state

polarization

measurements

were

carried

out

in

a

ChronosFDspectrofluorometer (ISS, Champaign IL). To investigate the interaction between
DREAM(64) and FITC-labeled PS1HL9, FITC-labeled site-1, and FITC-labeled site-2,
the samples were excited at 493 nm, and the emitted light was collected through a 500 nm
long-pass filter. Binding of site-1, site-2, and PS1HL9 to Pb2+-bound DREAM(64) were
probed by an increase in anisotropy. The fraction of site-1, site-2, and PS1HL9 bound to
Pb2+-bound DREAM(64) were calculated using Equation 1. Dissociation constants
between the titration of Pb2+DREAM(64) and site-1, site-2, and PS1HL9 were determined
by using a single-site binding model, Equation 2. All experiments were repeated three
times; average Kd values determined from 3 independent measurements are reported in
Table 4, and the standard deviations are shown as errors.
2.2 Methods used in chapter 4
2.2.1 General
CdCl2 and 1-anilinonaphthalene- 8-sulfonic acid (1,8-ANS) were purchased
from Sigma-Aldrich and Invitrogen, respectively, and used without further
purification. CdCl2 and 1,8-ANS stocks were prepared in 20 mM Tris pH 7.4 using
decalcified water. The synthetic peptide corresponding to the helix-9 of presenilin1 (PS1HL9), residues 445FYFATDYLVQPFMDQLAFHQFYI467 of the human
presenilin-1 C-terminal fragment with FITC covalently attached to the aminoterminus was purchased from ProImmune (Sarasota, FL, USA). A FITC labeled
peptides

corresponding

AAGVAAWLPFARAAAIGWMPV)

to

residues
and
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residues

2-22
70-90

(FITC(FITC-

LLGSTEKEFFFNEDTKEYFFD) of human Kv4.3 and labeled site 1 and site 2,
respectively, were obtained from Think Peptides and received at more than 98%
purity. Unless noted otherwise, all other chemicals were purchased from SigmaAldrich or Fisher Scientific.
2.2.2 Isolation and purification of DREAM constructs
Expressions and purifications of recombinant mouse WTDREAM(64)
(residue 65–256), WTDREAM(160) (residue 161–256), DREAM(E186Q)
(residue 65–256 with mutation at position 12 in the loop of EF3), and
DREAM(E234Q) (residue 65–256 with mutation at position 12 in the loop of EF4)
constructs were carried out following published protocols (Osawa, Tong et al. 2001,
Gonzalez, Pham et al. 2014). The purified protein stock solutions were stored in 20
mM Tris pH 7.4. SDS-PAGE was employed for assessing the purity of all DREAM
constructs.
2.2.3 Sample preparation
Protein samples were prepared diluting concentrated protein stock in 20
mM Tris pH 7.4 and final protein concentrations were determined using ε280nm =
19,000 M-1cm-1for WTDREAM (64), DREAM(E186Q) and DREAM(E234Q) and
using ε280nm = 10,544 M-1cm-1 for WTDREAM (160). The concentrations of 1,8ANS was determined using ε350nm = 4,999 M−1cm−1, whereas concentrations of site1, site-2, and PS1HL9 were determined using ε493nm = 75,000 M−1 cm−1.To prepare
ApoDREAM samples, protein stock was solubilized in 20 mM Tris pH 7.4. 2 mM
EDTA was added to prepare metal-free samples. Ca2+ or Cd2+DREAM samples were
prepared by adding 2 mM Ca2+ and 100 µM Cd2+, respectively. Cd2+Ca2+DREAM
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was prepared by adding 100 µM Cd2+ to DREAM in the presence of 2 mM Ca 2+.
For the titration measurements, concentrated stocks of site-1, site-2, and PS1HL9
were diluted in 20 mM Tris pH 7.4 to have the final concentration of 0.5 µM.
2.2.4 Steady-state emission spectra
Steady-state emission spectra were recorded at room temperature (20°C)
using Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies).
Tryptophan emission spectra were measured using 295 nm excitation along the 0.2
cm path of a 0.2 x 1.0 cm path length quartz cuvette, 1,8-ANS emission spectra were
measured using 350 nm excitation light along the 0.2 cm path of a 0.2 x 1.0 cm path
length quartz cuvette. The emission spectra were normalized to 1 at the maximum
emission wavelength for the apoprotein in Fig. 2 and for Ca2+DREAM:1,8-ANS
complex in Figure 4. The equilibrium dissociation constant for 1,8-ANS association
to Cd2+-bound DREAM was obtained by titrating Cd2+-bound WTDREAM(64)
into 10 µM 1,8-ANS. The increase in emission intensity at an emission maximum
of 468 nm was recorded and data were fitted to the single-site binding model
according to Equation 1.
F =

(Kd + [nPt ] + [Lt ])-√(Kd + [nPt ] + [Lt ])2 - 4[nPt ][Lt ]
[nPt ]

……………………………………......... (1)

where F is the change in fluorescence intensity, Kd is the equilibrium dissociation
constant, n is the number of binding sites, Pt is the total concentration of the protein,
and Lt is the total concentration of the ligand. Three independent measurements
were carried out to determine the average value of F.
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2.2.5 Circular dichroism
Far-UV circular dichroism measurements were conducted at room
temperature (20°C) using a J-810 Jasco CD spectrometer through the 2 mm path of
a (2 mm x 10 mm) quartz cuvette. Data were collected from 200 to 250 nm.
Secondary structure prediction tool K2D3 was used for calculating the percentage
of secondary structure content of DREAM constructs (Louis‐Jeune, Andrade‐Navarro
et al. 2012).
2.2.6 Fluorescence lifetime measurements
Frequency-domain fluorescence lifetime measurements were carried out at
20°C using a ChronosFD Spectrofluorometer (ISS, Champaign IL). The fluorescence
lifetime of 1,8-ANS–WTDREAM(64) complexes were determined using the 305
nm laser diode output as excitation light and emission was recorded using the
combination of a 400 nm long-pass filter and a 600 nm short-pass filter (Andover
Corp., Salem, NH). To measure Trp lifetimes, samples were excited with 280 nm
laser diode output and emission was recorded using a 320 nm long-pass filter. 1,4bis(5-phenyloxazol-2-yl)benzene (POPOP) in ethanol was used as a reference for
lifetime measurements (τ = 1.35 ns). The lifetime modulation-phase data were
analyzed using Vinci analysis software. The goodness of the fit was determined
based on 2 values and residuals.
2.2.7 Thermodynamics of Cd2+ displacement of Ca2+ from EF-hand of DREAM
Thermodynamic parameters for Cd2+ association to DREAM were
determined using a VP-ITC isothermal calorimeter (Microcal Inc. Northampton,
MA). DREAM protein stock in 20 mM Tris was diluted to prepare 10 µM DREAM
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protein solution in 5 mM Tris pH 7.4, 100 mM NaCl and 100 μM CaCl2 and dialyzed
overnight three times against the buffer described above. After dialysis, the
concentration of protein solution was determined and the protein solution was
loaded in the reaction cell. 1 mM Cd2+ stock solution prepared in the dialysate buffer
was used as the titrant. ITC experiments were performed three times at 25 ˚C by
adding 30 aliquots (6 µL each) of 1 mM Cd2+ stock into 10 µM WTDREAM(64)
and 10 µM WTDREAM(160). Data were fitted with the sequential model (2 sets
of sites) using the Microcal ITC analysis plug-in Origin 7.0 The overall apparent
dissociation constant (Kapp) for Cd2+ binding to Ca2+DREAM was calculated based
on individual association constants according to Equation 2 (Aravind, Chandra et al.
2008).
Kapp =

1
√K1K2

…………………………………………………………………….. (2)

where K1 and K2 are apparent association constants for Cd2+ binding to
Ca2+DREAM.
The overall equilibrium dissociation constant (Kd) for Cd2+ binding to apoDREAM
was calculated from the overall apparent dissociation constant using Equation 3
(Kirberger, Wong et al. 2013).
Kd =

KappKdCa2+
(KdCa2+ + [Ca2+]T)

………………………………………………………………. (3)

where KdCa2+ represents the equilibrium dissociation constant for Ca2+ binding to
apoDREAM, which was previously reported to be 1 μM (Osawa, Dace et al. 2005);
[Ca2+]T is the total concentration of Ca2+, which is 100 µM.
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2.2.8 Steady-state anisotropy measurements
The steady-state anisotropy measurements were conducted at room
temperature (20°C) using a ChronosFD spectrofluorometer (ISS, Champaign IL). To
investigate whether FITC-tagged PS1HL9, FITC-tagged site-1, or FITC-tagged site2 binds to Cd2+-bound DREAM, Cd2+-bound DREAM constructs were titrated into
0.5 µM PS1HL9, 0.5 µM site-1, or 0.5 µM site-2 peptides. Samples were excited at
470 nm and emitted light was recorded through a 500 nm long-pass filter (Andover
Corp., Salem, NH). Three independent measurements were carried out and average
values of anisotropy change were plotted as a function of Cd 2+DREAM
concentration and analyzed using Equation 1.
2.3 Methods used in chapter 5
2.3.1 General
The LiCl was purchased from Sigma-Aldrich and used as received. 100 mM LiCl
stock was prepared by dissolving LiCl in 20 mM Tris buffer pH 7.4. To eliminate residual
Ca2+, 20 mM Tris buffer was prepared in decalcified ultrapure 18 MΩ deionized water.
Peptides with a sequence corresponding to the site-1 and site-2 binding sites from T1
domain of Kv channel with a FITC fluorescence probe attached to the N- terminus (FITCsite-1 of human KV4.3) (FITC-AAGVAAWLPFARAAAIGWMPV) and (FITC-site-2 of
human KV4.3) (FITC-LLGSTEKEFFFNEDTKEYFFD) were purchased from Think
Peptides and received at higher than 98 % purity. The synthetic peptide derived for helix9 of presenilin-1 (FITC-445FYFATDYLVQPFMDQLAFHQFYI467) of human PS1-CTF
was purchased from ProImmune (Sarasota, FL, USA). All other chemicals were purchased
from Sigma-Aldrich or Thermo Fisher unless stated otherwise. The concentration of
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peptides mimicking site-1, site-2, and helix-9 of presenilin-1 were measured by using
ε493nm= 75000 M−1 cm−1 (Crabtree, Shammas 2018).
2.3.2 Isolation and purification of DREAM constructs
In the present study, a truncated form of DREAM protein that carries residues 65256 (DREAM(64)) was used, as the full-length protein readily forms inclusion bodies.
Recombinant

mouse

DREAM(64),

DREAM(160),

DREAM(E168Q),

and

DREAM(E234Q) constructs were expressed in E. coli BL21 (DE3) cells and purified
according to published procedures(Osawa, Tong et al. 2001, Gonzalez, Pham et al. 2014).
Briefly, corresponding mouse DREAM plasmid was transfected in E. coli BL21(DE3)
competent cells and grown in Terrific Broth medium at 37°C in the presence of 100 μg/mL
ampicillin. Protein expression was induced by adding 0.5 mM IPTG. Cells were grown for
an additional 12 hours at room temperature and harvested by 20 min centrifugation at 5000
RPM and 4 oC. The cell pellet was resuspended in lysis buffer (100 mM Tris buffer pH
8.0, 0.5 M NaCl, 1 mM CaCl2, 5 mM MgCl2, 5 mM imidazole, 1.0 % Triton-X100, 0.5 %
Tween 20, and 10% glycerol, 20 μg/mL DNAse, and 200 μg/mL lysozyme) and sonicated
in an ice bath for 30 cycles at 30% duty cycle. The cell lysate was centrifuged at 5000 rpm
for 4 hours and the supernatant was loaded to a Ni-NTA column equilibrated with buffer
A (20 mM Tris pH 7.4, 300 mM NaCl, 0.5 mM CaCl2, and 5mM imidazole). The Ni-NTA
column was loaded with DREAM and then washed extensively with buffer A and
increasing concentration of imidazole (5-40 mM) and protein was eluted in buffer A and
250 mM imidazole. Selected fractions were loaded onto a DEAE-Sepharose anion
exchange column previously equilibrated with 20 mM Tris pH 7.4, washed with 20 mM
Tris pH 7.4 and 50 mM NaCl, and then eluted with 20 mM Tris, pH 7.4 and 200 mM NaCl.
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After anion exchange, the protein was dialyzed twice against two liters of 20 mM Tris pH
7.4 for 12 hours. The purified protein was stored in 20 mM Tris pH 7.4. The purity of all
protein constructs was assessed using SDS-PAGE. Protein concentration was determined
by UV-VIS spectrophotometry using ε280nm = 19,000 M-1cm-1 for DREAM (64) and ε280nm
= 10,544 M-1cm-1 for DREAM (160) (Pham, Dhulipala et al. 2015). Apoprotein samples
were prepared by dialyzing the isolated protein three times against 20 mM Tris buffer that
was prepared using decalcified water. The absence of Ca2+ bound DREAM in apoDREAM
samples was confirmed based on the emission spectra of apoDREAM in the
absence/presence of EDTA. Li+DREAM samples were prepared by adding 50 µM or 1
mM LiCl to 20 µM protein in 20 mM Tris pH 7.4, Mg2+DREAM samples were prepared
by the addition of 5 mM MgCl2 and 1 mM EGTA to 20 µM protein in 20 mM Tris pH 7.4,
and Ca2+ DREAM samples were prepared by adding 1 mM CaCl2 to 20 µM protein in 20
mM Tris pH 7.4.
2.3.3 Isolation and purification of rCaM
Rat calmodulin (rCaM) plasmid was a kind gift from J. P. Davis (The Ohio State
University, Columbus, OH). The plasmid was subcloned in BL21(DE3) cells and purified
using phenyl sepharose chromatography as previously described (George, Su et al. 1993).
2.3.4 Steady-state emission spectra measurements
Emission spectra for a single Trp residue in DREAM constructs were measured in
a 0.2 x 1-cm path length quartz cuvette with 295 nm excitation along the 0.2-cm path using
a custom ChronosFDspectrofluorometer (ISS, Champaign, IL). The concentration of
DREAM constructs was 20 µM. The equilibrium dissociation constant for Li+ binding to

46

apoDREAM was determined by adding small aliquots of Li+ stock solution to 20 µM
apoDREAM(64) in 20 mM Tris buffer pH 7.4.
The apparent equilibrium dissociation constant, Kd was obtained according to Eq.1.
ΔF=

(Kd + [nPt ] + [Lt ]) -√(Kd + [nPt ] + [Lt ])2 - 4[nPt ][Lt ]
n𝑃𝑡

…………………….. (1)

where Kd is the dissociation constant, Pt is total protein concentration, n is the number of
binding sites, Lt is the total ligand concentration. The experiment was repeated three times
and the average fluorescence intensity values were used to construct the titration curve.
2.3.4 Circular dichroism measurements
Far UV-CD spectra were recorded using a J-810 Jasco CD spectrometer. 20 µM
DREAM in 20 mM Tris buffer, pH 7.4 and 1 mM Ca2+ and/or 50 µM Li+, were placed in a
quartz cuvette (1 mm x 10 mm) and data were collected from 200 nm to 250 nm.
2.3.5 ITC measurements
Isothermal calorimetry titrations were used to determine the thermodynamics of Li+
binding to DREAM constructs. Titrations were carried out using a VP-ITC isothermal
calorimeter (Microcal Inc. Northampton, MA). Protein solutions were dialyzed against 5
mM Tris, pH 7.4, prepared in decalcified water for 12 hours. Water was decalcified using
Chelex-100 . The buffer was exchanged three times during the dialysis. 100 mM Li+ stock
solution was prepared by dissolving LiCl in an ITC dialyzate buffer. The reaction cell was
loaded with ~20 µM protein solution in 5 mM Tris, pH 7.4. The concentration of Li+ in the
syringe was 1000 µM; 30 aliquots (6 µL each) of Li+ stock solutions were titrated into 20
µM DREAM constructs at 25 ˚C. Three independent ITC experiments were conducted.
Thermodynamic parameters were obtained by fitting the isotherms with the sequential
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model (two sets of sites) using the Microcal ITC analysis plug-in Origin 7.0. Overall
dissociation constant was obtained from individual association constants by using Equation
2 (Aravind, Chandra et al. 2008).
Kd =

1
√K1K2

………………………… (2)

where Kd represents overall dissociation constant for Li+ binding to apoDREAM
constructs, whereas K1 and K2 represent association constants of Li+ binding to
apoDREAM constructs.
To determine whether Li+ binds to Ca2+DREAM, we titrated 30 aliquots (6 µL each)
of 100 mM Li+ into 20 µM DREAM(64) in the presence of 100 µM Ca2+ at 25 ˚C.
2.3.6 Molecular Dynamics
The protein structure of DREAM was taken from the Protein Data Bank (PDB ID:
2JUL) (Lusin, Vanarotti et al. 2008). We considered residues 76 to 256 of the DREAM
monomer for the molecular simulations. The CHARMM-GUI web-server was used to set
up the system for molecular dynamics simulation (Jo, Kim et al. 2008). The Ca2+ ions
bound to the protein in the crystal structure were removed and lithium ions were placed
randomly in the solution. The system was solvated using TIP3 water molecules and
neutralized by counterions. All-atom molecular dynamics simulations were performed
using NAMD 2.12 with CHARMM36m force field at 300 K temperature (Phillips, Braun
et al. 2005). The system was minimized for 10,000 steps and equilibrated for 200 ps with
backbone and side chain restraints, followed by a 200-ns production run using 2 fs time
step. The SHAKE algorithm was used for constraining covalent bonds and particle mesh
Ewald method was employed for long-range electrostatic interactions. Langevin

48

temperature coupling with a friction coefficient of 1 ps was used to control the temperature.
Analysis of the trajectory as well as visualization of accessible surface area was done with
VMD (Humphrey, Dalke et al. 1996).
2.3.7 Fluorescence lifetime measurements
Frequency-domain

fluorescence

1,8-ANS

lifetime

measurements

were

performed using a ChronosFDspectrofluorometer (ISS, Champaign IL). Samples were
excited using an output of 300 nm laser diode and emission was collected through a
combination of 400 nm long-pass filter and 600 nm short-pass filter (Andover Corp.). 1,4bis(5-phenyloxazol-2-yl) benzene (POPOP) in ethanol was used as a reference in lifetime
measurements (τ = 1.35 ns). Experimental data were fitted by using a three exponential
decay model in Vinci software (ISS, Champaign IL). The 2 parameters and residuals were
used as a criterion for the goodness of the fit.
2.3.8 Steady-state polarization measurements
The

steady-state

polarization

measurements

were

carried

out

in

a

ChronosFDspectrofluorometer (ISS, Champaign IL). To investigate the interaction between
DREAM(64) and FITC-labeled peptides, samples were excited at 493 nm and the emitted
light was collected through a 500 nm long pass filter (Andover Corp). For anisotropy
measurements, 20 µM DREAM was added to 0.5 µM FITC labeled peptides in the
absence/presence of 1 mM Li+ or 1 mM Ca2+. The presented anisotropy values represent
the average values of 3 independent measurements.
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2.4 Methods used in chapter 6
2.4.1 General
Barium chloride, strontium chloride, arsenic pentoxide, and mercuric oxide were
purchased from Sigma-Aldrich. Manganese chloride tetrahydrate was purchased from
Fisher Scientific. 1,8-ANS was purchased from Invitrogen.
2.4.2 Isolation and purification of DREAM
Recombinant mouse DREAM(64) was expressed and purified following
published protocols (Osawa, Tong et al. 2001, Gonzalez, Pham et al. 2014). SDSPAGE gel electrophoresis was used for evaluating the purity of the protein.
2.4.3 Sample preparation
Concentrated DREAM(64) protein stock was diluted into 20 mM Tris pH
7.4 to get 20 µM DREAM(64). Protein concentration was determined using ε280nm
= 19,000 M-1cm-1. 1,8-ANS concentration was determined using ε350nm = 4,999
M−1cm−1. 1 mM of Ba2+, Sr2+, As5+, Hg2+, or Mn2+ was added to DREAM(64) or
DREAM(64):1,8-ANS complex both in the absence and presence of 1 mM Ca2+ to
investigate impact of these metals addition on Trp emission and 1,8-ANS emission
spectrum.
2.4.4 Steady-state emission spectra
Steady-state emission experiment was conducted at room temperature
(20°C) employing Cary Eclipse Fluorescence Spectrophotometer (Agilent
Technologies). Samples were excited with 295 nm excitation light through the 0.2
cm path of a 0.2 x 1.0 cm path length quartz cuvette to obtain tryptophan emission
spectra.1,8-ANS emission spectra were obtained by exciting the samples with 350
50

nm excitation light through the 0.2 cm path of a 0.2 x 1.0 cm path length quartz
cuvette.
2.5 Methods used in chapter 7
2.5.1 Isolation and purification of DREAM(K87A)
Expressions and purifications of recombinant mouse DREAM(K87A)
were executed following published protocols (Osawa, Tong et al. 2001, Gonzalez,
Pham et al. 2014). Concentrated protein stock solutions were stored in 20 mM Tris
pH 7.4. The purity of the protein was assayed by SDS-PAGE gel electrophoresis.
2.5.2 Sample preparation
Protein samples were prepared by diluting concentrated stock in 20 mM Tris
pH 7.4 and final protein concentrations were determined using ε280nm = 19,000 M1

cm-1. The concentrations of 1,8-ANS was determined using ε350nm = 4,999 M−1cm−1,

whereas concentrations of site-1, site-2, and PS1HL9 were determined using ε493nm
= 75,000 M−1 cm−1. For Trp emission, 1,8-ANS study, CD study, and lifetime
studies, the concentration of DREAM(K87A) was 20 µM. apoDREAM(K87A) was
prepared by adding 1 mM EDTA to protein solution. Ca2+DREAM(K87A) samples
were prepared by adding 1 mM Ca2+ to protein solution in the absence of EDTA or
EGTA. Mg2+DREAM(K87A) was prepared by adding 5 mM Mg 2+ to protein
solutions in the presence of 1 mM EGTA. Ca2+Mg2+DREAM(K87A) was prepared
by adding 5 mM Mg2+ to DREAM(K87A) in the presence of 1 mM Ca2+. For the
titration measurements, concentrated stocks of site-1, site-2, and PS1HL9 were
diluted in 20 mM Tris pH 7.4 to get the final concentration of 0.5 µM.
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2.5.3 Steady-state emission spectra
Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies) was
employed at room temperature (20°C) to record steady-state emission spectra. For
tryptophan emission, samples were excited with 295 nm excitation light along the
0.2 cm path of a 0.2 x 1.0 cm path length quartz cuvette. For 1,8-ANS emission,
samples were excited through 350 nm excitation light along the 0.2 cm path of a 0.2
x 1.0 cm path length quartz cuvette.
2.5.4 Circular dichroism
A J-810 Jasco CD spectrometer was employed at room temperature (20°C)
to measure far-UV circular dichroism measurements through the 2 mm path of a (2
mm x 10 mm) quartz cuvette. Data were recorded from 200 to 250 nm. The
percentage of secondary structure content was obtained using secondary structure
prediction tool K2D3 (Louis‐Jeune, Andrade‐Navarro et al. 2012).
2.5.5 Fluorescence lifetime measurements
Frequency-domain fluorescence lifetime measurements were conducted at
room temperature (20°C) utilizing a ChronosFD Spectrofluorometer (ISS,
Champaign IL). The fluorescence lifetime of 1,8-ANS–DREAM(K87A) complexes
were measured by exciting the samples through 305 nm laser diode output and
emission was collected using a combination of a 400 nm long-pass filter and a 600
nm short-pass filter (Andover Corp., Salem, NH). For Trp lifetimes, 280 nm laser
diode output was used to excite the samples and emission was recorded using a 320
nm long pass filter. 1,4-bis(5-phenyloxazol-2-yl)benzene (POPOP) in ethanol was
the reference for lifetime measurements (τ = 1.35 ns). Vinci analysis software was
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employed to analyze the modulation-phase data. 2 values and residuals of the fit
was used to evaluate the goodness of the fit.
2.5.6 Steady-state anisotropy measurements
The steady-state anisotropy measurements were carried out at room
temperature (20°C) employing a ChronosFD spectrofluorometer (ISS, Champaign
IL). To investigate whether mutation of Lys87 to Ala impacts DREAM interactions
with binding partners, DREAM(K87A) samples were added to FITC-tagged peptide
helix 9 of presenilin-1 (PS1HL9) and FITC-tagged site-1 and site-2 of T-1 domain
of Kv4 channel. Samples were excited through 493 nm excitation light and emitted
light was collected through a 500 nm long-pass filter (Andover Corp., Salem, NH).
200 µM DREAM(K87A) in the presence of 1 mM Ca 2+ or 1 mM EDTA was added
to 0.5 µM PS1HL9. Corresponding wild-type DREAM (DREAM(64)) was also
added to the same peptide in the same day as a control experiment. Similarly, 100
µM and 200 µM of DREAM(K87A) were respectively added to 0.5 µM site 1 and
site 2 peptides of the T1 domain of Kv4 channel in the presence of Ca 2+ or EDTA.
DREAM(64) was added to both site 1 and site 2 peptides on the same day as a
control.
2.6 Methods used in chapter 8
2.6.1 Isolation and purification of DREAM constructs
Recombinant mouse DREAM(64), DREAM(160), DREAM(E186Q),
and DREAM(E234Q) were expressed and purified following published protocols
(Osawa, Tong et al. 2001, Gonzalez, Pham et al. 2014). SDS-PAGE gel
electrophoresis was employed for assessing the purity of the protein.
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2.6.2 Sample preparation
Concentrated protein stock was diluted into 20 mM Tris pH 7.4 to get the
desired

concentration.

For

DREAM(64),

DREAM(E186Q),

and

DREAM(E234Q), protein concentrations were determined using ε280nm = 19,000 M1

cm-1. For DREAM(160), protein concertation was determined using ε280nm =

10,544 M-1cm-1. 1,8-ANS concentration was determined using ε350nm = 4,999
M−1cm−1; site-1 and site-2 concentrations were determined using ε493nm = 75,000
M−1 cm−1. For Trp emission, 1,8-ANS emission, circular dichroism, and lifetime
studies, the concentration of each DREAM protein construct was 20 µM.
apoDREAM samples were prepared by adding 1 mM EDTA to protein solutions
that were stored in 20 mM Tris. Ca2+DREAM samples were prepared by adding 1
mM Ca2+ to protein solutions that were stored in 20 mM Tris. For the titration
measurements, 0.5 µM site-1, site-2, and PS1HL9 were prepared by diluting
concentrated stock into 20 mM Tris pH 7.4.
2.6.3 Steady-state emission spectra
Steady-state emission spectra were obtained at room temperature (20°C)
utilizing Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies).
Samples were excited through 295 nm excitation light through the 0.2 cm path of a
0.2 x 1.0 cm path length quartz cuvette to obtain tryptophan emission spectra.
Samples were excited with 350 nm excitation light through the 0.2 cm path of a 0.2
x 1.0 cm path length quartz cuvette to obtain 1,8-ANS emission spectra.
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2.6.4 Circular dichroism
Far-UV circular dichroism spectra were recorded employing a J-810 Jasco
CD spectrometer through the 2 mm path of a (2 mm x 10 mm) quartz cuvette. Data
were collected from 200 to 250 nm. Secondary structure prediction tool K2D3 was
used to determine the percentage of secondary structural content of the protein.
(Louis‐Jeune, Andrade‐Navarro et al. 2012).
2.6.5 Fluorescence lifetime measurements
Frequency-domain fluorescence lifetime measurements were recorded at
room temperature (20°C) employing a ChronosFD Spectrofluorometer (ISS,
Champaign IL). The fluorescence lifetime of 1,8-ANS–DREAM complexes were
measured by exciting the samples with 305 nm laser diode output and emission were
recorded using a combination of a 400 nm long-pass filter and a 600 nm short-pass
filter (Andover Corp., Salem, NH). A 280 nm laser diode output was used to excite
the samples and emission was recorded using a 320 nm long-pass filter for
determining the lifetime of tryptophan. The reference for lifetime measurements was
1,4-bis(5-phenyloxazol-2-yl)benzene (POPOP) in ethanol (τ = 1.35 ns). Vinci
analysis software was utilized to analyze the modulation-phase data. 2 values as
well as residuals of the fit was used to evaluate the goodness of the fit.
2.6.6 Steady-state anisotropy measurements
The steady-state anisotropy measurements were conducted at room
temperature (20°C) utilizing a ChronosFD spectrofluorometer (ISS, Champaign IL).
100 µM DREAM(E186Q) and 100 µM DREAM(E234Q) samples were added to
FITC-tagged site-1 and site-2 of the T-1 domain of Kv4 channel both in the presence
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and absence of Ca2+. Samples were excited with 493 nm excitation light and emitted
light was collected through a 500 nm long-pass filter (Andover Corp., Salem, NH).
Corresponding 100 µM wild-type DREAM (DREAM(64)) was also added to the
same peptide in the same day as a control experiment both in the presence and
absence of Ca2+.

56

3. LEAD BINDS TO DREAM AND MODULATES ITS INTERACTIONS WITH
BINDING PARTNERS: A LINK BETWEEN NEURONAL CALCIUM SENSORS
AND LEAD NEUROTOXICITY.
3.1 Background and significance
Pb2+ is an anthropogenic toxicant and has been viewed as a global health concern
(Deibler, Basu 2013). The chronic and acute exposure to Pb2+ cause neurophysiological
and psychological deficiencies through altering the development of the neuronal system or
through direct interactions with neuronal proteins (Mason, Harp et al. 2014). Especially
children are sensitive to Pb2+ exposure as Pb2+ intoxication leads to learning difficulties,
IQ drop and cognitive deficiencies (Canfield, Henderson Jr et al. 2003, Weisskopf, Hu et
al. 2004). Several metal-binding proteins have been identified as targets for Pb2+
neurotoxicity as Pb2+ displaces physiological ligands such as calcium and zinc; however,
the mechanism of Pb2+ induced toxicity remains obscure. It was reported that at
subnanomolar concentrations, Pb2+ activates protein kinase C (PKC), a family of proteins
that mediate central nervous system development and cell proliferation, by replacing a Ca2+
ion bound to the C2 domain (Markovac, Goldstein 1988, Long, Rosen et al. 1994, Morales,
Lasagna et al. 2011). Pb2+ was also shown to directly inhibit the constitutive kinase activity
of PKC through binding to a lower affinity site in the catalytic domain. Several studies
have demonstrated that Pb2+ interacts with calcium-binding protein calmodulin (CaM),
and modulate interactions between CaM and its downstream partners what may play a
considerable role in Pb2+-induced neurotoxicity (Gorkhali, Huang et al. 2016). For
example, Habermann et al.(Habermann, Crowell et al. 1983) reported that Pb2+ replaces
Ca2+ bound to EF-hands in CaM and Pb2+:CaM complex activates calcium-dependent
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phosphodiesterase and myosin light chain kinase. Pb2+ can also bind to sites other than EFhands, which may disrupt multiple downstream activities and therefore contribute to lead
neurotoxicity (Kern, Wisniewski et al. 2000, Goldstein, Ar 1983). Statistical analysis of
the structures of Pb2+-bound proteins available from the protein data bank (PDB) showed
that an oxygen atom from amino acids (mainly Glu and Asp) represents the prominent
binding ligand for Pb2+, followed by oxygen from water, sulfur, and nitrogen (Kirberger,
Yang 2008). The basic geometry of Ca2+-bound EF-hand was found to be conserved in
Pb2+-bound EF-hand, as both metals, Ca2+ and Pb2+, use the same binding ligands,
(Kirberger, Yang 2008) suggesting that Pb2+ could tightly bind to EF-hands of other
neuronal calcium-binding proteins (CaBPs). Indeed, the multitude of symptoms associated
with Pb2+ poisoning points towards multiple molecular targets in neuronal tissue.
Neuronal Calcium Sensor (NCS) is a subgroup of EF-hand superfamily, which
includes frequenin (NCS1), recoverin, GCAP, neurocalcin, and potassium channelinteracting protein 1–4 (Burgoyne 2007). NSC proteins are predominantly expressed in
brain and retina, where they regulate diverse intracellular processes, including vision
transduction, DNA expression, neurotransmission, neuron development, cognitive
functions, potassium voltage channel kinetics, etc. (Ames, Lim 2012, Burgoyne, Weiss
2001, Burgoyne 2007). Although NCS proteins have relatively low sequence homology
with CaM, NCS proteins comprise four EF-hands analogous to CaM. Similarly, NCS
proteins are sensitive to increased intracellular Ca2+ concentration and bind Ca2+ with ~ 10
times higher affinity than CaM (McCue, Haynes et al. 2010).
Downstream regulatory element antagonist modulator (DREAM), alternatively
known as calsenilin or potassium channel-interacting protein 3 (KChIP3), is a 29 kDa NCS
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protein, which is involved in numerous biological processes, such as gene apoptosis, pain
sensation, memory and learning processes, and modulation of Kv4 voltage channels
expression and kinetics (An, Bowlby et al. 2000, Buxbaum, Choi et al. 1998, Carrion, Link
et al. 1999). In the nucleus, it regulates the expression of prodynorphin and c-fos gene by
binding to the DRE (downstream regulatory element) sequence in a calcium-dependent
manner (Carrion, Link et al. 1999, Cheng, Pitcher et al. 2002). In the absence of Ca2+,
DREAM associates to the DRE promoter region and consequently inhibits gene
transcriptions. These genes have been found to be involved in cell homeostasis, apoptosis,
and pain modulation (Costigan, Woolf 2002, Fontán-Lozano, Romero-Granados et al.
2009). In the cytoplasm, DREAM interacts with the carboxy-terminal fragment (CTF) of
presenilin-1(PS1) and facilitate the production of the Aβ42 peptide, a peptide involved in
Alzheimer’s disease (Buxbaum, Choi et al. 1998). DREAM also binds to the T1 domain of
potassium channels and regulates their translocation to membrane and gating kinetics (An,
Bowlby et al. 2000). The role of DREAM in memory retention, learning, pain sensing, and
Alzheimer’s disease emphasizes the multifunctional nature of this protein (Buxbaum, Choi
et al. 1998, Costigan, Woolf 2002, Fontán-Lozano, Romero-Granados et al. 2009). In the
absence of interacting partners, DREAM does not possess an enzymatic activity, and thus
its ability to regulate diverse biological processes arises from interaction with different
binding partners.
The three-dimensional NMR structure of Ca2+-bound DREAM (residue 78-256)
is presented in Figure 3.1 (Lusin, Vanarotti et al. 2008). DREAM contains two domains,
and each of the domains is composed of two EF-hands (Figure 3.1). A short N- terminus
-helix together with EF1 (residue 90-119) and EF2 (residue 128-157) form an N–terminal
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domain, whereas EF3 (residue 163-192) and EF4 (residue 211-240) and a 13 residue long
C-terminal -helix form a C-terminal domain. Both domains are arranged in a tandem array
and form a flexible structure with the solvent-exposed hydrophobic groove (Lusin,
Vanarotti et al. 2008). The four EF-hands have the distinct metal binding property (Gifford,
Walsh et al. 2007). EF-hand 1 does not bind metal because sterically hindered amino acid
residues in the EF-hand loop (Cys 104 and Pro 105) prevent binding of metal; EF-2 binds
Mg2+ selectively due to the presence of Asp in the 12th position of the EF-loop instead of
usual glutamate; and EF-hand 3 and EF-hand 4 bind Ca2+ selectively (Gifford, Walsh et al.
2007, Lusin, Vanarotti et al. 2008, Osawa, Dace et al. 2005, Osawa, Tong et al. 2001). In
addition, we have recently shown that EF-hands in DREAM are capable of binding nonphysiological metal Tb3+ with higher affinity than Ca2+ (Gonzalez, Ramos et al. 2016).
DREAM protein is expressed in the hippocampus, the part of the brain involved
in learning and memory consolidation (Carrion, Link et al. 1999, Fontán-Lozano, RomeroGranados et al. 2009). The hippocampus region is strongly impacted by Pb2+ as the Pb2+
exposure alters the expression of 167 hippocampus genes in rats (Schneider, Anderson et
al. 2011) and chronic exposure to Pb2+ leads to cell death (Weisskopf, Hu et al. 2004, Chao,
Moss et al. 2007). Also, Pb2+ poisoning leads to a decrease in neuronal density in the
hippocampus (Weisskopf, Hu et al. 2004). Because DREAM is expressed in the
hippocampus and Pb2+ strongly binds to EF-hands in calmodulin, we hypothesize that
DREAM may represent a molecular target for Pb2+ poisoning. In this report, we implement
a combination of fluorescence and calorimetric techniques to show that Pb2+ binds at the
EF-hands in the C-terminal domain of DREAM. Then, we investigate whether Pb2+ binding
to DREAM modulates the interaction between DREAM and intracellular partners. We
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report that Pb2+ binds to two EF-hands in DREAM with equilibrium affinity constant
higher than that determined for Ca2+. Pb2+association triggers changes in the DREAM

Figure 3.1 Structure of Ca2+ bound DREAM (PDB entry
2JUL). The four EF-hands of DREAM are colored in orange
(EF-hand 1), green (EF-hand 2), blue (EF-hand 3), and red
(EF-hand 4). The helix-1 and helix-10 are shown in cyan. Ca2+
ions bound to EF-hand 3 and EF-hand 4 are shown as yellow
spheres.
secondary and tertiary structures that are analogous to the Ca2+ association, including
increased exposure of hydrophobic cavities on the DREAM surface. Such structural
reorganization results in increased affinity for small hydrophobic molecules such as 1,8ANS. Pb2+association also modulates interactions between DREAM and model peptides
that correspond to binding sites of intracellular partners Kv channels and presenilin. These
results indicate that DREAM, and other NCS, may represent molecular targets for Pb2+,
and association of Pb2+ to the members of the NCS subfamily may lead to
neuropathological conditions attributed to Pb2+ neurotoxicity.
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3.2 Results and discussion
3.2.1 Pb2+ Association Alters the Secondary and Tertiary Structure of DREAM.

Tryptophan emission is a popular tool to probe structural transitions in proteins.
Ca2+ binding to DREAM protein that lacks first 64 amino acid residues (DREAM(64))
triggers structural changes that lead to a decrease in the emission intensity of the tryptophan
residue W169, which is located between the N- and C- terminal domain (Pham, Dhulipala
et al. 2015, Carrion, Mellstrom et al. 1998). The emission spectra of DREAM(64) in the
presence of Ca2+, Pb2+, Ca2+Pb2+ and in the apoform are shown in Figure 3.2A. The
emission intensity of Trp decreases by ~24% at 335 nm upon binding of Pb 2+ to the
apoprotein, pointing towards analogous structural rearrangement at the interface between
EF-hand 2 and EF-hand 3 as observed upon Ca2+ binding. Interestingly, the quenching of
Trp emission intensity in Pb2+-bound DREAM(64) is more pronounced compared with
Ca2+-bound DREAM(64). Addition of Pb2+ to Ca2+ bound DREAM(64) results in the
emission spectrum that is nearly superimposable with the emission spectrum of Pb2+-bound
DREAM(64), suggesting that

Pb2+ effectively displaces Ca2+ from the EF-hands,

pointing towards a higher affinity of Pb2+ for the Ca2+ binding sites in DREAM. To
determine the equilibrium dissociation constant for Pb2+ interactions with DREAM, Pb2+
was titrated into Ca2+-bound DREAM(64) and the fraction of Pb2+ bound to the protein
was calculated from the decrease in the Trp emission intensity at 329 nm according to
Equation 1 (Figure 3.2B). Data were fitted to Equation 2 and the apparent dissociation
constant was determined to be 2.0 ± 0.2 µM (Figure 3.2B). Using the Kd value previously
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Figure 3.2. Fluorescence emission spectra of 20 μM DREAM(Δ64) in the metal
free form and in the presence of Ca2+ and/or Pb2+. Conditions: 20 mM Tris buffer
(pH 7.4), 1mM EDTA, 1 mM Ca2+, 40 μM Pb2+, and 1mM Ca2+and 40μM Pb2+;
samples were excited at 295 nm and experiments were carried out at 20 °C (A).
Titration curve for Pb2+ binding to Ca2+DREAM. The fraction bound was
determined based on decrease in Trp169 emission intensity at increasing Pb2+
concentration. Conditions: 20 μM DREAM(Δ64) in 5 mM Tris, pH 7.4 and 100
μM Ca2+. Experimental points correspond to the averadge value determined from
three independent measurments. The solid line represents the fit using Equation
2; the standard deviations are shown as error bars (B). Fluorescence emission
spectra of 20 μM DREAM(Δ160). Conditions as described for Figure 3.2A (C).
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determined for Ca2+ binding to apoDREAM(64) (Kd = 1 μM), (Osawa, Dace et al. 2005)
the equilibrium dissociation constant for the Pb2+ association to DREAM(64) was found
to be 20 ± 2 nM (Equation 3), indicating that Pb2+ binds to EF-hands in DREAM with 50
times higher affinity than Ca2+. This is consistent with the previous study for Pb2+ titration
to CaM, in which a 10-times higher affinity for Pb2+ binding to the N-terminal domain of
CaM compared with Ca2+ was reported (Kirberger, Wong et al. 2013).
Among four EF-hands found in the DREAM structure, only EF-hand 3 and EFhand 4 in the C- terminal domain bind Ca2+ with the high affinity. To probe that Pb2+
replaces Ca2+ from the EF-hand located in the C-terminal domain, we measured the
emission spectra of DREAM construct that corresponds to the C-terminal domain,
DREAM(160), under conditions identical to those for DREAM(64) (Figure 3.2C). Pb2+
association to DREAM(160) shows an analogous decrease in emission intensity as
observed for Ca2+ binding in agreement with Pb2+ binding to EF-3, EF-4, or both. The Trp
emission spectra are slightly red-shifted in DREAM(160) (λmax for apo and Pb2+
DREAM((160) are 341 nm and 335 nm, respectively) compared with DREAM(64 (λmax
for apo and Pb2+ DREAM((64) are 335 nm and 329 nm, respectively)), which could be
explained by an increased solvent exposure of Trp side chain in this construct.
Pb2+association to DREAM(64) is further supported by CD data. Far-UV CD data reveals
that CD signal at 208-222 nm decreases upon Pb2+ binding (Figure 3.3A). Interestingly, the
CD spectrum of Pb2+-bound DREAM(64) is intermediate between the signal for apo and
Ca2+DREAM(64). The decrease in CD signal in Ca2+- or Pb2+-bound DREAM(64) can
be attributed to an increase of -helical content as well as rearrangement of -helices. The
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addition of Pb2+ to Ca2+DREAM(64) leads to a CD spectrum that is identical with Pb2+bound DREAM(64), providing further evidence of Ca2+ displacement by Pb2+. Analysis
of the far-UV CD data using secondary structure prediction tool K2D3 shows that -helical
property of the protein increases from 64% in apoDREAM(64)

to 72% in Pb2+

DREAM(64) and Ca2+Pb2+ DREAM(64) and 74% in Ca2+DREAM(64). Contrary to
far-UV CD data, near-UV CD signal increases upon Ca2+ and Pb2+ binding (Figure 3.3B).

Figure 3.3. (A) Far-UV CD spectra of 20 μM DREAM(Δ64) in the presence
of 1mM EDTA, 1mM Ca2+, 40 µM Pb2+, and (1mM Ca2+ and 40 μM Pb2+) in
20 mM Tris (pH 7.4). (B) Near-UV CD spectra of 40 μM DREAM(Δ64) in
the presence of 1mM EDTA, 1mM Ca2+, 40 µM Pb2+, and (1mM Ca2+ and 40
μM Pb2+) in 5 mM phosphate (pH 7.4).
The peaks between 256–272 nm could be attributed to phenylalanine residues, whereas the
peak near 292 nm is likely due to the tyrosine residue. The comparable increase in the nearUV CD-signal upon Ca2+ and Pb2+ binding suggest that the tertiary structure of Pb2+-bound
DREAM(64) is analogous to Ca2+-bound DREAM(64). The near-uv CD spectrum of
Pb2+-DREAM(64) is identical with Ca2+Pb2+-DREAM(64) corroborate far-UV CD data
and fluorescence data that Pb2+ displaces Ca2+ from the EF-hand.
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We have also determined the Trp169 lifetime in phase modulation measurements
(Figure 3.4 and Table 3.1). The data were analyzed using a sum of a Gaussian distribution
model and a discrete exponential decay. Two lifetimes were observed for both apo and
metal-bound DREAM(64) and were previously attributed to the presence of two Trp 169
rotamers (t and g+) (Pham, Dhulipala et al. 2015). G+-rotamer corresponds to more
solvent-exposed Trp 169 side chain and thus displays the longer lifetime, whereas being
more efficiently quenched by nearby amino acid residues, the t-rotamer exhibits a shorter
lifetime (Pham, Dhulipala et al. 2015). Upon binding of Pb2+, the average lifetime of Trp
169 decreases from 4.4 ± 0.1 ns to 3.8 ± 0.1 ns, which is due to a decrease in the fractional
intensity contribution associated with the longer lifetime and slightly faster Gaussian decay
(from 2.1 ± 0.1 ns for apoDREAM to 1.6 ± 0.2 ns for Ca2+ or Pb2+DREAM) (Table 3.1).
These data are consistent with the steady-state emission data, suggesting that the
association of Pb2+ to DREAM triggers a structural transition that is analogous to that
triggered by Ca2+ association to EF-hand 3 and EF-hand 4.
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Figure 3.4. Frequency-domain intensity decay of 20 µM apo (squares),
Ca2+(circle), Pb2+ (up triangle), and Ca2+Pb2+(down triangle)DREAM(64) in
20 mM Tris (pH 7.4). The phase delay is shown as solid symbols and
modulation ratio as empty symbols. Solid lines represent data fitting using a
(one Gaussian distribution and single exponential decay) model.
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Table 3.1. Fluorescence decay parameters for DREAM(64) as a function of Ca2+/Pb2+ binding to EF-hands.
Samples
τ1 (ns)
τ2 (ns)
f1(%)
f2(%)
w1
<τ> (ns)
1(%)
2(%)

2

apo
2.1 ± 0.1
17.1 ± 0.2 5.9 ± 0.1 82.9 ± 0.2 41.2 ± 0.4 59.8 ± 0.4 1.1 ± 0.1 4.4 ± 0.1
2.9
2+
Ca
1.6 ± 0.2
15.9 ± 0.4 5.9 ± 0.1 84.1 ± 0.4 49.3 ± 0.3 51.7 ± 0.3 1.0 ± 0.1 3.8 ± 0.1
1.6
2+
Pb
1.6 ± 0.2
15.8 ± 0.3 5.9 ± 0.1 84.2 ± 0.3 49.6 ± 0.4 51.4 ± 0.4 1.0 ± 0.1 3.8 ± 0.1
1.6
Ca2+Pb2+ 1.6 ± 0.2
15.8± 0.5 5.9 ± 0.1 84.2 ± 0.5 50.5 ± 0.5 49.5 ± 0.5 1.0 ± 0.1 3.8 ± 0.2
1.6
Recovered from global analysis of the phase and modulation data using a (one Gaussian distribution and discrete single
exponential decay) model. 1 is the decay time of the Gaussian distribution with a width of distribution w1; 2 is the lifetime
of the discrete single exponential term; 1 and 2 are pre-exponential decays; f1 and f2 are exponential decay fraction. 2
represents the goodness of the fit. Lifetime parameters represent average of three independent measurements; standard
deviations are shown as errors. Phase and modulation errors were set at ≤ 0.2° and ≤ 0.004 respectively.
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3.2.2 Pb2+ Binding promotes DREAM Interactions with Hydrophobic Molecule 1,8-ANS.
We have previously shown that Ca2+ modulates DREAM affinity for small
organic molecules such as 1,8-ANS and arachidonic acid (Gonzalez, Miksovska 2014). To
investigate whether Pb2+ binding influences DREAM interactions with hydrophobic
molecules, we have monitored Pb2+-bound DREAM interactions with 1,8-ANS. This probe
offers a spectroscopic approach for assessing the hydrophobicity of the protein surface due
to its increase in the emission intensity upon the association to hydrophobic patches on the
protein surface. 1,8-ANS emission intensity increases in the presence of apoDREAM(Δ64)
because of 1,8-ANS binding to the protein. The further increase in the emission of Pb2+ or
Ca2+-bound DREAM(Δ64) compared with the apo form suggest that 1,8-ANS associates
to the hydrophobic cavities on the DREAM (Δ64) surface with a higher affinity in the
presence of Ca2+ or Pb2+ (Figure 3.5A). The emission spectrum of Pb2+-bound
DREAM(Δ64):1,8-ANS complex is identical with Ca2+Pb2+-DREAM(Δ64), suggesting
that Pb2+ binds to DREAM(Δ64) with higher affinity and displaces Ca2+ from EF-hand,
which is consistent with CD and Trp emission data. DREAM(160):1,8-ANS complexes
show emission spectra that are analogous to DREAM(Δ64):1,8-ANS complexes (Figure
3.5B). We determined the affinity of the 1,8-ANS probe for DREAM by titrating the
constant amount of 1,8-ANS against DREAM(Δ64) (Figure 3.5C). The fraction of 1,8ANS bound to protein was calculated from the increase in emission intensity at 466 nm
(Equation 1), and binding isotherm (Figure 3.5C ) was analyzed according to Equation 2.
The Kd value obtained for 1,8-ANS binding to Pb2+-bound DREAM(Δ64) is 87 ± 4 µM
(Figure 3.5C ), which is similar to the Kd value obtained for Ca2+-bound DREAM(Δ64)
(107±11 µM) (data not shown), suggesting that Ca2+- and Pb2+-bound DREAM(Δ64) have
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similar affinity for 1,8-ANS. The affinity of Pb2+ DREAM (Δ64) for 1,8-ANS complex is
approximately two times higher compared with the value previously determined for the
apo form (195±20 µM) (Gonzalez, Miksovska 2014), which is consistent with an increased
accessibility of the 1,8-ANS binding sites in Pb2+ bound protein.

Figure 3.5. Emission spectra of (A) 1,8-ANS:DREAM(Δ64)
and (B) 1,8-ANS:DREAM(Δ160) complexes as a function
of Pb2+ or Ca2+ binding to the protein. Conditions: 20 µM
DREAM(Δ64) and 20 µM 1,8-ANS; excited at 350 nm. (C)
Titration of 10 µM 1,8-ANS with Pb2+DREAM(Δ64). The fit
of the experimental data using Equation 2 is shown as a solid
line. Inset: 1,8-ANS structure.
The 1,8-ANS fluorescence lifetimes are also sensitive to structural changes
associated with Ca2+ binding to DREAM(Δ64). To investigate whether Pb2+ binding to
DREAM influences the lifetime of 1,8-ANS, we measured the lifetime of
DREAM(Δ64):1,8-ANS complexes (Figure 3.6). 1,8-ANS bound to apoDREAM exhibits
two fluorescent lifetimes (1 = 4.8 ± 0.1 ns and 2 = 17.2 ± 0.1 ns), which can be attributed
to 1,8-ANS associated to at least two 1,8-ANS binding sites on DREAM surface (Table
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3.2). Previously, we used AutoDock software version 4.2 to identify 1,8-ANS binding sites
on DREAM surface (Gonzalez, Miksovska 2014, Morris, Huey et al. 2009). One binding
site was found between the helix 8 and helix 9 (EF-hand 4). This binding site is partially
solvent-exposed and 1,8-ANS bound to this side was associated with a shorter lifetime.
The second site was identified between the EF-hand 3 and EF-hand 4. This is a more

Figure 3.6. Frequency-domain intensity decay of 40 μΜ 1,8ANS binding to 40 μΜ DREAM(Δ64) in presence of EDTA
(squares), Ca2+ (circle), Pb2+ (up triangle), and Ca2+Pb2+
(down triangle). The phase delay is shown as solid symbols
and modulation ratio as empty symbols. Solid lines represent
data fitting using three-exponential decay model.
hydrophobic side and 1,8-ANS bound to this site is likely to exhibit a longer lifetime.
Addition of Pb2+ to apoDREAM(Δ64):1,8-ANS complex leads to an increase in the longer
lifetime (2 = 18.4 ± 0.2 ns) and an approximately two-fold increase in the corresponding
pre-exponential parameter α2 compared with the apoprotein, suggesting Pb2+ association to
EF-hand 3 and EF-hand 4 increases the affinity for 1,8-ANS binding to the DREAM and
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leads to an increased accessibility of the hydrophobic cavity in the C-terminal domain.
Individual 1,8-ANS lifetimes are moderatedly changed by Pb2 to DREAM (Δ64), which
is consistent with 1,8-ANS binding to identical binding sites in Ca2+-free, Pb2+-, and Ca2+bound protein.
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Table 3.2. Fluorescence decay parameters for DREAM(64)–1,8-ANS complexes as a function of
Ca2+ and/or Pb2+ binding to EF-hands.
1,8-ANS
f2(%)
1 (ns)
1(%)
2 (ns)
2(%) f1(%)
2
apoDREAM(64)

4.8 ± 0.1 11.3 ± 0.8 17.2 ± 0.1 16.2 ± 0.7 14.3 ± 0.5 80.9 ± 0.6

2.0

Ca2+DREAM(64)

5.1 ± 0.2 15.1 ± 0.7 18.3 ± 0.2 34.5 ± 0.58.9 ± 0.4 88.5 ± 0.8

1.8

Pb2+DREAM(64)

5.1 ± 0.3 15.1 ± 0.6 18.4 ± 0.2 33.2 ± 0.49.1 ± 0.3 88.3 ± 0.6

1.7

1.1
Pb2+Ca2+DREAM(6 5.0 ± 0.2 15.2 ± 0.5 18.4 ± 0.3 35.3 ± 0.69.3 ± 0.4 88.1 ± 0.5
4)
Data recovered from Globals software using a sum of three discrete exponential decays with fixed 1,8ANS lifetime (0 = 0.28 ns). Lifetime parameters represent average of three independent
measurements; standard deviations are shown as errors. Phase and modulation errors were set at ≤ 0.2°
and ≤ 0.004 respectively.
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3.2.3 Pb2+ Binding to DREAM is Entropy Driven.
To complement the results from fluorescence experiments, ITC studies were
carried out to determine thermodynamic parameters for the Pb2+ association to
Ca2+DREAM(64) and Ca2+DREAM(160) (Figure 3.7A,B). Isothermal calorimetry data

Figure 3.7. ITC isotherms for Pb2+ displacement of Ca2+ from (A) DREAM
(Δ64) and (B) DREAM (Δ160). The upper panels of the profile reflect the
thermal power expressed in units of microcalories per second, whereas the
lower panel represents integrated reaction heats (ΔH) expressed in units of
kilocalories per mole. The solid line represents the best fitting curve with
parameters listed in Table 3.3.
reveal that displacement of Ca2+ from DREAM is endothermic and can be modeled as a
sequential process with two binding sites. Satisfactory fits were obtained using both a oneset of sites model and sequential process with two sites. Because we used the sequential
model previously to analyze Tb3+ binding to Ca2+DREAM (Gonzalez, Ramos et al. 2016),
a sequential model with two sites was employed here and the thermodynamic parameters
are listed in Table 3.3. Two Pb2+ ions bind to Ca2+DREAM(64) with Kapp values 2.63 ±
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0.18 µM and 8.74 ± 0.02 µM, respectively. The profile of the ITC isotherm for Pb2+
displacement of Ca2+ bound to DREAM(64) is similar to binding isotherm for Tb3+
displacement of Ca2+ bound to DREAM(64) (Gonzalez, Ramos et al. 2016), points
towards a similar mechanism for Ca2+ displacement from DREAM(64) by Pb2+ and Tb3+
(Table 3.3). The calorimetric study for the Pb2+ displacement of Ca2+ bound at the EFhands of DREAM(160) under conditions identical to those for the Pb2+ displacement of
Ca2+ bound at the EF-hands of DREAM(64) (Figure 3.7B) provides thermodynamic
parameters that are nearly identical to the parameters for Pb2+ displacement of Ca2+ bound
from DREAM(64) (Table 3.3). These results suggest that the first 160 amino acid residues have a
negligible role in modulating Pb2+ interactions with EF-hands in the DREAM C-terminal domain in
the presence of Ca2+. In both protein constructs, Pb2+ associates to two binding sites with a relatively
high affinity (see below). However, we cannot eliminate the potential presence of additional sites for
Pb2+ of lower affinity in the DREAM N- or C- terminal domain as precipitation of Ca2+-bound
DREAM at increased Pb2+concentrations (above 50 μM) prevented detection of those sites.
Pb2+ displacement of Ca2+ from the EF-hand of the DREAM(64) is associated with G
of -14.48 ± 0.08 kcal mol-1, which is identical to the Pb2+ displacement of the Ca2+ from the EF-hand
of the DREAM(160) G= -14.52 ± 0.05 kcal·mol -1. Using the overall Kapp value obtained from
ITC measurements (4.81 ± 0.06 µM), we determined the Kd value for Pb2+ binding to apoDREAM to be 47 ± 0.6 nM, which is similar to the value obtained from fluorescence titration
data (Kd = 20 ± 2 nM). The reaction is entropy-driven as positive reaction enthalpy and positive
entropy change are associated with the Pb2+ binding to Ca2+ DREAM. The entropy gain
cannot be attributed to release of the water molecule(s) to the bulk solvent as the hydration
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sphere of Ca2+ consists of eight water molecules (Jalilehvand, Spångberg et al. 2001), whereas
six molecules were found the first hydration sphere of Pb2+ (Marcus 1991). Kirberger and
Yang (Kirberger, Yang 2008) have analyzed the X-ray structures of Ca2+-bound CaM and
Pb2+-bound CaM and reported a marginal change in the EF-hand geometry, suggesting that
observed entropy-driven for Pb2+ binding to Ca2+DREAM may originate from subtle
changes in the DREAM conformation. This is in agreement with the spectroscopic data
presented here which shows decreased Trp emission intensity in Pb2+DREAM compared
with Ca2+DREAM.
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Table 3.3. ITC parameters recovered for Tb3+ and Pb2+ displacement of Ca2+ from EF hands of DREAM using a
sequential model.
Kapp1
(µM)

Kapp2
(µM)

H1
(kcal/mol)

H2
(kcal/mol)

TS1
(kcal/mol)

TS2
(kcal/mol)

DREAM(64) + Pb2+

2.63 ± 0.18

8.74 ± 0.02

6.58 ± 0.39

6.10 ± 0.55

14.15 ± 0.47

13.01 ± 0.55

DREAM(160) + Pb2+

2.94 ± 0.41

8.72 ± 0.01

6.92 ± 0.07

6.64 ± 0.09

14.45 ± 0.03

13.53 ± 0.08

12

13 ± 9

18 ± 6

20 ± 9

24 ± 0.4

DREAM(64) + Tb

3+

4.5

All Experiments conducted in triplicate at 25 °C, errors are standard deviations. Data for the Tb3+ association to DREAM
are from ref (Gonzalez, Ramos et al. 2016).
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3.2.4 Pb2+ Association to DREAM Facilitates DREAM’s Interactions with Intracellular
Partners.
Jo et al. (Jo, Jang et al. 2005) previously reported that DREAM binds to the Cterminal of presenilin-1 (PS1-CTF) in the presence of Ca2+ and stimulates γ- secretase
activity which facilitates the generation of Aβ42 in Alzheimer’s disease. To determine
whether Pb2+ association to DREAM modulates DREAM affinity for presenilin, the
equilibrium binding constant for helix-9 of presenilin-1 (PS1HL9) association to DREAM
was measured. We used PS1HL9 as a model for presenilin-1 since pull-down studies have
shown that DREAM interacts with residues from helix-9 (Buxbaum, Choi et al. 1998,
Pham, Miksovska 2016). FITC-labeled PS1HL9 was titrated with Pb2+-bound
DREAM(64) and the change in the anisotropy was probed (Figure 3.8A,B). The fraction

Figure 3.8A,B. Titration of 0.5 μM PS1HL9 with Pb2+DREAM (64). Left
panel represents raw anisotropy data. Right panel shows fraction bound
that was calculated using Equation 1. In both cases, solid lines correspond
to fit of the experimental data using Equation 2.
of DREAM bound to PS1HL9 was then plotted as a function of Pb2+-bound DREAM(64)
concentration and the dissociation constant was recovered using Equation 2 (Table 3.4 and
Figure 3.8A,B). Titration data shows that Pb2+DREAM binds PS1HL9 with a four-time
lower affinity compare to Ca2+-bound DREAM(64) (Kd = 2.56 ± 0.23 µM and 0.6 ± 0.1
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µM, respectively). However, the affinity of Pb2+DREAM and Ca2+DREAM for PS1HL9 is
enhanced compared to apo DREAM(64) (Kd = 183 ± 12 µM) (Table 3.4) (Pham,
Miksovska 2016). Several studies demonstrated that an early life exposure to Pb2+
promotes

developmental reprogramming of

APP gene expression, leading to an

augmented expression of amyloid precursor protein during adulthood (Huang, Bihaqi et al.
2011, Wu, Basha et al. 2008, Basha, Murali et al. 2005, Basha, Wei et al. 2005). The
interaction between Pb2+-bound DREAM and PS1HL9 observed here suggest that elevated
concentrations of Pb2+ may directly impact the proteolytic processing of the β-amyloid
precursor protein.
In addition to binding to presenilin, DREAM and other KChIPs are integral
auxiliary subunits of A-type potassium voltage channels and the formation of Kv4–KChIP
complex has been shown to result in modulation of gating properties, surface expression
and subunit assembly of Kv4 channels (An, Bowlby et al. 2000, Gonzalez, Pham et al.
2014, Bahring, Dannenberg et al. 2001, Scannevin, Wang et al. 2004). Although DREAM
binds to Kv channels in a Ca2+-independent manner, the presence of Ca2+ modulates
kinetics of Kv channel inactivation (Patel, Campbell et al. 2002). Crystallographic studies
demonstrated that the T-1 domain at the N-terminus of Kv4 interacts with KChIPs (An,
Bowlby et al. 2000, Pioletti, Findeisen et al. 2006, Bahring, Dannenberg et al. 2001,
Scannevin, Wang et al. 2004). Two binding sites were found to be involved in binding of
Kv4.2 to KChIP1, namely site-1, which is comprised of non-polar residues 2–22 and site2, containing more polar residues 70–90 (Callsen, Isbrandt et al. 2005). Our previous
research showed that both site-1 and site-2 interact with DREAM in a calcium-dependent
manner (Gonzalez, Pham et al. 2014). To determine whether Pb2+ binding to DREAM EF-
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hands modulates interactions between DREAM and site-1 and site-2, we titrated FITCtagged site-1 and site-2 with Pb2+-bound DREAM(64) in anisotropy measurements

Figure 3.9A,B. Titration of 0.5 μM Kv4.3 (2–22) “site-1” with
Pb2+DREAM(64). Right panel shows fraction bound that was calculated
using Equation 1. In both cases, solid lines correspond to fit of the experimental
data using Equation 2.
(Figure 3.9A,B and 3.10A,B). The equilibrium dissociation constants were determined
analogously as described above for PS1HL9 (Table 3.4 and Figure 3.9A,B and 3.10A,B).

Figure 3.10A,B. Titration of 0.5 μM Kv4.3 (70–90) “site-2” with
Pb2+DREAM(64). Right panel shows fraction bound that was calculated
using Equation 1. In both cases, solid lines correspond to fit of the
experimental data using Equation 2.
The titration data show that Pb2+-bound DREAM has 50-times higher affinity for “site-2”
(Kd = 10.61 ±0 .40 µM) and 12-times higher affinity for “site-1” (Kd = 5.9 ± 0.6 µM)
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compared with the previously determined dissociation constant for metal-free DREAM
(Table 3.4) (Gonzalez, Pham et al. 2014)48. Analogous Kd values for Ca2+-bound
DREAM(64) and Pb2+-bound DREAM(64) association to site-1 and site-2 indicate that
in the absence of Ca2+, Pb2+ association to DREAM may impact the deactivation kinetics
of Kv channels complexes in a manner analogous to Ca2+ association. Considering the
implication of Kv channels in hippocampus-dependent learning and memory (Lugo,
Brewster et al. 2012), the Kv channels:KChIP complexes may represent a molecular target
contributing to Pb2+ induced memory and learning deficiencies. Previously, Gorkhali et al.
(Gorkhali, Huang et al. 2016) have proposed that neuronal calcium sensor 1 (NCS-1) may
be a plausible target for Pb2+ neurotoxicity. NCS-1 was associated with numerous neuronal
processes, including regulation of neurotransmission, nuclear Ca2+ regulation, cognitive
functions, and neuron development through interactions with various downstream partners,
including the dopamine receptors, calcineurin, and phosphatidylinositol-4 kinase-IIIb
(Gorkhali, Huang et al. 2016, Boeckel, Ehrlich 2018). Considering high sequence identity
of the C-terminal domain of neuronal calcium sensors (Ames, Lim 2012) and significant
amount of Pb2+ in the brain (0.52–4 ppm) due to occupational and environmental exposure
to the Pb2+ (Barry, Mossman 1970, Grandjean 1978), especially in the hippocampus
(Grandjean 1978), other members of NCS family are likely to bind Pb2+ with higher affinity
than that for Ca2+ and be involved in Pb2+-induced neurotoxicity.
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Table 3.4. Equilibrium dissociation constants for presenilin-1 helix 9 “PS1HL9”, Kv4.3(2-22)
“site-1”, and Kv4.3(70-90) “site-2” binding to DREAM constructs.
PS1HL9
Site-1
Site-2
Kd (μM)
Kd (μM)
Kd (μM)
apoDREAM(Δ64)
183 ± 12
70 ± 3
~500
Ca2+DREAM(Δ64)
0.6 ± 0.1
2.7 ± 0.1
10 ± 1
2+
Pb DREAM(Δ64)
2.56 ± 0.23
5.9 ± 0.6
10.61 ± 0.40
Determined using steady-state anisotropy change. Data were fitted to Equation 2. Data for
apoDREAM(Δ64) and Ca2+DREAM(Δ64) are from reference (Pham, Miksovska 2016) and
(Gonzalez, Pham et al. 2014), respectively. Titrations of Pb2+DREAM(Δ64) with PS1HL9, site-1
and site-2 were conducted in triplicate. Average Kd values are reported and standard deviations are
shown as errors.
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3.3 Summary
In this report, we demonstrate that Pb2+ binds to EF-hands in DREAM for the first
time. Based on fluorescence emission, circular dichroism, ITC, and fluorescence lifetime
data, we provide compelling evidence that Pb2+ is able to induce structural changes
analogous to Ca2+ binding. Pb2+ binding to DREAM also alters DREAM interaction with
intracellular partners, such as presenilin-1 and site-1 and site-2 of potassium voltage
channel. These results imply that DREAM and possibly other neuronal calcium sensors
bind Pb2+ with a high affinity in vivo, and Pb2+ interactin with neuronal calcium sensors
could explain lead-induced neurotoxicity.
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4.

CADMIUM

ASSOCIATION

TO

DREAM

PROMOTES

DREAM

INTERACTIONS WITH INTRACELLULAR PARTNERS IN A SIMILAR
MANNER AS ITS PHYSIOLOGICAL LIGAND, CALCIUM.
4.1 Background and significance
Cd2+ has been recognized as one of the most toxic environmental and
industrial pollutants which exerts adverse health effects in general population
because of its prolonged half-life in human (15–20 years) and low rate of excretion
from the human body (Järup, Åkesson 2009, Roels, Bernard et al. 1993, Satarug, Moore
2004, Jin, Lu et al. 1998). It has been assigned as class I carcinogen by the
International Agency for Research on Cancer (IARC Working Group on the
Evaluation of the Carcinogenic Risk of Chemicals to Humans 1993). Occupational
and as well as non-occupational exposure, including consumption of tobacco
products, food, and dietary intake (Satarug, Moore 2004, IARC Working Group on
the Evaluation of the Carcinogenic Risk of Chemicals to Humans 1993, IPCS 1992)
to Cd2+ has been associated with different cancers, including stomach, testis, renal
and others (Waalkes 2000, Pesch, Haerting et al. 2000, Joseph, Muchnok et al.
2001). The central nervous system is also susceptible to Cd2+ toxicity (Cao, Chen et
al. 2009, Lopez, Figueroa et al. 2003), especially in children, elderly people, and
pregnant women. Elevated concentration of Cd2+ has been reported in children with
mental retardation and learning difficulties compared with a reference group (Pihl,
Parkes 1977, Marlowe, Errera et al. 1983, Capel, Pinnock et al. 1981). Other studies
have shown that Cd2+concentration in hair is inversely related to the intelligent
quotient (Thatcher, Lester et al. 1982, Thatcher, McAlaster et al. 1984). An
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increasing number of clinical investigations have suggested that Cd 2+ intoxication is
a probable etiological factor of neurodegenerative diseases, such as Parkinson’s
disease, Huntington’s disease, and Alzheimer’s disease (Okuda, Iwamoto et al.
1997, Johnson 2001, Panayi, Spyrou et al. 2002). The mechanism through which
Cd2+ exerts its toxic effects remains unresolved. Oxidative stress, interference with
Ca2+- and Zn2+-dependent processes, epigenetic modification, apoptosis induction,
and effects on neurotransmitters were proposed to be the underlying mechanism
(Wang, Du 2013, Méndez-Armenta, Rios 2007). Animal model studies have shown that
Cd2+ exposure has been associated with increased production of reactive oxygen
species which in turns results in increased lipid peroxidation, altered calcium
homeostasis, and DNA damage (Méndez-Armenta, Villeda-Hernández et al. 2003, El‐
Maraghy, Gad et al. 2001, Kumar, Agarwal et al. 1996, Lopez, Arce et al. 2006, Manca,
Ricard et al. 1991). Even at relatively low concentrations, Cd2+ inhibits all known
pathways of Ca2+ influx and thereby interferes with the Ca2+ homeostasis (MéndezArmenta, Rios 2007). Yoshida (Yoshida 2001) has shown that Cd2+-exposed neurons
have a dose-dependent elevated concentration of cytoplasmic and nuclear Ca 2+.
Another study has shown that 50 μM Cd2+ inhibits Ca2+ influx into hepatocytes
through receptor-operated Ca2+-channels (Thevenod, Jones 1992). The central
nervous system is highly sensitive to Cd2+ exposure as 24-hour exposure to Cd2+
results in a decrease in dopamine, serotonin, and norepinephrine concentration
(Lafuente, Gonzalez-Carracedo et al. 2003, Lafuente, Fenández-Rey et al. 2001).
Additionally, experimental studies on rabbits and newborn rats exposed to an
elevated Cd2+ concentration have demonstrated extensive hemorrhages in the
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cerebral and cerebellar cortices, neuroglial cells with cytolysis, altered Purkinje
cells, and several pyramidal cells with pyknotic nuclei (Gabbiani, Baic et al. 1967,
Wong, Klaassen 1982). Studies on mice have demonstrated that Cd2+ exposure
impairs hippocampus-dependent memory and learning (Wang, Zhang et al.
2017). Rigon et al. (Rigon, Cordova et al. 2008) and Kanter et al. (Kanter, Unsal et
al. 2016) have shown that Cd2+ administration causes a decrease in cell vitality and
neuronal apoptosis in the hippocampus in a rat model.
Cd2+ has been shown to occupy Ca2+ binding site of CaM (Forsén, Thulin et
al. 1980, Andersson, Forsen et al. 1983) and promotes CaM association and activation
of phosphodiesterase and myosin light chain kinase (Suzuki, Chao et al. 1985, Chao,
Bu et al. 1995, Mazzei, Girard et al. 1984). Suzuki et al. (Suzuki, Chao et al. 1985)
and Mazzei et al. (Mazzei, Girard et al. 1984) postulated that Cd2+competition with
Ca2+ for EF-hands on CaM is the key of CaM toxicity at the molecular level. Studies
on protein kinase C have shown that Cd2+ binding to protein kinase C, displaces Zn2+
from the regulatory domain and facilitates binding of protein kinase C to a nuclear
protein (Block, Freyermuth et al. 1992). Other studies have shown that Cd2+ can
displace Ca2+ from its binding sites in troponin C, the calcium-binding subunit of
the muscle protein complex troponin (Ellis, Strang et al. 1984, TELEMAN,
DRAKENBERG et al. 1983).
Neuronal calcium sensor (NCS) is a subgroup of EF-hand superfamily that
includes potassium channel-interacting protein 1–4, recoverin, NCS-1, GCAP, and
neurocalcin. These proteins are mainly expressed in the brain and retina where they
transduce Ca2+ signals and regulate a myriad of intracellular processes (Ames, Lim
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2012, Burgoyne, Weiss 2001, Burgoyne 2007). Even though NCS proteins share
comparatively low sequence similarity with CaM, they are composed of four EFhands analogous to CaM and are sensitive to changes in intracellular Ca 2+
concentration (McCue, Haynes et al. 2010). Downstream regulatory element
antagonist modulator (DREAM), also known as potassium channel-interacting
protein 3 (KChIP3) or calsenilin, is a 29 kDa NCS protein that is expressed in the
hippocampus and has been shown to regulate numerous cellular processes. DREAM
is the first Ca2+-regulated transcriptional repressor (Carrion, Link et al. 1999). In the
Ca2+-free state, DREAM binds to the downstream regulatory element (DRE) of
human prodynorphin and c-fos genes and consequently represses transcription,
whereas Ca2+ binding alters protein oligomerization resulting in decreased affinity
for DRE sequence (Carrion, Link et al. 1999, Cheng, Pitcher et al. 2002).
Prodynorphin and c-fos genes have been associated with apoptosis, pain modulation,
and cell homeostasis (Costigan, Woolf 2002, Fontán-Lozano, Romero-Granados et al.
2009). It has been demonstrated that in the presence of Ca2+, DREAM interaction
with carboxy-terminal fragment (CTF) of presenilin-1 (PS1) and presenilin-2 (PS2)
stimulates the activity of γ- secretase, which facilitates cleavage of amyloid
precursor protein and eventually overproduces Aβ42 peptide, a peptide associated
with Alzheimer’s disease (Buxbaum, Choi et al. 1998, Jo, Jang et al. 2005). DREAM
also associates with the T1 domain of potassium channels and regulates their
translocation to the membrane, K+ current, and gating properties (An, Bowlby et al.
2000). DREAM has been linked to memory and learning processes by acting as a
transcriptional repressor of CREM in a calcium-dependent fashion (Fontán-Lozano,
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Romero-Granados et al. 2009). Study of Rashid et al. (Abd Rashid, Hapidin et al.
2017) proposed that DREAM protein may participate in the mechanism of nicotine
treatment-prevented learning and memory impairment in REM sleep-deprived rats
by changing its expression level in the hippocampus. Recent studies have shown that
Ca2+ bound DREAM binds to CaM and the formation of DREAM:CaM complex
eliminates nonspecific interaction between DREAM and DRE sites and increases
activation of calcineurin (Gonzalez, Arango et al. 2015, Ramachandran, Craig et al.
2012).
The three-dimensional NMR structure of N-terminal truncated Ca2+-bound
DREAM (residue 78-256) (Lusin, Vanarotti et al. 2008), shown in Figure 4.1,
reveals that DREAM possesses two domains, with each domain comprising of two
EF-hands. EF-1 (residue 90-119) and EF-2 (residue 128-157) along with a short N-

Figure 4.1. NMR structure of Ca2+-bound DREAM monomer (PDB entry
2JUL). The four EF-hands of DREAM are shown in raspberry (EF-hand
1), slate (EF-hand 2), teal (EF-hand 3), and firebrick (EF-hand 4); Ca2+
ions are shown as magenta spheres; W169 is shown as limon stick; and
rest of the protein is shown in limon.
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terminus -helix form an N–terminal domain, whereas EF-3 (residue 163-192) and
EF-4 (residue 211-240) combined with a 13-residue long C-terminal -helix form a
C-terminal domain. Among four EF-hands of DREAM, EF-hand 1 is not functional
because the presence of the CPXG sequence at the EF-hand loop distorts Ca2+binding geometry. The presence of Asp at the 12th position of the EF-2 loop makes
this EF-hand specific for Mg2+ and EF-3 and EF-4 bind Ca2+ with a Kd of 1–10 µM
(Gifford, Walsh et al. 2007, Osawa, Dace et al. 2005, Osawa, Tong et al. 2001). We
have recently shown that the EF-3 and EF-4 do not exclusively bind Ca2+ as they
can also bind non-physiological metals Tb3+ and Pb2+ with an affinity that is superior
to that for Ca2+ (Azam, Miksovska 2018, Gonzalez, Ramos et al. 2016).
4.2 Results and discussion
4.2.1 Cd2+ binding promotes the structural reorganization of DREAM.
A single tryptophan residue (W169) in WTDREAM(64) sequence is
located between the N- and C-terminal domain and its emission properties can be
used to probe inter-domain structural changes associated with the metal binding to
DREAM. It has been shown previously that in the presence of Ca2+, W169 emission
intensity decreases and the emission spectrum undergoes a concomitant shift to the
lower wavelength of 330 nm (Pham, Dhulipala et al. 2015). Close inspection of
WTDREAM(64) and WTDREAM(160) structures reveals that four charged
amino acid residues (K168, N172, E165, and E253) are located within 6 Å of the
indole ring of W169 and may serve as Trp emission quenchers. The decrease in
emission intensity can be explained by a model in which Ca 2+ binding causes
structural rearrangement of the protein that brings the quencher amino acid
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residue(s) closer to the indole ring of W169 resulting in a decrease of tryptophan
emission intensity. The blue shift of emission maximum upon Ca2+ binding is
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Figure 4.2. Effects of Ca2+ and Cd2+ on emission properties of
W169 in (A) DREAM(Δ64), (B) DREAM(Δ160), (C)
DREAM(E186), and (D) DREAM(E234Q). Conditions: 20 µM
protein in 20 mM Tris pH 7.4, 2 mM EDTA or 2 mM Ca2+, and/or
100 µM Cd2+. Emission spectra were recorded using 295 nm
excitation light.
state. To investigate whether Cd2+ binds to WTDREAM(64), we measured
emission spectra of WTDREAM(64) in the presence of Cd2+ (Figure 4.2A). Trp
at the emission maximum of 335 nm decreases by ~25% upon addition of Cd 2+ and
the emission maximum shifts to 329 nm, suggesting structural reorganization at the
interface of EF-2 and EF-3 analogous to rearrangements triggered by the Ca 2+
binding. Interestingly, Cd2+ association with WTDREAM(64) leads to a more
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pronounced decrease in emission intensity than observed for Ca2+ association. The
addition of Cd2+ to Ca2+bound WTDREAM(64) results in an emission spectrum
identical to Cd2+ bound WTDREAM(64), indicating Cd2+ binds to DREAM with
a higher affinity and displaces Ca2+ from the EF-hands.
Because the EF-3 and EF-4 of DREAM bind Ca2+, it is expected that the
EF-3 and EF-4 may also bind Cd2+ as Cd2+ shares similar physical properties with
Ca2+. To investigate whether Cd2+ binds at EF-3 and EF-4, first, we measured
emission spectra of WTDREAM(160), a protein construct that lacks EF-1 and EF2, under identical conditions as for WTDREAM(64) (Figure 4.2B). Cd2+
association causes a decrease in emission intensity analogous to Ca2+ binding,
suggesting that Cd2+ binds at EF-hand in the C- terminal domain. The bathochromic
shift of the emission maximum in WTDREAM(160) (λmax = 353 nm) construct
compared to WTDREAM(64) (λmax = 335 nm) indicates that W169 sidechain in
WTDREAM(160) is located in the more polar environment due to the absence of
the N terminal domain.
To provide additional insight into Cd 2+ interaction with DREAM, we
prepared DREAM(E186Q) and DREAM(E234Q) constructs with EF-3 and EF-4,
respectively, being nonfunctional due to the replacement of Glu residue at the 12 th
position of EF-hand loop. Upon Cd2+ addition to DREAM(E186Q), the emission
intensity decreases in a similar way as observed for WTDREAM(64) and
WTDREAM(160), suggesting that Cd2+ binds at EF-4 and triggers structural
changes that modulate emission properties of W169 (Figure 4.2C). Interestingly, the

91

emission spectrum of Cd2+ bound DREAM(E234Q) is nearly identical to that for
apoDREAM(E234Q) (Figure 4.2D). Although these results may suggest that EF-4
does not bind Cd2+, at least at metal concentrations probed here, this interpretation
is inconsistent with the data obtained for Cd 2+ binding to DREAM(234Q):1,8-ANS
complex and with the ITC results as shown below. The nearly identical emission
spectra of apoDREAM(E234Q) and Cd2+DREAM(E234Q) suggest that Cd2+
association to EF-3 does not promote structural changes that impact the emission
properties of W169. This is consistent with the molecular dynamic data (Pham,
Dhulipala et al. 2015) as the superposition of MD simulations structures of
apoDREAM and Ca2+DREAM monomer reveals that the EF-3 undergoes a minor
reorientation upon Ca2+ association, whereas Ca2+ binding to EF-4 leads to
repositioning of α-helices from a perpendicular to parallel orientation and
displacement of α-helix 10. The decrease in the emission intensity of W169 upon
Ca2+ or Cd2+ association can be explained with a model in which Ca 2+ or Cd2+
binding to EF-4 bring the residue E253, located in α-helix 10, closer to the indole
ring of W169, resulting in more efficient quenching of W169 emission.
To determine the dissociation constant for Cd2+ binding to DREAM, Cd2+
stock was titrated into DREAM(64) protein in the presence of 100 μM Ca2+ (Figure
4.3). Data were fitted to Equation 1 which reveals that Cd 2+ binds to DREAM protein
with an apparent dissociation constant 8 ± 1 μM. Substituting the value of apparent
dissociation constant in Equation 3, equilibrium dissociation constant for Cd 2+
binding to DREAM protein determined to be 80 nM.
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Figure 4.3. Emission spectra of DREAM(64) as a function of increasing
concentration of Cd2+. Conditions: 20 μM WTDREAM(64) in 20 mM Tris
in presence of 100 μM Ca2+. The emission spectra were recorded using 295
nm excitation (A). The decrease in the emission intensity of DREAM(64)
due to the Cd2+ binding to Ca2+DREAM. The experimental data were fitted
using Equation 1 for obtaining equilibrium dissociation constant (B).
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Figure 4.4. Far-UV CD spectra of (A) 20 µM DREAM(Δ64), (B) 20 µM
DREAM(Δ160), (C) 20 µM DREAM(E186), and (D) 20 µM
DREAM(E234Q). Conditions as described in Figure 4.2.
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The structural reorientation of DREAM upon Cd 2+ association was also
determined by far-UV CD spectroscopy. CD data presented in Figure 4.4 show that
that CD signal at 208-222 nm decreases upon Cd2+ binding to WTDREAM(64),
WTDREAM(160), and DREAM(E186Q) (Figure 4.4A–C). The decrease in the
CD signal at 220 and 208 nm indicates an increase in an α-helical content and/or
reorganization of α-helices. Similar CD spectra of WTDREAM(64) constructs in
Ca2+- and Cd2+-bound form suggests that binding of both metals causes analogous
secondary structural rearrangement, which is consistent with Trp emission results.
Also, the CD signal of DREAM(E234Q) is not affected by Cd 2+ association to the
apo-protein (Figure 4.4D). Far-UV CD data have been analyzed using secondary
structure prediction tool K2D3 (Louis‐Jeune, Andrade‐Navarro et al. 2012) and results
reveal that Cd2+ increases the -helical property of the protein by ~ 6% in
WTDREAM(64) and DREAM(E186Q) and by ~10 % in WTDREAM(160).
In addition to steady-state emission properties of W169, we have
characterized W169 fluorescence in frequency-domain measurements (Figure 4.5
and Table 4.1). Modulation-phase data were analyzed using a three discrete
exponential decay model. Such multi-exponential decay of the single W169 residue
can be attributed to the presence of multiple rotamers of the indole side chain and/or
by the presence of multiple conformational states as proposed in Ref (Pham,
Dhulipala et al. 2015). The average lifetime of W169 decreases from 3.8 ns in
apoWTDREAM(64) to 3.1 ns and 3.2 ns in Ca2+ and Cd2+ bound protein,
respectively. The decrease in the average lifetime can be attributed to the decrease
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of the individual lifetimes and a concomitant increase in the pre-exponential factor
1 upon Ca2+ or Cd2+ binding to the protein (Table 4.1). Fluorescence decay
parameters

observed

for

Cd2+WTDREAM(64)

closely

resembles

Ca2+WTDREAM(64), pointing towards a similar environment of W169 in Cd2+
and Ca2+ bound DREAM.

Figure 4.5. Frequency-domain intensity decay of 20 µM
apoDREAM(64)
(square),
Ca2+DREAM(64)
(circle),
2+
Cd DREAM(64) (up triangle), and Cd2+Ca2+DREAM (64) (down
triangle). Solid symbols represent phase delay, whereas empty symbols
represent modulation ratio. Solid lines correspond to the fitting of the
data using a sum of three exponential decay model.
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Table 4.1. Fluorescence decay parameters of WTDREAM(64) in the presence and absence of
Ca2+ and Cd2+.
τ1
τ2
τ3
f1
f2
f3
<τ>
1
2
3
2
(ns)
(ns)
(ns)
(%)
(%)
(%)
(%)
(%) (%) (ns)
apo
0.24 ± 2.5 ± 7.1 ± 17.3 ± 45.4 ± 37.3 ± 75.1 19.2 5.9
3.8
1.5
0.03
0.1
0.3
0.8
3.0
0.3
Ca2+
0.16 ± 1.9 ± 6.3 ± 22.0 ± 37.5 ± 40.5 ± 84.5 12.1 3.3
3.1
0.9
0.02
0.1
0.2
0.9
2.0
2.0
Cd2+
0.16 ± 1.9 ± 6.3 ± 22.3 ± 37.3 ± 40.4 ± 84.6 12.0 3.2
3.2
0.6
0.02
0.1
0.2
0.2
2.0
2.0
Cd2+Ca2+ 0.16 ± 2.0 ± 6.3 ± 22.5 ± 37.5 ± 40.0 ± 83.9 12.3 3.6
3.2
0.9
0.02
0.1
0.3
0.9
2.0
2.0
Recovered from Vinci analysis software using a sum of three discrete exponential decays. Phase
and modulation errors were respectively set at ≤ 0.2° and ≤0.004. τ1, τ2, and τ3 represent lifetimes
of the three discrete exponential decays; f1, f2and f3 are exponential decay fractions; 1, 2, and 3
represent pre-exponential factors. 2 represents the goodness of the fit.
Samples
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4.2.2 Cd2+ regulates DREAM affinity for 1,8-ANS
We have shown previously that Ca2+ association increases DREAM
affinity for small hydrophobic molecules such as 1,8-ANS and arachidonic acid
(Gonzalez, Miksovska 2014). To probe whether Cd2+ association impacts DREAM
affinity for 1,8-ANS, the emission spectra of WTDREAM(Δ64):1,8-ANS complex
in the metal-free form and in the presence of Ca 2+ or Cd2+ were determined. 1,8ANS has been extensively used for evaluating hydrophobicity of the protein surface
as 1,8-ANS is nearly non-fluorescent in aqueous solutions and its emission intensity
increases upon the association to hydrophobic cavities on the protein surface
(Cardamone, Puri 1992). The effect of Cd2+ binding on DREAM affinity for 1,8ANS is shown in Figure 4.6. The rise in the emission intensity of 1,8-ANS in the
presence of apoWTDREAM(Δ64) is indicative of 1,8-ANS binding to hydrophobic
patches on the protein surface. The fluorescence intensity increases further upon
Cd2+ addition to WTDREAM(Δ64), due to an additional binding of 1,8-ANS to the
protein

(Figure

4.6).

Interestingly,

the

emission

intensity

of

Cd2+WTDREAM(Δ64):1,8ANS complex is lower than that measured for
Ca2+WTDREAM(Δ64):1,8ANS. These results suggest that overall structural
changes triggered by Cd2+ binding to DREAM are somewhat limited and do not
include a full exposure of the hydrophobic surface as observed in the case of Ca2+
binding. Analogous increase in emission intensity is observed for Cd2+ binding to
metal-free DREAM(E186Q):1,8-ANS and DREAM(E234Q):1,8-ANS complex,
indicating, that both EF-3 and EF-4 binds Cd2+ and the metal association to either
EF-hand increases the accessibility of the 1,8-ANS binding sites. The emission
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intensity of the Cd2+DREAM (Δ160):1,8-ANS complex is comparable to that for
Ca2+DREAM(Δ160):1,8-ANS. The emission maxima for both complexes are red-
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Figure 4.6. Emission spectra of (A) 1,8-ANS:DREAM(Δ64), (B) 1,8ANS:DREAM(Δ160), (C) 1,8-ANS:DREAM(E186), and (D) 1,8ANS:DREAM(E234Q) complexes. Conditions: Conditions: 20 µM protein in
20 mM Tris pH 7.4, 20 µM 1,8-ANS, 2 mM EDTA or 2 mM Ca2+, and/or 100
µM Cd2+ . Emission spectra were recorded using 350 nm excitation light.
WTDREAM(64) likely due to the large solvent exposure of the hydrophobic cavity
in DREAM(Δ160) construct. To determine the equilibrium affinity constant for 1,8ANS binding to DREAM, we titrated WTDREAM(Δ64) into a constant amount of
1,8-ANS and analyzed the experimental data using Equation 1 (Figure 4.7).
Equilibrium

dissociation

constant

recovered

for

1,8-ANS

binding

to

Cd2+WTDREAM(Δ64) (Kd = 84 ± 4 µM) is two-fold lower than that previously
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determined for 1,8-ANS binding to apoWTDREAM(Δ64) (195 ± 20 µM)
(Gonzalez, Miksovska 2014), supporting the idea that Cd2+ association with
DREAM leads to increased exposure of hydrophobic cavities. However, the K d
value for 1,8-ANS binding to Cd2+WTDREAM(Δ64) (84 ± 4 µM) is higher than the
value previously determined for ANS binding to Ca2+WTDREAM(Δ64) (Kd = 62 ±
4 µM) (Gonzalez, Miksovska 2014). This is in agreement with the steady-state
emission spectra that show lower emission intensity of Cd 2+WTDREAM(64):1,8ANS compare to Ca2+WTDREAM(64):1,8-ANS.

Figure 4.7. Titration curve for 1,8-ANS binding to
Cd2+DREAM(Δ64). The solid line represents the best
fit of the experimental data using Equation 1. Standard
deviations are shown as error bars.
To corroborate the findings of the WTDREAM(Δ64):1,8-ANS steadystate emission study, we measured the lifetime of WTDREAM(Δ64):1,8-ANS in
metal-free form and in the presence of Cd2+ or Ca2+ (Figure 4.8 and Table 4.2). The
fluorescence decay parameters for 1,8-ANS bound to WTDREAM(64) are
sensitive to metal-induced structural rearrangement. 1,8-ANS in 20 mM Tris shows
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Figure 4.8 Frequency-domain intensity decay of 40 μΜ 1,8-ANS:54
μΜ DREAM(Δ64) complexes in the presence of EDTA (squares),
Ca2+ (circle), Cd2+ (up triangle), and Cd2+Ca2+ (down triangle). Solid
symbols represent phase delay, whereas empty symbols represent
modulation ratio. Solid lines represent the fitting of the data using
three-exponential decay model.
a single lifetime of 0.28 ns, but upon binding to metal-free WTDREAM(Δ64) two
additional lifetimes (1 = 4.1 ns and 2 = 16.9 ns) were resolved, which can be
attributed to 1,8-ANS association to two distinct 1,8-ANS binding sites on DREAM
surface. Previously, we used a molecular docking approach to identify 1,8-ANS
binding sites (Gonzalez, Miksovska 2014) and attributed the shorter lifetime (1 =
4.1 ns) to 1,8-ANS association to a partially solvent-exposed binding site between
the EF-3 and EF-4. The longer lifetime (2 = 16.9 ns) can be assigned to 1,8-ANS
binding to a nonpolar solvent restricted binding site between helix-8 and helix-9 of
EF-4. Cd2+ addition to metal-free WTDREAM(Δ64):1,8-ANS results in an increase
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in the longer lifetime (2 = 17.8 ns) and the 2 parameter increases from 21.9% for
metal-free

WTDREAM(Δ64):1,8-ANS

complex

to

36.7%

for

Cd2+WTDREAM(Δ64):1,8-ANS complex (Table 4.2). Also, Ca2+ binding to metalfree WTDREAM(Δ64):1,8-ANS complex leads to more pronounced increase in preexponential factor 2 than Cd2+ association, in agreement with the results from the
emission data that show higher emission intensity of WTDREAM(Δ64):1,8-ANS
complex in the presence of Ca2+ with respect to Cd2+ (Table 4.2). The small
alteration of individual WTDREAM:1,8-ANS complex lifetimes upon Ca2+ or Cd2+
association compare to metal-free WTDREAM(Δ64) is indicative of 1,8-ANS
binding to identical binding sites in metal-free, Cd2+-, and Ca2+-bound protein (Table
4.2).
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Table 4.2. Fluorescence decay parameters of WTDREAM(64):1,8-ANS complexes.
Samples
f1 (%)
f2 (%)
1 (ns)
1 (%)
2 (ns)
2 (%)
apo
4.1 ± 0.1
15.5
15.4 ± 0.9 16.9 ± 0.2 21.9
83.0 ± 1.0
2+
Ca
4.3 ± 0.2
16.9
9.7 ± 0.6 18.0 ± 0.1 42.7
88.9 ± 0.5
2+
Cd
4.3 ± 0.3
15.9
9.6 ± 0.6 17.8 ± 0.2 36.7
88.8 ± 0.6
2+
2+
Cd Ca
4.3 ± 0.2
15.9
9.8 ± 0.6 17.9 ± 0.1 36.8
88.9 ± 0.5

0 (%)
62.6
40.3
47.4

2
0.9
0.9
0.8

47.2

0.9

Data recovered from Vinci analysis software using a sum of three discrete exponential decays with fixed 1,8ANS lifetime (0 = 0.28 ns). Phase and modulation errors were respectively set at ≤ 0.2° and ≤0.004. 0, 1,
and 2 represent lifetimes of the three discrete exponential decays; f0, f1and f2 are exponential decay fractions;
0, 1, and 2 represent pre-exponential factors. 2 represents the goodness of the fit.
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4.2.3 Cd2+ associates with DREAM through an entropy-driven process.
The thermodynamic parameters associated with Cd2+ binding to
Ca2+WTDREAM(64) and Ca2+WTDREAM(160) were determined using ITC
(Figure 4.9). The binding isotherms were analyzed using a sequential model with
two binding sites and the fitting parameters are listed in Table 4.3. Cd2+displacement

of Ca2+

Figure 4.9. ITC isotherms for the displacement of Ca2+ by Cd2+ from
EF-hand of (A) DREAM (Δ64) and (B) DREAM (Δ160). The upper
panels of the profiles represent the thermal power expressed in
µcal.s-1, whereas the lower panels show integrated reaction heats
(ΔH) expressed in kcal. mole-1. The solid lines represent the best
fitting curve using sequential model (2 sites). Thermodynamics
parameters recovered from the model are listed in Table 4.3.
from EF-hands of WTDREAM(64) is an entropy-driven process as

evidenced by a positive change in enthalpy (Htotal = 25  5 kcal mol-1). Two Cd2+
ions associate with Ca2+WTDREAM(64) with apparent association constants of 22
± 4 M-1 and 7 ± 1 M-1. Slightly lower affinity constants were measured for
WTDREAM(160), K1 = 18 ± 2 M-1 and K2 = 5 ± 2 M-1, in agreement with Cd2+
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binding to the C- terminal domain. Based on these results we can not unambiguously
assign the affinity constants to the individual EF-hands in the C- terminal domain.
Using Equation 2 and 3, the overall apparent dissociation constant for Cd 2+ binding
to Ca2+WTDREAM(64) was determined to be 9 ± 1 μM and the overall
dissociation constant for Cd2+ binding to metal-free WTDREAM(64) was found to
be 89 ± 10 nM, which is in agreement with the value obtained from fluorescence
titration (80 ± 10 nM). These results show that apoDREAM binds Cd2+ with
approximately 10-fold higher affinity than Ca2+. This is somewhat surprising, as
another EF-hand protein, calmodulin, binds Cd2+ with 3-fold lower affinity than its
physiological ligand Ca2+ (Milos, Schaer et al. 1989).
The Cd2+ association to both EF-hands shows a positive reaction
enthalpy and entropy change. The gain of entropy over enthalpy cannot be explained
in term of a water molecule(s) release as previous Raman and computational study
suggested [Cd(OH2)6]2+ clusters to be thermodynamically stable (Rudolph, Pye
1998), whereas a first hydration sphere of Ca2+ ion can include up to 8 water
molecules (Jalilehvand, Spångberg et al. 2001, Marcus 1991). The X-ray structures of
skeletal troponin C shows only small differences in the coordination of Cd2+
compared to Ca2+ with both metals adopting distorted pentagonal bipyramidal
coordination (Rao, Satyshur et al. 1996). On the other hand, in the X-ray structure
of the N- terminal domain of cardiac troponin C, Cd2+ bound to EF-1 exhibit noncanonical coordination with a Cys residue serving as a coordinating ligand (Fulcher
2015). Unlike Ca2+, Cd2+ is a soft metal and forms a covalent bond with thiol ligands
(Choong, Liu et al. 2014). In the sequence of mouse DREAM, Cys 181 is located
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in the EF-3 loop and thus may participate in Cd2+ metal coordination. However,
structural studies are necessary to conclusively identify which residues participate
in Cd2+ coordination.
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Table 4.3. Thermodynamic parameters determined for displacement of Ca2+ by Cd2+ from EF hands of
DREAM.
K1 x 104
(M-1)

K2 x 104 H1
( M-1)
(kcal mol-1)

H2
TS1
-1
(kcal mol ) (kcal mol-1)

TS2
(kcal mol-1)

DREAM(64) + Cd2+

22 ± 4

7±1

9±5

17 ± 2

16 ± 5

23 ± 2

DREAM(160) + Cd2+

18 ± 2

5±2

10 ±3

16 ± 4

17 ± 3

22 ± 4

All experiments were conducted three times at 25 °C. Data were fitted with a sequential model (2 sites);
errors represent standard deviations from three independent measurements.
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4.2.4 Cd2+ Modulates DREAM Interactions with Binding Partners.
It has been shown previously that Ca2+ association facilitates DREAM
interaction with C-terminal domain of presenilin-1 which stimulates the activity of
γ- secretase and consequently facilitates the generation of Aβ42, a peptide that has
been linked to Alzheimer’s disease (Jo, Jang et al. 2005). To investigate whether
Cd2+ binding impacts DREAM affinity for presenilin, the equilibrium dissociation
constant for DREAM association with PS1HL9 has been determined. We have
chosen PS1HL9 as a model for presenilin-1 as earlier studies have shown that
DREAM interacts with the residues from helix-9 of presenilin-1 (Buxbaum, Choi et
al. 1998, Pham, Miksovska 2016). Cd2+DREAM was titrated into the solution of
FITC-tagged PS1HL9 and the change in the anisotropy was determined and plotted
as a function of Cd2+DREAM concentration (Figure 4.10). The equilibrium

Figure 4.10 Titration of 0.5 μM PS1HL9 against Cd2+-bound
DREAM constructs. The solid lines represent the fits of the
experimental data using Equation 1; standard deviations are
shown as error bars.
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dissociation constant was obtained by fitting the titration data to Equation 1.
Cd2+WTDREAM(64) has 10-fold lower affinity for PS1HL9 (Kd = 6 ± 1 µM) than
Ca2+WTDREAM(64) (Kd = 0.6 ± 0.1 µM, respectively) and about 30-times higher
affinity for PS1HL9 than apoWTDREAM(64) (Kd = 183 ± 12 µM) (Table 4.4),
suggesting Cd2+ association modulates DREAM interaction with presenilin-1.
PS1HL9

binds

to

Cd2+WTDREAM(160)

with

a

Kd

similar

to

Cd2+WTDREAM(64) confirms that N-terminal doesn’t have any role in PS1HL9
binding (Table 4.4). To determine Cd2+ binding to which EF-hand regulates
DREAM interactions with PS1HL9, we investigated PS1HL9 binding to
Cd2+DREAM(E186Q) and Cd2+DREAM(E234Q). Both Cd2+DREAM(E234Q) and
Cd2+DREAM(E186Q) have a lower affinity for PS1HL9 (Table 4.4). This finding is
consistent with our previous finding that Ca2+DREAM(E186Q) has a lower affinity
for PS1HL9 than Ca2+DREAM(E234Q) (Pham, Miksovska 2016). It has been
shown in transgenic mice model that Cd2+ treatment increases the level of Aβ42 and
aggravates behavioral symptoms of Alzheimer’s disease (Li, Lv et al. 2012). The
observed Cd2+ modulation of DREAM interaction with PS1HL9 indicates that at
high concentration Cd2+, the formation of Cd2+DREAM complex might facilitate of
β-amyloid precursor protein cleavage to produce Aβ42 and contribute to
Alzheimer’s disease
DREAM, as well as other members of KChIPs, are integral auxiliary
subunits of A-type potassium voltage channels and binding of KChIPs to Kv4
channels has been shown to result in regulation of fast component of ITO current in
heart and ISO current in brain, modulation of gating properties, increased surface
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expression and facilitation of subunit assembly of Kv4 channels (An, Bowlby et al.
2000, Bourdeau, Laplante et al. 2011, Gonzalez, Pham et al. 2014, Bahring,
Dannenberg et al. 2001, Scannevin, Wang et al. 2004, Niwa, Nerbonne 2010).
Although binding of DREAM to Kv channels is Ca 2+ independent, the presence of
Ca2+ alters the kinetics of Kv channel inactivation (Patel, Campbell et al. 2002).
Crystallographic studies have shown that Kv4 interacts with KChIPs through its Nterminus of T1 domain and resulting Kv4–KChIPs complex is octamer (4:4 manner)
in which each KChIPs molecule simultaneously interacts with two Kv4.3 molecules
(Pioletti, Findeisen et al. 2006, Wang, Yan et al. 2007a). Two binding sites are
involved in the formation of Kv4–KChIPs octamer. Site-1 of Kv4 channel is
composed of non-polar residues 2–22 and it binds to the deep hydrophobic pocket
on the surface of KChIPs, whereas site-2 (residue 70–90) of Kv4 channel is
composed of predominately polar residues and interacts with N-terminal helix-2 of
KChIPs through the salt bridge and hydrophobic interaction (Pioletti, Findeisen et
al. 2006, Callsen, Isbrandt et al. 2005, Wang, Yan et al. 2007a). Previous research
in our group has demonstrated that Ca2+ and Pb2+ modulate the interaction between
DREAM and site-1 and site-2 (Azam, Miksovska 2018, Gonzalez, Pham et al.
2014). To investigate whether Cd2+ association with DREAM alters DREAM
interactions with site-1 and site-2, Cd2+DREAM constructs were titrated into FITClabeled site-1 and site-2 and the change in FITC-labeled peptide anisotropy was
monitored (Figure 4.11 and 4.12). Equilibrium dissociation constants were obtained
by fitting the data to Equation 1 and the values are listed in Table 4.4. Titration
results reveal that Cd2+WTDREAM(64) has seven-fold higher affinity for site-1
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Figure 4.11. Titration of 0.5 μM Kv4.3 (2–22) “site-1” against
Cd2+-bound DREAM constructs. The solid lines represent the
fits of the experimental data using Equation 1; standard
shown as error bars.
(Kd = 10 ± 1 deviations
µM) than are
apoDREAM(64)
(Kd = 70 ± 1) µM), and its affinity for
site-1 is approximately four-times lower than that of Ca2+WTDREAM(64) (Table
4.4). Considering that a hydrophobic site-1 binds to the hydrophobic cavity on
DREAM surface, these results are consistent with WTDREAM(64):1,8-ANS
emission data that demonstrate a lower exposure of hydrophobic surface for Cd 2+bound protein compared to Ca2+-bound protein that may result in a lower affinity for
site-1 (Table 4.4). DREAM(E186) and DREAM(E234Q) did not show any binding
to site-1 in metal-free form and in Cd2+-bound form. Inactivating EF-3 in
DREAM(E186Q)

or

EF-4

in

DREAM(E234Q)

might

trigger

structural

reorganizations in the protein which disturb the hydrophobic cavity and
consequently abolish binding of site-1. Site-2 shows relatively weaker binding to
Cd2+DREAM(64) than Ca2+WTDREAM(64), but the affinity of site-2 binding
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Figure 4.12. Titration of 0.5 μM Kv4.3 (70–90) “site-2” against Cd2+bound DREAM constructs. The solid lines represent the fits of the
experimental data using Equation 1; standard deviations are shown as
error bars.
Cd2+WTDREAM(64) is 15-times higher than site-2 binding to metal-free
DREAM(64), indicating Cd2+ binding may promote DREAM interactions with
site-2 (Table 4.4). Cd2+DREAM(E186) and Cd2+DREAM(E234Q) bind to site-2
with an affinity comparable to site-2 association with Cd2+WTDREAM(64),
suggesting binding of Cd2+ to a single EF-hand is sufficient to promote the site-2
association to DREAM (Table 4.4). Taken together, the above results suggest that
Cd2+ binding to DREAM may impact the deactivation kinetics of Kv channels
complexes. Kv channel–KChIP complexes may represent a molecular target for
Cd2+-induced memory and learning deficiencies as Kv channels have been
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implicated in hippocampus-dependent memory and learning (Lugo, Brewster et al.
2012). Considering high sequence homology of the neuronal calcium sensors
(Ames, Lim 2012) and involvement of Cd2+ in different types of cancers (Waalkes
2000, Pesch, Haerting et al. 2000, Joseph, Muchnok et al. 2001) and
neurodegenerative diseases, (Okuda, Iwamoto et al. 1997, Johnson 2001, Panayi,
Spyrou et al. 2002) other members of NCS family could bind Cd 2+ with high
affinity and contribute to Cd2+-induced toxicity.
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Table 4.4. The equilibrium dissociation constants for PS1HL9, site-1 site-2 binding to DREAM
constructs.
DREAM constructs

PS1HL9
Kd (µM)

Site-1
Kd (µM)

Site-2
Kd (µM)

DREAM(64)
apo
183 ± 12
70 ± 3
̴500
2+
Ca
0.6 ± 0.1
2.7 ± 0.1
10 ± 1
Cd2+
6±1
10 ± 1
34 ± 1
DREAM(160)
apo
no binding
̴450
n.d.
Ca2+
11 ± 1
24 ± 1
n.d
2+
Cd
7±1
16 ± 1
n.d
DREAM(E186Q)
apo
149 ± 22
no binding
n.d.
2+
Ca
32 ± 1
no binding
n.d.
Cd2+
16 ± 1
no binding
43 ± 2
DREAM(E234Q)
apo
146 ± 14
no binding
n.d.
2+
Ca
8±1
no binding
n.d.
Cd2+
10 ± 1
no binding
36 ± 2
Data for DREAM(64), DREAM(160), DREAM(E186Q), and DREAM(E234Q) interactions
with PS1HL9 in apo and Ca2+-bound form are taken from reference (Pham, Miksovska 2016); data
for DREAM(64) and DREAM(160) interactions with site-1 and site-2 in apo and Ca2+-bound
form are taken from reference (Gonzalez, Pham et al. 2014).
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4.3 Summary
In this article, using a combination of spectroscopic and calorimetric techniques we
first time report Cd2+ binding to EF-hands in DREAM. We also show that Cd2+
association with DREAM modulates DREAM interactions with interacting partners,
such as site-1 and site-2 of potassium voltage channel and presenilin-1. Interestingly,
despite the fact that Cd2+ ion has similar ionic radii and charge/radius ratio values as
Ca2+, the association of Cd2+ to EF-3 and EF-4 leads to a conformational transition
that is somewhat restricted compared to that determined for the binding of the
physiological ligand, Ca2+. This is evident by 1,8-ANS emission data as well as by
lower affinity constants for binding of peptides that mimic physiological effector
proteins presenilin and T1 domain of Kv channels. However, the superior affinity of
Cd2+ for DREAM suggest that under conditions of acute or chronic exposure to Cd 2+,
Cd2+ may bind to DREAM and probably other neuronal sensors and these
interactions may provide insight into molecular basis of Cd2+ induced neurotoxicity.
We hope this study will encourage future NMR and X-ray crystallography on Cd2+bound neuronal calcium sensors to provide atomic-level insight into the mechanism
of this neurotoxic metal’s interactions with neuronal calcium sensors.
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5. BINDING OF THE NEUROPROTECTIVE AGENT LITHIUM TO NEURONAL
CALCIUM SENSOR PROTEIN DREAM: A NEW INSIGHT INTO LITHIUM
THERAPY.
5.1 Background and significance

Li+-based compounds have been used extensively for the treatment of severe mental
disorders for more than six decades (Cade 1949, Marmol 2008, Vosahlikova, Svoboda
2016). However, the molecular mechanism of how lithium works remain one of the greatest
challenges in modern psychology. Recent in vivo and in vitro studies in humans and rodents
demonstrated the neuroprotective role of Li+ and proposed its probable application for
treatment of neurogenerative diseases such as Parkinson’s disease, Alzheimer’s disease
(AD), and Huntington’s disease (De Ferrari, Chacon et al. 2003, Youdim, Arraf 2004, Wei,
Qin et al. 2001, Senatorov, Ren et al. 2004, Forlenza, De-Paula, Vanessa de Jesus Rodrigues
et al. 2014). Despite numerous clinical applications of Li+ in psychopharmacology for
treating devastating diseases, the exact mechanism through which Li+ exerts its therapeutic
effects has not been elucidated yet. Several mechanisms have been proposed and its
molecular targets remain unknown. Inhibitions of inositol monophosphatase (IMPase) and
glycogen synthase kinase-3 beta (GSK-3β) are the most relevant mechanisms of action
(Forlenza, De-Paula, Vanessa de Jesus Rodrigues et al. 2014, Williams, Harwood 2000,
Brown, Tracy 2013). IMPase is overexpressed in bipolar disorder patients and this
overexpression causes inositol level increase (Dudev, Mazmanian et al. 2018, Haimovich,
Eliav et al. 2012). According to the inositol depletion hypothesis, Li+ treatment inhibits
IMPase by displacing native cofactor Mg2+ and eventually decreases the level of inositol
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(Harwood 2005, Hallcher, Sherman 1980). Experimental studies in transgenic mice models
overexpressing GSK-3β and in other animal models of Alzheimer’s disease (AD) have
demonstrated that chronic Li+ administration causes a remarkable decrease in tau
phosphorylation (Engel, Goñi‐Oliver et al. 2006, Leroy, Ando et al. 2010, Noble, Planel et
al. 2005). Similarly, it has been shown that chronic lithium administration reduces Aβ42
(overproduction of this peptide has been associated with AD) production through inhibition
of GSK-3β and through modulation of the amyloid precursor protein (APP) (Rockenstein,
Torrance et al. 2007, Su, Ryder et al. 2004). Multiple lines of studies have demonstrated
that chronic Li+ administration prevents or reverses neuronal cell death and thus Li+ can
act as a neuroprotective agent by up-regulating cell survival molecules, including brainderived neurotrophic factor (BDNF), cyclic

AMP-responsive element binding protein

(CREB), β-catenin, and brain grey matter volume, but by down-regulating pro-apoptotic
activities, such as excitotoxicity, Bax, caspase, cytochrome c release (Wada, Yokoo et al.
2005).
Increased expression of neuronal calcium sensor protein-1 (NCS-1) and reduced
gamma band activity has been reported in the brain of bipolar disorder patient (Koh, Undie
et al. 2003, Özerdem, Güntekin et al. 2011). NCS-1 overexpression is considered
responsible for the decrease in gamma-band activity (D'Onofrio, Kezunovic et al. 2015).
Li+ treatment has been shown to treat mood disturbances seen in bipolar disorder patients
by inhibiting the interaction between NCS-1 and inositol 1,4,5-triphosphate receptor
protein (Schlecker, Boehmerle et al. 2006a). Stasia D’Onofrio et al. (D'Onofrio, Hyde et
al. 2017) have demonstrated that lithium treatment reduces the effects of overexpression
of NCS-1 and thereby prevents the decrease of gamma-band activity, eventually restoring
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the normal level of gamma oscillation. Lithium-pilocarpine administration has been shown
to alter the expression of voltage-gated potassium channel 4.2 (Kv4.2) and potassium
channel-interacting protein (KChIP1) and to alter calcium homeostasis in rat hippocampus
(Su, Cong et al. 2008). A recent computation study based on competition between Na+ and
Li+ in various neurotransmitters and G-protein coupled receptors Na+ binding sites has
revealed that neutral protein ligands such as Thr/Ser hydroxyl group preferentially bind
Na+, whereas negatively charged ligands such as Asp/Glu carboxylate favor Li+ (Dudev,
Mazmanian et al. 2018).
Decades of research have shown that monovalent ion K+ activates enzymes
including pyruvate kinase, tryptophanase, tyrosinase, and Na+ activates thrombin, βgalactosidase, and tryptophan synthase (Page, Di Cera 2006, Gohara, Di Cera 2016). The
highest affinity for K+-protein interaction reported to be 0.08-0.6 mM range (Gohara, Di
Cera 2016). It has been shown that Na+ binds to thrombin with Kd 110 mM and Na+-bound
form of thrombin is responsible for the blood procoagulant function of the enzyme (Page,
Di Cera 2006). Na+ also can occupy the EF-hand of parvalbumin and attenuates affinity of
Ca2+ for parvalbumin (Henzl, Larson et al. 2004a). Li+ shares more similarity with Ca2+
than Na+ and K+, with charge/ionic radii ratio 1.47, 2.02, 1.03, 0.75 e/Å, respectively,
suggesting Li+ has more likelihood to occupy Ca2+ binding site than Na+ and K+ (Page, Di
Cera 2006).
Downstream regulatory element antagonist modulator (DREAM), also known as
calsenilin, or potassium channel-interacting protein 3 (KChIP3), is a 29 kDa neuronal
calcium sensor (NCS) protein, which is expressed in the hippocampus of the brain (Carrion,
Link et al. 1999). DREAM is a multifunction protein that has been linked to pain sensing,
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memory and learning process, AD, and modulation of Kv4 expression and kinetics (An,
Bowlby et al. 2000, Buxbaum, Choi et al. 1998, Cheng, Pitcher et al. 2002, Costigan, Woolf
2002, Fontán-Lozano, Romero-Granados et al. 2009, Jo, Jang et al. 2005, Abd Rashid,
Hapidin et al. 2017). DREAM contains two domains, with each domain composed of two
EF-hands. Nonfunctional EF-1 (residue 90-119) and EF-2 (residue 128-157) together with
a short N- terminus -helix form an N–terminal domain, whereas calcium-binding EF-3
(residue 163-192) and EF-4 (residue 211-240) along with a 13-residue long C-terminal helix form a C-terminal domain (Lusin, Vanarotti et al. 2008). Among four EF-hands of
DREAM, EF-1 is non-functional due to the presence of Cys 104 and Pro 105 at the EFhand loop, which distorts Ca2+-binding geometry; EF-2 selectively binds Mg2+ because of
the presence of Asp at the 12th position of the EF-loop rather than usual glutamate; and the
canonical EF-3 and EF-4 preferentially bind Ca2+ with a Kd 1–10 µM (Gifford, Walsh et al.
2007, Osawa, Dace et al. 2005, Osawa, Tong et al. 2001). We have recently reported that
EF-hands in DREAM are not calcium specific but can also bind lanthanide Tb3+ and toxic
metal Pb2+ with an affinity that is superior to affinity for Ca2+ (Azam, Miksovska 2018,
Gonzalez, Ramos et al. 2016). Based on the rationale of Li+ induced alteration of
expression of KChIP1 (a protein homologous to DREAM), propensity of Li+ binding
through negatively charged amino acid residues, impact of Li+ on hippocampus, and
preponderance of negatively charged amino acid residues at EF-hand of DREAM, we
postulate that DREAM is a molecular target of Li+. Our hypothesis is supported by our
computation data which shows three potential lithium binding sites.

In this

Communication, using multiple lines of evidence, we first time demonstrate that Li+ bind
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at EF-hand of DREAM; Li+ binding leads to secondary and tertiary structural
rearrangement of the protein; and Li+ modulates DREAM interaction with Kv4 channel.
5.2 Results and discussion
To test the hypothesis that Li+ binds to DREAM, our first approach was to probe the
impact of Li+ on emission spectra of DREAM(64) construct that contains residues 65–
256. Emission spectra reveal that Li+ addition to metal-free DREAM(64) causes ̴20%
decrease in emission intensity, which is identical to a decrease observed for Ca2+
association to DREAM(64), suggesting that both

Li+ and Ca2+ induce analogous

Figure 5.1. Impact of Li+ binding on tryptophan emission of (A) DREAM(Δ64),
(B) DREAM(Δ160), (C) DREAM(E186Q), and (D) DREAM(E234Q). In each
case, 20 µM protein samples in 20 mM Tris were excited at 295 nm;
concentrations of EDTA, Ca2+, and Li+ in each DREAM construct were 2 mM,
2 mM, and 50 µM, respectively; Ca2+Li+DREAM constructs were prepared by
adding 2 mM Ca2+ to DREAM constructs in the presence of 50 µM Li+.
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rearrangement in the protein tertiary structure resulting in the modification of the W169
surrounding (Figure 5.1A) and pointing towards the possibility that Li+ may bind to the
EF-hands. Also, no change in emission spectra was observed upon Li+ addition to
Ca2+DREAM(64) and vice versa indicating that Ca2+ and Li+ may bind to identical
binding sites. The addition of Li+ to Mg2+DREAM(64) leads to a comparable decrease in
emission intensity, suggesting that the occupation of EF-2 by Mg2+ does not impact Li+
interaction with DREAM. Analogous decrease in the emission spectra was observed upon
Li+ addition to the isolated C-terminal domain (DREAM(160)). In addition, the emission
spectrum of DREAM(160) shifts from 351 nm in the absence of Li+ to 348 nm in the
presence of metal (Figure 5.1B) pointing towards the Li+ binding site being located in the
C-terminal domain. The longer wavelength emission maxima observed for DREAM(160)
is indicative of a more polar environment of W169 in this construct. To provide further
insight into the location of Li+ binding site, we measured emission spectra of
DREAM(E186Q) and DREAM(E234Q) which have glutamate in the 12th position of the
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Figure 5.2. Impact of Li+ binding to DREAM(65-256) in the presence of 100 mM
Na+ or 100 mM K+. Condition: 20 µM DREAM(65-256), 2 mM Li+, excited at 295
nm.
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calcium-binding loop in EF-hand 3 or EF-hand 4, respectively, replaced by glutamine
(Figure 5.1C,D). Emission spectra unveil that Li+ or Ca2+ addition to DREAM(E186)
results in a comparable decrease in emission intensity as observed for DREAM(64),
whereas emission spectra of Li+DREAM(E234Q) and Ca2+DREAM(E234Q) are
superimposable to the spectrum for apoDREAM. This is consistent with the fact that Li+
or Ca2+ association to EF-4 triggers structural rearrangement which leads to a more
efficient

W169

emission

quenching.

The

identical

emission

spectra

for

apoDREAM(E234Q) in the absence or presence of Ca2+ or Li+ suggest an absence of

Figure 5.3. Impact of Li+ binding on far-UV CD spectra of (A) 20 µM
DREAM(Δ64), (B) 20 µM DREAM(Δ160), (C) 20 µM
DREAM(E186Q), and (D) 20 µM DREAM(E234Q) in 20 mM Tris.
Concentrations of EDTA, Ca2+, and Li+ in each DREAM construct
were 2 mM, 2 mM and 50 µM, respectively; Ca2+Li+DREAM
constructs were obtained adding 2 mM Ca2+ to DREAM constructs in
the presence of 50 µM Li+. All experiments were conducted at 18°C
using a J-810 Jasco CD spectrometer through the 2 mm path of a (2
mm x 10 mm) quartz cuvette.
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conformational change affecting the W169 emission due to the metal binding to this EFhand. To eliminate non-specific interactions between Li+ and DREAM, emission spectra
were also recorded in the presence of 100 mM NaCl or 100 mM KCl (Figure 5.2). The
addition of Li+ to DREAM in the presence of monovalent salts leads to the analogous
emission decrease, eliminating the contribution of the non-specific Li+ binding to DREAM.
To gain insight into the impact of Li+ binding on protein secondary structure, we
measured the far-UV CD spectra of DREAM constructs (Figure 5.3 A–D). CD spectra
unveil that ellipticity decreases analogously upon Li+ and Ca2+ binding to DREAM
constructs. The decrease in ellipticity could be attributed to an increase in -helices,

Figure 5.4. ITC isotherms for Li+ binding to EF-hand of metal-free A)
DREAM(Δ64) and B) DREAM(Δ160). 30 x 6 μL of 1 mM Li+ were titrated into 20
μM DREAM.Contribution of buffer was corrected. Thermal power expressed in
µcal.s-1 is shown in the upper panels of the profiles, whereas integrated reaction
heats (ΔH) expressed in kcal.mole-1 is shown in the lower panels. The solid lines
correspond to the best fitting curve using sequential model with two sites;
thermodynamics parameters obtained from the model are listed in Table 1.
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rearrangement of -helices, or both. Similar CD spectra of Li+DREAM and Ca2+DREAM
can be interpreted bythe fact that Li+ association triggers secondary structural
rearrangement analogous to Ca2+ association.
Thermodynamic parameters for Li+ binding to apoDREAM(64) were
characterized in ITC study (Figure 5.4A and Table 5.1). Analysis of binding isotherms for
Li+ association to apoDREAM(64) using a two side sequential binding model reveals
presence of two binding sites with association constants of 9.3 ± 1.7 x 104 M-1 and 9 ± 1
x103 M-1

and comparable association constants were measured for Li+ binding to

apoDREAM(160) (Figure 5.4B and Table 5.1). Li+ binding to the higher affinity site is
an endothermic reaction with a negligible change in enthalpy whereas association to the
lower affinity site displays a positive enthalpy and entropy change. The apparent
equilibrium dissociation constant (Kd) for Li+ association to metal-free DREAM(64) and
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Figure 5.5. A) Emission intensity of 20 µM metal-free DREAM(Δ64) upon Li+
addition; DREAM(Δ64) was prepared in 20 mM Tris, excited at 295 nm B) Titration
curve for Li+ binding to metal-free DREAM(Δ64). ΔF was calculated based on
decrease in Trp169 emission intensity at emission maximum. Solid line represents fit
of the data using Equation 2.
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DREAM(160) is 34 ± 4 μM and 50 ± 4 μM, respectively, indicating one order of
magnitude lower affinity of EF-hands for Li+ than for its physiological ligand calcium
(Equation 1). The analogous Kd value was obtained by observing changes in the Trp
emission upon Li+ titration into apoDREAM sample (Figure 5.5). The titration curve was
analyzed using a single binding site model, (Equation 2) and provided an equilibrium
dissociation constant of 31 ± 5 μM in a good agreement with the ITC results. We have also
measured binding isotherms for Li+ association to DREAM in the presence of 100 µM
Ca2+. The titration resulted in a negligible signal confirming that Li+ does not associate to
Ca2+-bound DREAM either due to the occupation of binding sites by Ca2+ or Li+ binding
sites does not overlay with binding sites for Ca2+, but are inaccessible in Ca2+ bound
DREAM.
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Table 5.1. Thermodynamics parameters recovered for Li+ binding to EF-hand of metal-free DREAM.
Samples

K1 X 104 K2 X 104
(M-1)
(M-1)

H1
(kcal/mole)

H2
(kcal/mole)

TS1
(kcal/mole)

TS2
(kcal/mole)

DREAM(64) + Li+

9.3 ± 1.7

0.9 ± 0.1

8.8 ± 0.4

- 8.6 ± 0.2

15.5 ± 0.3

- 3.2 ± 0.3

DREAM(160) + Li+

7.3 ± 0.6

0.6 ± 0.1

7.8 ± 0.8

3.3 ± 0.8

14.3 ± 0.8

8.0 ± 1.1

ITC experiments were performed three times at 25°C; parameters represent average of three independent
measurements, standard deviations are shown as errors.
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The 200 ns molecular dynamic (MD) simulation of Li+DREAM complex structure revealed
several Li+ binding sites on the protein surface (Figure 5.6). Li+, as a hard atom,
preferentially interacts with oxygen atoms. One Li+ binding site on DREAM surface is
formed by sidechain residues that coordinate Ca2+ in the EF-hand 4, namely Ap 223 and
Glu 234. Another binding site is formed by side chains of residues Asp134 and Asp 141
that belongs to the Mg2+ binding EF-hand 2. Li+ ions were also found to bind to other
negatively charged residues, namely Asp242 and Glu243 at the C- terminus and Glu164
and Asp 134 at the N-terminal domain. However, these interactions are likely to be transient
and unlikely to contribute to the observed changes in the DREAM secondary and tertiary
structure. Interestingly, Li+ association to the protein leads to the stabilization of the protein
structure as evident from the decreased root mean square fluctuation of backbone atoms
during the last 50 ns of the simulation with respect to the initial 20 ns. Previous data
showed that the lithium cation is coordinated with 4 to 6 oxygen atoms in complex with
carboxylic acids (Olsher, Izatt et al. 1991). A survey of the protein data bank reveals 29
protein structures with bound Li+ ion. In the majority of cases, Li+ is coordinated to the
protein through two to four oxygen atoms, predominantly from the side chains of aspartic
acid residue and from carbonyl oxygen in agreement with the MD data presented here.
As calmodulin (CaM) and parvalbumin were previously shown to bind monovalent
cations Na+ and K+ albeit with a millimolar affinity (Henzl, Larson et al. 2004b), we tested
if Li+ associates to rat CaM and trigger changes in the protein secondary or tertiary
structure. The CD spectrum of rat CaM in the presence of Li+ overlays with that for
apoCaM, whereas upon Ca2+ addition, the CD signal decreases which are consistent with
Ca2+ binding to apoCaM suggesting that Li+ does not bind to CaM or its association does
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Figure 5.6. (a) Lithium ions strongly bound to DREAM protein as revealed by the molecular
simulations. One of the binding sites (right) is also a calcium binding site. b) Other transient
binding sites observed during the simulations. (c) Root mean square fluctuation of backbone
atoms in protein for the first 50 ns (black) and the last 50 ns (red) of simulation. Protein
conformational flexibility is significantly reduced upon biding with lithium ions. (d) Root
mean square deviation of protein with respect to time, showing a stable protein-Li+complex.
not cause changes in the protein secondary structure (Figure 5.7A). The absence of Trp
residue in CaM sequence allows for monitoring CaM structural change associated with
metal binding to the N- terminal domain using intrinsic Phe emission and binding of metal
to the C- terminal domain using intrinsic Tyr emission (VanScyoc, Sorensen et al. 2002).
The emission spectrum of apoCaM using 250 nm excitation shows an emission maximum
at 300 nm that corresponds to the emission of Phe residues located in the N- terminus (
Figure 5.7B). The emission intensity increases upon the addition of 2 mM Ca2+, but no
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Figure 5.7. Impact of Li+ binding on secondary structure of 20 µM rCaM in 20 mM Tris
(A). Consequence of Li+ binding on the phenylalanine emission (B) and tyrosine
emission (C) of the same protein in the same condition. Samples were excited at 250 nm
and 277 nm for Figure (B) and (C), respectively. Concentrations of EDTA, Ca2+ and Li+
were 2 mM, 2 mM, and 2 mM, respectively.
increase was observed upon the addition of 2 mM Li+. The 277 nm excitation leads to the
emission spectrum with a maximum at 304 nm (Figure 5.7C). Addition of 2 mM Li + to
apoCaM does not result in changes in the emission spectrum of Tyr residues located in the
C- terminal domain whereas addition of 2 mM Ca2+ increases the emission intensity at 304
nm in agreement with Ca2+ binding to the EF-hand 3 and 4 in the C- terminal domain.
These results suggest that Li+ does not bind to EF-hand of CaM or its binding does not
cause structural changes that are analogous to those triggered by Ca2+ association. Thus
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unlike CaM, the EF-hands in the DREAM are able to bind Li+ at submillimolar
concentration, suggesting that Li+ binding to EF-hands may be specific for DREAM and
possibly other NCS proteins. This is supported by a previous result that demonstrated a
decrease in the Trp residue emission upon Li+ binding to neuronal calcium sensor 1 (NCS1), although no further characterization of Li+ interactions with isolated NCS-1 protein
(Schlecker, Boehmerle et al. 2006b).
Previous studies from our group have shown that binding of Ca2+ or toxic metals
such as Cd2+ or Pb2+ alters DREAM interaction with hydrophobic molecule 1,8-ANS
(Azam, Miksovska 2018, Gonzalez, Miksovska 2014). 1,8-ANS has been widely used for
assaying hydrophobicity of protein surface as emission intensity of 1,8-ANS increases
upon binding to hydrophobic cavities on the protein surface. Utilizing AutoDock software
version 4.2, we identified probable 1,8-ANS binding sites on the DREAM surface
(Gonzalez, Miksovska 2014, Morris, Huey et al. 2009). One binding site was identified
between then helix-8 and helix-9 of EF-4, while another site was found between EF-3 and
EF-4. To investigate whether Li+ association impacts DREAM affinity for 1,8-ANS, we
measured emission spectra of DREAM–1,8-ANS in the presence of Ca2+, Li+, and in the
metal-free form (Figure 5.8). Increase in emission intensity of 1,8-ANS upon binding to
apoDREAM

confirms

1,8-ANS

binding

to

DREAM(64).

Compared

with

apoDREAM(64)–ANS, higher emission intensity is observed for Li+DREAM(64)–
ANS, suggesting Li+ binding exposes the hydrophobic cavity on the DREAM surface,
which facilitates 1,8-ANS binding. However, Li+DREAM(64)–ANS has a lower
emission intensity than Ca2+DREAM(64)–ANS, indicating Ca2+ association to DREAM
exposes the hydrophobic cavity more than Li+ association. DREAM(160)–ANS
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complexes follow the same trend as DREAM(64)–ANS, providing additional evidence
that Li+ binds to the C- terminal domain and its interaction with protein exposes the
hydrophobic cavity of DREAM. To corroborate the finding of emission study, we
determined lifetimes of

DREAM(64)–ANS complexes utilizing frequency domain

fluorometry (Figure 5.9 and Table 5.2). 1,8-ANS bound to metal-free DREAM shows two
fluorescent lifetimes (1 = 4 ns and 2 = 16.8 ns), which is consistent with 1,8-ANS binding
to two distinct binding sites on DREAM surface (Table 5.2). Li+ association with metalfree DREAM(Δ64):1,8-ANS leads to an increase in longer lifetime (2 = 17.9 ns) and an
increase in the pre-exponential factor 2 from 21.2% in metal-free DREAM(Δ64):1,8ANS to 35.8% in Li+DREAM(Δ64):1,8-ANS, bolstering the findings of emission study
that Li+ binding to DREAM induces structural reorganization in the protein that exposes
the hydrophobic cavity. Additionally, Ca2+ association with metal-free DREAM(Δ64):1,8-

Figure 5.8. Consequences of Li+ binding on emission spectra of (A) 1,8ANS:DREAM(Δ64), (B) 1,8-ANS:DREAM(Δ160complexes. Conditions: 20 µM
DREAM, 20 µM 1,8-ANS; excited at 350 nm. Concentrations of EDTA, Ca2+, and Li+
were same as tryptophan emission.
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ANS causes further increase in 2, which is consistent with additional changes in the
protein structure.
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Figure 5.9. Frequency-domain intensity decay of 40 μΜ 1,8-ANS:54 μΜ
DREAM(Δ64) complexes in 20 mM Tris and in the presence of 2 mM EDTA
(squares), 2 mM Ca2+ (circle), 50 µM Li+ (up triangle), and (2 mM Ca2+ and
50 µM Li+) Ca2+Li+ (down triangle). Phase delay and modulation ratio are
respectively shown as solid and empty symbols. Solid lines correspond to the
fitting of the data using three-exponential decay model.
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Table 5.2. Fluorescence decay parameters for Li+ and/or Ca2+ binding to DREAM(64)–1,8-ANS complexes.
τ1 (ns)
τ2 (ns)
f1 (%)
f2 (%)
0 (%)
1 (%)
2 (%)
2
4.0 ± 0.1 16.8± 0.2
62.4
15.4
21.2
15.1 ± 0.9 83.2 ± 1.0 1.0
apoDREAM(64)
2+
4.2 ± 0.2 18.1 ± 0.1 41.2
16.5
42.3
9.8 ± 0.6 89.1 ± 0.5 0.9
Ca DREAM(64)
+
4.1 ± 0.2 17.9 ± 0.2 48.6
15.6
35.8
9.6 ± 0.5 89.2 ± 0.5 0.9
Li DREAM(64)
2+ +
4.2 ± 0.2 18.1 ± 0.1 41.0
16.8
42.2
9.7 ± 0.5 89.1 ± 0.5 0.9
Ca Li DREAM(64)
Data obtained from Vinci analysis software using a sum of three discrete exponential decays with fixed 1,8-ANS lifetime
(0 = 0.28 ns). 0, 1, and 2 represent lifetimes of the three discrete exponential decays; f0, f1and f2 are exponential decay
fractions; 0, 1, and 2 represent pre-exponential factors. 2 represents the goodness of the fit. Phase and modulation
errors were respectively set at ≤ 0.2° and ≤0.004.
Samples
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It has been shown previously that Ca2+ modulates DREAM interactions with Kv4 channels
and presenilin-1 (An, Bowlby et al. 2000, Jo, Jang et al. 2005, Gonzalez, Pham et al. 2014,
Pham, Miksovska 2016). Recent studies from our group have shown that Pb2+ and Cd2+
also modulate the aforementioned interactions (Azam, Miksovska 2018). To investigate
whether Li+ association to the protein also alters DREAM interactions with Kv4 channel,
we measured changes in the anisotropy of FITC-labeled peptides that correspond to
residues 2–22 and 70–90 of Kv4.3 upon addition 100 µM DREAM(64) and 200 µM
DREAM(64), respectively (Figure 5.10A,B). Anisotropy of Kv4.3(2–22) increases from
0.063 ± 0.008 to 0.099 ± 0.007, 0.229 ± 0.014, and 0.218 ± 0.010 upon addition of metalfree DREAM(64), Ca2+DREAM(64), and Li+DREAM(64), respectively, and
anisotropy of Kv4.3(70–90) increases from 0.074 ± 0.005 to 0.116 ± 0.004, 0.193 ± 0.012,
and 0.186 ± 0.009 upon addition of metal-free DREAM(64), Ca2+DREAM(64), and
Li+DREAM(64), respectively. Significantly higher anisotropy of Kv4.3(2–22)–Li+
DREAM(64) and Kv4.3(70–90)–Li+DREAM(64) compared with the corresponding
apo-form indicates an increased affinity of Li+DREAM for Kv4.3(2–22) and Kv4.3(70–
90. Similar anisotropy values of Kv4.3(2–22)–DREAM(64) and Kv4.3(2–22)–
DREAM(64) in the presence of Li+ and Ca2+suggest that Li+ increases affinity between
DREAM and Kv4 channel in a manner analogous to Ca2+. We have also probed if Li+
impacts on DREAM interactions with presenilin-1. A FITC-tagged peptide corresponds to
helix-9 of presenilin-1(PS1HL9) were titrated with a saturation concentration of
DREAM(64) (100 µM) (Figure 5.10C). Anisotropy value of PS1HL9 increases from
0.068 ± 0.004 in the absence of protein to 0.095 ± 0.003 in the presence of apoDREAM
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Figure 5.10. Impact of Li+ association with DREAM on DREAM
interactions with interacting partners. 100 µM, 200 µM, and 100 µM
DREAM(Δ64) were respectively added to FITC-labeled A) 0.5 μM Kv4.3(2–22). B) 0.5 μM Kv4.3-(70–90), and C) 0.5 μM PS1HL9. Samples were
excited at 470 nm; emission was recorded through 500 nm long-pass filter.
Concentrations of EDTA, Ca2+, and Li+ were same as Trp emission study.
and 0.252 ± 0.009 in the presence of Ca2+DREAM, and 0.097 ± 0.009 upon binding to
Li+DREAM(64). Similar anisotropy values of metal-free DREAM(64)–PS1HL9 and
Li+DREAM(64)–PS1HL9 indicate that Li+ association to DREAM doesn’t enhance
DREAM interaction with presenilin-1. Although additional studies are necessary, these
results are consistent with the fact that Ca2+ association to DREAM facilitates DREAM
interaction with presenilin-1, resulting in an increase in the accumulation of Aβ42, a
peptide whose overproduction has been linked to Alzheimer’s disease, whereas Li+
administration has been shown to decrease Aβ42 production (Jo, Jang et al. 2005,
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Rockenstein, Torrance et al. 2007, Su, Ryder et al. 2004). These results may provide a first
molecular insight into the neuroprotective role of Li+.
5.3. Summary
Utilizing a combination of fluorescence and calorimetric techniques, we first time
comprehensively demonstrate that Li+ binds at EF-hand of DREAM; Li+ also modulates
DREAM interaction with Kv4 channel. Our findings could open up a new avenue for NMR
and X-ray crystallographic studies for obtaining detailed structural information of
Li+DREAM. Our study also encourages in vivo study in an animal model for investigating
the impact of Li+ administration on DREAM expression and the impact of Li+ treatment
on DREAM interactions with interacting partners. Our findings also re-emphasized the
potential of Li+ for the treatment of manic disorders and neurodegenerative diseases.
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6. INVESTIGATION OF FEW OTHER METALS BINDING TO DREAM.
6.1 Background and significance
Mn2+ is a transitional metal which is a cofactor of various enzymes. It is essential
to support basic physiological function in the cells (Martinez-Finley, Gavin et al. 2013).
However, overexposure to Mn2+ leads to its accumulation in the brain, which causes
neurotoxicity to several brain regions, including the hippocampus, frontal cortex,
substantia nigra, and striatum (Robison, Zakharova et al. 2012, Tuschl, Mills et al. 2013).
Studies have suggested that elevated Mn2+ level has been associated with Alzheimer's
disease (Tong, Yang et al. 2014). Studies on non-human primate brain demonstrated that
chronic Mn2+ exposure leads to aggregation of amyloid-β in the frontal cortex, indicating
overexposure to Mn2+ might be related to cognitive and memory deficits (Guilarte 2010).
But the underlying mechanism of Mn2+-induced neurotoxicity has not been resolved yet.
Mn2+ accumulation could influence the homeostasis of the brain microenvironment and has
been implicated in cognitive impairment, developmental disorders and neurodegenerative
diseases (Yu, Zhou 2018, Lucchini, Placidi et al. 2017). Mn2+ can replace Mg2+ from the
active center of different enzymes including DNA-polymerase, RNA-polymerase,
adenylate and guanylate cyclases (Bähre, Danker et al. 2014, Lakhin, Efremova et al. 2013,
Lakhin, Tarantul et al. 2014). Displacement of Mg2+ from the active center of enzyme is a
probable mechanism

of Mn2+

intoxication. Besides the alteration of brain

microenvironment homeostasis, the promotion of oxidative stress and the generation of
reactive oxygen species are considered the possible mechanism of action (Milatovic, Yin
et al. 2007, Gunter, Gavin et al. 2006, Archibald, Tyree 1987). It has been shown that Mn2+
binds to EF-hands in Ca2+ binding protein calmodulin and EF-hand protein calprotectin,
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which is a heterodimer of S100A8 and S100A9 (Senguen, Grabarek 2012, Gilston, Skaar
et al. 2016). Interestingly, calprotectin has a higher affinity for Mn2+ in the presence of Ca2+
compared with the corresponding metal-free form (Brophy, Nolan 2015, Damo, Kehl-Fie
et al. 2013). Since Mn2+ impacts the hippocampus region of the brain and associates to EFhand proteins and DREAM is located in the hippocampus and it’s an EF-hand protein, we
investigated whether Mn2+ binds to DREAM and alters its tertiary structural
rearrangements and impacts interaction with hydrophobic molecule both in the presence
and absence of Ca2+.
Chronic arsenic exposure from groundwater is considered one of the worst
environmental disorders in the world. More than 100 million people in the world, especially
South Asian countries Bangladesh and India, are at risk of cancers and other arsenic-related
diseases (Jain, Ali 2000, von Brömssen, Jakariya et al. 2007, Argos, Kalra et al. 2010). The
United States Environmental Protection Agency (EPA) and International Agency for
Research on Cancer (IARC) have classified arsenic as a human carcinogen. Chronic arsenic
exposure also has been associated with noncancerous effects (Chen, Wang et al. 2007,
Chen, Graziano et al. 2011). It is widely considered that inorganic arsenate, a molecular
analog of phosphate, can replace phosphate in some biochemical reactions (Hughes 2002).
For instance, the substitution of phosphate with arsenate could inhibit the generation of
adenosine 5′-triphosphate (ATP) during oxidative phosphorylation (Hughes 2002).
Trivalent arsenic species have been shown to associate with protein due to high affinity for
sulfhydryl groups (Summers 2009, Kitchin, Wallace 2005, Zhao, Chen et al. 2012). Arsenic
binding to a particular protein could alter its conformation and interaction with interacting
partners which could be a possible mechanism of arsenic toxicity. Arsenic binding to
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protein has been associated with inactivation of about 200 enzymes, including glutathione
S-transferase, glutathione peroxidase, glutathione reductase, thioredoxin reductase,
thioredoxin peroxidase, pyruvate kinase galectin-1 (Ratnaike 2003, Webb 1966, Müller,
Walter et al. 1995, Chouchane, Snow 2001, Lu, Chew et al. 2007, Chang, Lee et al. 2003,
Lin, Huang et al. 2006). Trivalent arsenic species also have been demonstrated to inhibit
the activities of various DNA repair proteins such as formamidopyrimidine-DNA glycosylase (Fpg) and xeroderma pigmentosum group A protein (XPA). Each of these proteins
comprises a zinc ﬁnger DNA binding domain (Walter, Schwerdtle et al. 2007, Hartwig,
Blessing et al. 2003).The association of arsenic compounds with these repair proteins
resulted in the release of zinc. On the other hand, arsenic compounds have been used as
drugs for more than 2400 years (Doyle 2009, Waxman, Anderson 2001). Particularly, As203
has been used for the treatment of patients suﬀering from acute promyelocytic leukemia
(APL), probably because of arsenic association with cysteine residues in zinc ﬁngers of
the aberrant promyelocytic leukemia-retinoic acid receptor (PML-RAR) fusion protein
expressed by these patients (Zhang, Yan et al. 2010, Jeanne, Lallemand-Breitenbach et al.
2010). Since our study demonstrated toxic metals such as lead and cadmium bind to
DREAM (Azam, Miksovska 2018, Azam, St Luis et al. 2019), in this case, we investigated
whether As5+ binds to DREAM and triggers tertiary structural rearrangements.
Mercury is a very toxic metal, which naturally presents in the environment
(Clarkson 2002). It exists in three different forms, namely, elemental mercury (0), inorganic
mercury (I, II), and organic mercury. Among them, organic mercury is considered supertoxic (Park, Zheng 2012, Carocci, Rovito et al. 2014). After exposure, mercury is
translocated to the bloodstream and important organs, ultimately causing kidney,
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cardiovascular, gastrointestinal, immune, and nervous system malfunction (Clarkson
2002). The toxic effect exerted by numerous mercury compounds could be best explained
by binding of Hg2+ to cysteine-thiol and seleno-cysteine residues of critical enzymes (Jan,
Ali et al. 2011, Branco, Canário et al. 2012, Carvalho, Chew et al. 2008, Clarkson, Magos
2006). Mercury binding causes dramatic changes to the SH group as mercury is much
larger than the H that it displaces. If the SH is essential for enzyme activity, binding of Hg2+
causes inhibition of that activity. For instance, binding of mercury causes inhibition of
protein kinase C activity (Saijoh, Inoue et al. 1988). Binding of mercury to the SH group
of protein can also lead to unfolding, precipitation, and aggregation of the protein
(Konyaeva, Myshkin 1998a, Khromova, Myshkin 2000). In addition to binding to cysteine
residues, Hg2+ has been shown to bind to non-cysteine residues of some proteins, including
hemoglobin and chymotrypsin. Binding of Hg2+ to non-cysteine residues protects
hemoglobin against aggregation (Konyaeva, Myshkin 1998c, Konyaeva, Myshkin 1998b,
Stratton, Ericksen et al. 2017, Myshkin, Khromova 2000). In the absence of inaccessible
cysteine residues, Hg2+ binds to histidine residues of digestive enzyme chymotrypsin,
which causes denaturation of the enzyme (Stratton, Ericksen et al. 2017). Considering the
similar ionic radii of Pb2+, Cd2+, and Hg2+ and the previously reported binding of Hg2+ to
calcium binding sites on CaM (Vig, Nath et al. 1989), we set forth to determine whether
heavy metal Hg2+ binds to DREAM and induces tertiary structural rearrangements both in
the presence and absence of Ca2+.
Alkaline earth metals Sr2+ and Ba2+ have been shown to bind to EF-hand protein
CaM and calcium-binding protein-1 from Entamoeba histolytica (EhCaBP1) (Kursula,
Majava 2007, Kumar, Ahmad et al. 2012). Among different EF-hands of DREAM, Mg2+
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binds to EF-2 selectively, whereas EF-3 and EF-4 bind Ca2+ preferentially. Since Sr2+ and
Ba2+ have similar ionic radii (1.21 and 1.38Å, respectively ) as Ca2+ (1.06Å) (Gu, Cooper
2000), we set out to determine whether Sr2+ and Ba2+ bind to EF-hand of DREAM and
trigger tertiary structural rearrangement of the protein.
6.2 Results and discussion
Tryptophan emission is a widely-used tool to probe structural rearrangement of
the proteins. Our previous studies have shown that DREAM undergoes structural
rearrangement upon binding of Ca2+, Pb2+, Cd2+, and Tb3+ in the EF-hand of the protein
and emission intensity of tryptophan decreases upon binding of above metals (Azam,
Miksovska 2018, Azam, St Luis et al. 2019, Gonzalez, Ramos et al. 2016, Pham, Dhulipala
et al. 2015). We have also demonstrated that hydrophobic cavities of DREAM become
more accessible to hydrophobic molecules 1,8-ANS in the presence of above metals
compared with metal-free form. Consequently, the emission intensity of DREAM:1,8-ANS
is higher in the presence of above metals compared with corresponding metal-free form
(Azam, Miksovska 2018, Azam, St Luis et al. 2019, Gonzalez, Ramos et al. 2016,
Gonzalez, Miksovska 2014). To investigate whether As5+, Hg2+, Mn2+, Ba2+, or Sr2+ binds
to DREAM, we added 1 mM of barium chloride, strontium chloride, arsenic pentoxide,
mercuric

oxide

and

manganese

chloride

into

DREAM(64)

protein

and

DREAM(64):1,8-ANS complex both in the presence and absence of Ca2+ (Figure 6.1–
6.5A–D). Our results show that addition of As5+, Hg2+, Mn2+, Ba2+, or Sr2+ doesn’t alter
emission intensity of DREAM(64) or emission intensity of DREAM(64):1,8-ANS,
suggesting either As5+, Hg2+, Mn2+, Ba2+, or Sr2+ does not bind to DREAM(64) or binding
of As5+, Hg2+, Mn2+, Ba2+, or Sr2+ does not trigger structural rearrangements of DREAM.
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Figure 6.1. Impact of 1 mM Mn2+ addition on Trp emission of metal-free and Ca2+-bound
DREAM(64) (A,B) and emission of metal free and Ca2+-bound DREAM(64):1,8ANS (C,D).
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Figure 6.2. Impact of 1 mM As5+ addition on Trp emission of metal-free and Ca2+-bound
DREAM(64) (A,B) and emission of metal free and Ca2+-bound DREAM(64):1,8-ANS
(C,D).
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Figure 6.3. Impact of 1 mM Hg2+ addition on Trp emission of metal-free and Ca2+-bound
DREAM(64) (A,B) and emission of metal free and Ca2+-bound DREAM(64):1,8-ANS
(C,D).
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Figure 6.4. Impact of 1 mM Ba2+ addition on Trp emission of metal-free and Ca2+-bound
DREAM(64) (A,B) and emission of metal free and Ca2+-bound DREAM(64):1,8-ANS
(C,D).
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Figure 6.5. Impact of 1 mM Sr2+ addition on Trp emission of metal-free and Ca2+-bound
DREAM(64) (A,B) and emission of metal free and Ca2+-bound DREAM(64):1,8ANS (C,D).
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6.3. Summary
Encouraged by the fact that toxic metals Cd2+ and Pb2+ bind to DREAM, we
investigated whether toxic metals Mn2+, As5+, and Hg2+ bind to DREAM. Additionally, we
investigated whether alkaline earth metals Ba2+ and Sr2+ bind to DREAM. On the basis of
the fact that addition of As5+, Hg2+, Mn2+, Ba2+, or Sr2+ did not change the emission intensity
of DREAM(64) or DREAM(64):1,8-ANS complexes, we conclude that either As5+,
Hg2+, Mn2+, Ba2+, or Sr2+ does not bind to DREAM or addition of As5+, Hg2+, Mn2+, Ba2+,
or Sr2+ does not trigger structural rearrangements of DREAM.
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7. ROLE OF LYS RESIDUE AT POSITION 87 OF DREAM IN ALLOSTERIC
REGULATION

OF

DREAM

INTERACTIONS

WITH

INTERACTING

PARTNERS.
7.1 Background and significance
Downstream regulatory element antagonist modular (DREAM), alternative
known as KChIP3/calsenilin, is a 29kDa NCS protein which is expressed in the brain
and heart and regulate a wide spectrum of biological processes (An, Bowlby et al.
2000, Buxbaum, Choi et al. 1998, Carrion, Link et al. 1999). DREAM is the only
Ca2+ binding protein that can directly interact with DNA sequence (DRE) of genes
(prodynorphin and c-fos genes) and represses transcription of these genes (Carrion,
Link et al. 1999). In the absence of Ca2+, DREAM interacts with DRE of human
prodynorphin and c-fos genes and inhibit transcription of these genes, but Ca2+
association induces conformation change in the protein that prevents binding of
DRE and consequently reactivates the transcription (Carrion, Link et al. 1999,
Cheng, Pitcher et al. 2002). Prodynorphin and c-fos genes have been linked to pain
modulation, cell homeostasis, and apoptosis. Repression of the transcription of DRE
by DREAM highlights its role in the regulation of the above processes (Costigan,
Woolf 2002, Fontán-Lozano, Romero-Granados et al. 2009).
In the cytoplasm, DREAM interacts with carboxy-terminal fragment (CTF) of
presenilin-1 (PS1) and presenilin-2 and stimulates the activity of γ- secretase complex in
a Ca2+-dependent manner, which facilitates production of amyloid-beta plaques of
Alzheimer’s disease (Buxbaum, Choi et al. 1998, Jo, Jang et al. 2005). DREAM also
associates with the T1 domain of voltage-gated potassium channels and plays a
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crucial role in the regulation of fast ITO and ISA current in the heart and brain,
respectively. The above interaction also promotes the translocation of the channel to
the membrane and modulates the gating properties of the channel (An, Bowlby et
al. 2000). It has been shown recently that DREAM protein might be involved in the
mechanism of nicotine treatment-prevented learning and memory impairment in
REM sleep-deprived rats by modulating its expression level in the hippocampus
(Abd Rashid, Hapidin et al. 2017).
DREAM protein contains 256 amino acid residues. 3-D structure of the fulllength DREAM is not known yet because its poor solubility prevented structural
determination of the first 77 residues by NMR-studies (Lusin, Vanarotti et al. 2008). After
the deletion of the first 64 residues, the solution structure of Ca2+DREAM (residue 65-256)
was resolved (Lusin, Vanarotti et al. 2008). That’s why in our study we used DREAM
protein that possesses residues 65-256. DREAM protein contains four EF-hands. Each EFhand has a distinct metal binding property. EF-1 doesn’t bind any metal because it has
sterically hindered proline residues in the EF-hand loop. EF-2 binds Mg2+ preferentially as
it has aspartate residue in the 12th position of the EF-hand loop. EF-3 and EF-4 bind Ca2+
selectively because glutamate residue is present in the 12th position of the EF-hand loop
(Osawa, Dace et al. 2005, Osawa, Tong et al. 2001). Recently, we have shown that EFhands of DREAM are also capable of binding heavy metals Pb2+ and Cd2+(Azam,
Miksovska 2018, Azam, St Luis et al. 2019)
Our previous studies demonstrated that DREAM undergoes tertiary structural
rearrangement upon Ca2+, Tb3+, Pb2+, or Cd2+ binding. We also have shown hydrophobic
cavities of DREAM that binds hydrophobic molecule 1,8-ANS becomes more accessible
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to 1,8-ANS in the presence of Ca2+, Tb3+, Pb2+, or Cd2+ association, compared with metalfree form (Azam, Miksovska 2018, Azam, St Luis et al. 2019, Gonzalez, Ramos et al. 2016,
Gonzalez, Miksovska 2014). Additionally, we demonstrated that helix-9 of presenilin-1 is
involved in DREAM–presenilin-1 interaction and site-1 (residues 2–22) and site-2
(residues 70–90) peptides of T-1 domain of Kv4.3 channel are involved in DREAM– Kv4.3
channel interaction (Pioletti, Findeisen et al. 2006, Gonzalez, Pham et al. 2014, Pham,
Miksovska 2016, Wang, Yan et al. 2007a). We have used accelerated molecular dynamics
to get insight about the mechanism of allosteric regulation of DREAM
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Figure 7.1. Left: aMD structure of Ca2+DREAM. EF-hands are shown in different
colors: EF-hand 1, yellow; EF-hand 2, blue; EF-hand 3, green; EF-hand 4, red; rest
part of the protein is shown in cyan; two Ca2+ are shown as green spheres; Trp169,
Glu165, and Lys87 are show as sticks. Right: Distance between Lys87 and Glu165
side chains determined from 100 ns accelerated molecular simulation of
DREAM(64).
interactions with intracellular partners. Unlike the NMR structure of DREAM, aMD data
indicate the presence of a salt bridge between Lys87 and Asp 165 that couples the loop
between helix-1 and helix-2 in the N- terminal domain with the EF-3 in the C- terminal
domain (Figure 7.1). We hypothesize that the salt bridge involved in the propagation of
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calcium-triggered structural changes between the C- terminal and N- terminal domain. To
determine the contribution of Lys87 to the interdomain communication Lys87 was mutated
to Ala and the impact of the mutation on DREAM secondary and tertiary structures and
DREAM interactions with interacting partners were investigated.
7.2 Results and discussion
7.2.1 Impact of Lys87 to Ala mutation on DREAM secondary and tertiary structures.
It has been well established from our previous study that emission maximum of
wild-type DREAM (64) in metal-free form is 335 nm and emission maximum shifts to
329 nm upon Ca2+ binding (Azam, Miksovska 2018, Gonzalez, Ramos et al. 2016, Osawa,
Tong et al. 2001). Emission maximum of Trp169 in DREAM(K87A) is 5 nm red-shifted
compared with corresponding wild-type protein, suggesting Trp169 is more solvent
exposed in DREAM(K87A) (Figure 7.2A). The increase in solvent accessibility can be
explained by the fact that the absence of salt bridge destabilizes the protein structure. Ca2+
binding to DREAM(K87A) leads to decrease in ellipticity which is similar to Ca2+ binding

Figure 7.2. (A) Intrinsic fluorescence of 20 µM DREAM(K87A) in the
presence of 1 mM EDTA, 5 mM Mg2+, and 1 mM Ca2+; excited at 295 nm. (B)
Far-UV CD spectra of DREAM(K87A) under identical condition.
to corresponding WTDREAM(64) (Figure 7.2B). Analyzing of the far-UV CD data with
secondary structure prediction tool K2D3 reveals that DREAM(K87A) contains 53%,
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54%, 63%, and 65% -helical character in apo, Mg2+, Ca2+, and Ca2+Mg2+-bound form,
respectively. Interestingly, both metal-free and metal-bound form of DREAM(K87A) show
about 10% less -helical character than corresponding WTDREAM(64), suggesting that
the disruption of the salt bridge makes the protein more flexible. Analogously, emission
spectra of 1,8-ANS in the presence of DREAM(K87A) is 10 nm red-shifted compared with
corresponding wild-type protein, indicating the hydrophobic cavity that binds 1,8-ANS is

Figure 7.3. Fluorescence emission of DREAM(K87A):1,8ANS complex. Condition: 20 µM DREAM(K87A), 20 µM 1,8ANS, excited at 350 nm.
more solvent exposed in DREAM(K87A) (Figure 7.3). However, the decrease in emission
intensity of Trp and increase in emission intensity of 1,8-ANS upon calcium addition to
metal-free DREAM(K87A) are analogous to calcium addition to metal-free wild-type
protein, suggesting that the mutation of Lys to Ala does not prevent Trp transition and 1,8ANS binding to DREAM. Alteration of tertiary structure of the protein is further confirmed
by the lifetime data. Analogous to WTDREAM(64), W169 residue of DREAM(K87A)
exhibits three different lifetimes (Figure 7.4, Table 7.1), which could be due to the presence
of multiple rotamers of the indole side chain as well as multiple conformational states
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Figure 7.4. Frequency-domain intensity decay of 20
µM DREAM(K87A) in apo (square), Mg2+ (circle),
Ca2+ (upper triangle), and Ca2+Mg2+ (lower triangle)
bound form. Solid symbols correspond to phase delay;
empty symbols correspond to modulation ratio. Solid
lines represent data fitting using a sum of three
exponential decays model.
(Pham, Dhulipala et al. 2015). Similar to WTDREAM(64), upon Ca2+ binding the
average lifetime of W169 in DREAM(K87A) decreases by 0.3 ns, compared with
corresponding apo-form, which supports emission data. Analogous to WTDREAM(64),
1,8-ANS binds to two different binding sites on DREAM(K87A) surface as evident from
two distinct lifetimes of 1,8-ANS in 1,8-ANS:DREAM(K87A) complexes (Figure 7.5,
Table 7.2). While the mutation did not change the individual lifetimes of 1,8-ANS
significantly, it decreased the affinity for 1,8-ANS, as evident by smaller 1 and 2 values
compared with wild-type protein, likely due to the lower accessibility of the 1,8-ANS
binding sites.
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Figure 7.5. Frequency-domain intensity decay of
DREAM(K87A):1,8-ANS in apo (square), Mg2+
(circle), Ca2+ (upper triangle), and Ca2+Mg2+ (lower
triangle) bound form. Solid symbols correspond to
phase delay; empty symbols correspond to modulation
ratio. Solid lines represent data fitting using a sum of
three exponential decays model.
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Table 7.1: Fluorescence decay parameters of DREAM(K87A) in the presence and absence of metals.
Sample τ1
τ2
τ3
f1
f2
f3
< τ>
1
2
3
2
s
(ns)
(ns)
(ns)
(%)
(%)
(%)
(ns)
(%)
(%)
(%)
Apo
0.32 ±
2.7 ±
7.2 ±
8.9 ±
52.4 ±
38.1 ±
53.2
36.9
10.1
4.2
1.9
0.03
0.1
0.3
0.1
0.3
0.2
Mg2+
0.30 ±
2.6 ±
7.2 ±
8.4 ±
51.3 ±
40.1 ±
53.4
36.4
10.2
4.2
2.1
0.02
0.1
0.4
0.1
0.1
0.3
Ca2+
0.28 ±
2.4 ±
7.1 ±
10.5 ±
49.6 ±
38.8 ±
56.3
34.5
9.1
3.9
1.7
0.03
0.1
0.2
0.1
0.2
0.2
2+
Ca M 0.29 ±
2.4 ±
7.1 ±
10.7 ±
49.8 ±
39.1 ±
56.1
34.8
8.9
3.9
1.8
g2+
0.03
0.1
0.1
0.1
0.3
0.2
Recovered from Vinci analysis software using a sum of three discrete exponential decays. Phase and modulation errors
were set at ≤ 0.2° and ≤0.004, respectively. 1, 2, and 3 are lifetimes of the three discrete exponential decays; f1, f2and f3
represent exponential decay fractions; 1, 2, and 3 are pre-exponential factors.
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Table 7.2: Fluorescence decay parameters of DREAM(K87A):1,8-ANS complexes.
DREAM(K87A):1,8-ANS τ1
τ2
f0
f1
f2
0
1
2
2
(ns)
(ns)
(%)
(%)
(%)
(%)
(%)
(%)
apo
4.0 ± 16.4 ± 8.9 ± 33.4 ± 58.1
72.6 19.3 8.1
1.2
0.1
0.2
0.1
0.8
± 0.7
Mg2+
3.9 ± 16.2 ± 9.0 ± 33.1 ± 58.5 ± 72.8 18.9 8.3
1.3
0.1
0.2
0.1
0.8
0.7
2+
Ca
4.1 ± 16.9 ± 4.7 ± 21.8 ± 74.0 ± 63.3 20.3 16.4 1.1
0.1
0.2
0.1
0.6
0.6
Ca2+Mg2+
4.1 ± 16.9 ± 4.7 ± 21.1 ± 74.9 ± 63.1 20.1 16.8 1.1
0.1
0.2
0.1
0.6
0.6
Recovered from Vinci analysis software using a sum of three discrete exponential decays with 1,8ANS lifetime fixed to 0.28 ns. Phase and modulation errors were set at ≤ 0.2° and ≤0.004, respectively.
0, 1, and 2 are lifetimes of the three discrete exponential decays; f0, f1and f2 represent exponential
decay fractions; 0, 1, and 2 are pre-exponential factors.
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7.2.2 Consequence of Lys87 to Ala mutation on DREAM interactions with intracellular
partners.
Previous studies have shown that KChIP1, a protein with high sequence
homology with DREAM, interacts with the T-1 domain of Kv.4 channel through two
contact interfaces and this interaction has been demonstrated to result in increased surface
expression, alteration of gating properties, and subunit assembly facilitation of Kv4
channels (Bourdeau, Laplante et al. 2011, Pioletti, Findeisen et al. 2006, Wang, Yan et al.
2007b, Bahring, Dannenberg et al. 2001, Scannevin, Wang et al. 2004). Site 1(residues 1-

Figure 7.6. Anisotropy change associated with Kv4.3 site
1 (residues 2-22) (A), Kv4.3 site 2 (residues 70-90) (B)
and presenilin 1 helix 9 (PS1HL9) (C) binding to
DREAM(K87A) in the presence and absence of Ca2+.
20) of T1 domain of Kv4 channel interacts with N- and C- terminal hydrophobic cavity of
KChIP1. Site-2 (residue 70-78) of T1 domain of Kv4 channel interacts with KChIP1
through both stacking and salt bridge interaction (Pioletti, Findeisen et al. 2006, Wang, Yan
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et al. 2007a). Our previous result demonstrated that DREAM interacts with site 1 (residues
2-22) and site 2 (residues 70-90) of the T-1 domain of Kv channel. To investigate whether
Lys to Ala mutation at position 87 alters DREAM affinity for site 1 and site 2 of T-1 domain
of Kv channel, we titrated DREAM(K87A) into FITC-tagged 0.5 μM site-1 and site-2
peptide (Azam, Miksovska 2018, Azam, St Luis et al. 2019, Gonzalez, Pham et al. 2014)
(Figure 7.6A,B). Anisotropy value did not change upon the addition of saturation
concentration of metal-free and Ca2+-bound form of DREAM(K87A) to site 1 and site 2
peptides. As a control experiment, we added the corresponding metal-free and Ca2+-bound
form of WTDREAM(64) to site 1 and site 2 peptides. In this case, anisotropy value
increased significantly, especially in the presence of Ca2+, which is in agreement with our
previous study. Altogether, the above results suggest that disrupting interdomain
communication between N- and C- terminal of DREAM by mutating Lys87 to Ala inhibits
DREAM interactions with site 1 and site 2 of T1 domain of Kv channel. This result is
consistent with the notion of 1,8-ANS lifetime data where DREAM shows a weaker affinity
for hydrophobic molecule 1,8-ANS. We postulate that disrupting interdomain
communication disrupts the hydrophobic cavities that are involved in the binding of site 1
and site 2.
Previous studies have shown that DREAM interacts with the carboxyterminal fragment of presenilin-1 and stimulates the activity of ɣ-secretase complex which
in turn facilities production of Aβ42, a peptide associated with Alzheimer’s disease (Jo,
Jang et al. 2005). Previous results of our group have shown that DREAM interacts with
presenilin-1 of helix-9 (PS1HL9) in a calcium-dependent manner; DREAM interacts with
PS1HL9 through cation–π interaction, salt bridge, and hydrophobic interaction. More
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specifically, D450 and D458 of PS1HL9 form a salt bridge with R207 of DREAM; R200
of DREAM forms a cation–π interaction with F465 of PS1HL9; and F462 and F465 of
PS1HL9 forms hydrophobic interaction with F252 of DREAM (Pham, Miksovska 2016).
To investigate whether Lys to Ala mutation at position 87 influences the interaction
between DREAM and PS1HL9, we titrated DREAM(K87A), in metal-free form and in the
presence of Ca2+, into 0.5 μM PS1HL9. Interestingly, our results show that the anisotropy
value of PS1HL9 does not increase at all upon the addition of saturation concentration of
DREAM(K87A), both in apo and Ca2+-bound form. On the other hand, under identical
conditions, the anisotropy value of PS1HL9 increases significantly upon the addition of
corresponding WTDREAM(64), indicating mutation of Lys to Ala at position 87 inhibits
DREAM interactions with PS1HL9. We hypothesize that disrupting interdomain
communication allosterically inhibits hydrophobic interaction between DREAM and
PS1HL9 as supported by 1,8-ANS lifetime data where DREAM shows a weaker affinity
for hydrophobic molecule 1,8-ANS.
7.3 Summary
In this study, we have demonstrated that disrupting interdomain communication
between N- and C- terminal of DREAM by mutating Lys87 to Ala leads to solvent
exposure of Trp169 and DREAM-bound 1,8-ANS molecule as supported by emission data;
less accessibility of hydrophobic cavity of DREAM for 1,8-ANS association as evident
from lifetime data; and inhibition of DREAM interactions with site 1 and site 2 peptide of
T-1 domain of Kv channel and helix 9 of presenilin-1 based on anisotropy measurements.
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8. IMPACT OF EF-3 OR EF-4 INACTIVATION OF DREAM ON ITS SECONDARY
AND TERTIARY STRUCTURES AND INTERACTION WITH T-1 DOMAIN OF
KV CHANNEL.
8.1 Background and significance
Downstream regulatory element antagonist modulator (DREAM) is
a 29kDa protein that is expressed in the hippocampus of the brain (Carrion, Link et
al. 1999). Interestingly, this protein has three different names. It was discovered by
three independent research groups and each group named it differently. On the basis
of the fact that this protein interacts with presenilin and regulates the activity of γsecretase complex, one research group named it calsenilin (Buxbaum, Choi et al.
1998). Later, another group named it as downstream regulatory element antagonist
modulator (DREAM) as this protein interacts with downstream regulatory element
(DRE) and directly modulate transcription of downstream genes (Carrion, Link et
al. 1999). Finally, this protein was renamed as KChIPs as it has high sequence
similarity with KChIP-1 and KChIP-2 (An, Bowlby et al. 2000). DREAM is a
member of EF-hand superfamily; it also belongs to the neuronal calcium sensor
family. DREAM is a multifunctional protein that regulates numerous biological
processes, including gene apoptosis, pain sensation, and memory and learning
processes (An, Bowlby et al. 2000, Buxbaum, Choi et al. 1998, Carrion, Link et al.
1999).
DREAM has been associated with Alzheimer’s disease. It interacts with presenilin-1
(PS1) and presenilin-2 and stimulates the activity of γ- secretase complex in a calciumdependent manner and facilitates the generation of amyloid beta plaques in
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Alzheimer’s disease (Buxbaum, Choi et al. 1998, Jo, Jang et al. 2005). DREAM also
associate with the T1 domain of potassium channels and play a predominant role in
the modulation of fast ITO and ISA current in the heart and brain, respectively.
DREAM binding to the T1 domain of potassium channels also promotes
translocation of the channel to the membrane and alters the gating properties of the
channel (An, Bowlby et al. 2000). Ca2+-bound DREAM interacts with CaM and
DREAM:CaM complex formation inhibits DREAM interaction DRE sites and
facilitates activation of calcineurin (Gonzalez, Arango et al. 2015, Ramachandran,
Craig et al. 2012).
DREAM protein comprises 256 amino acid residues. It also contains four EFhands. The four EF-hands of DREAM differ in terms of metal binding property. EF-hand
1 doesn't bind any metal as the presence of sterically hindered amino acid residue proline
in the EF-hand loop (CPXG sequence) destroys metal-binding geometry. EF-2 binds Mg2+
selectively because of the presence of Asp at the 12th position of the EF-hand loop instead
of the usual glutamate. It has been demonstrated that Mg2+ binding to EF-2 stabilizes the
tertiary structure of DREAM which facilities DNA binding. EF-hand 3 and EF-hand 4
bind Ca2+ preferentially with Kd of 1–10 µM as glutamate is present at the 12th position
of the EF-hand loop (Gifford, Walsh et al. 2007, Lusin, Vanarotti et al. 2008, Osawa,
Dace et al. 2005, Osawa, Tong et al. 2001). Our recent studies have shown that heavy
metals Pb2+ and Cd2+ and lanthanide Tb3+ bind to EF-hand of DREAM with affinity higher
than that of Ca2+ (Azam, Miksovska 2018, Azam, St Luis et al. 2019, Gonzalez, Ramos et
al. 2016) In the absence of any metal, DREAM exists as a tetramer, but Ca2+ binding
triggers conformation changes in the protein that dissociates the tetramer into two dimers
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if the concentration of protein is below 150 µM. When the concentration of protein is above
200 µM, DREAM is tetramer in both metal-free forms and Ca2+ bound form (Osawa, Tong
et al. 2001).
It is well established that Ca2+ binding causes secondary and tertiary structural
rearrangements of the protein and subsequently modulates DREAM interaction with
binding partners (Osawa, Dace et al. 2005, Osawa, Tong et al. 2001, Pham, Dhulipala et
al. 2015). Our previous studies have also demonstrated that DREAM interacts with
hydrophobic molecule 1,8-ANS through hydrophobic cavities of its surface and
hydrophobic cavities that bind 1,8-ANS becomes more accessible to 1,8-ANS in the
presence of Ca2+ as evidenced by the fact that emission intensity of DREAM:1,8-ANS is
higher in presence of Ca2+ compared with corresponding metal-free form (Gonzalez,
Miksovska 2014). But the underlying mechanism of Ca2+-triggered structural
rearrangements of DREAM and modulation of interactions with binding partners is not
resolved yet. In this study, we mutated glutamate residue at 12th position of EF-3
(DREAM(E186Q)) or EF-4 (DREAM(E234Q)) to glutamine for making these EF-hands
incapable of binding Ca2+ and investigated whether mutations impact Ca2+-triggered
secondary and tertiary structural rearrangements of the protein and whether mutations
impact Ca2+-induced modulation of DREAM interaction with hydrophobic molecule 1,8ANS and T-1 domain of Kv channel.
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8.2 Results and discussion
8.2.1 Consequence of EF-3 or EF-4 inactivation of DREAM on Its Secondary and Tertiary
Structure
The previous study demonstrated that Ca2+ binding triggers tertiary structural
rearrangements of DREAM and emission intensity decreases upon Ca2+ binding to
DREAM(64) and C-terminal of the DREAM, DREAM(160)(Gonzalez, Ramos et al.
2016, Pham, Dhulipala et al. 2015). It is also well established from the previous study that
Ca2+ binds to EF-3 and EF-4 at the C-terminal of the protein. As a control experiment, we

Figure 8.1. Steady-state Trp emission spectra of 20 µM DREAM(64),
DREAM(160), DREAM(E186Q), and DREAM(E234Q) in the absence
and presence of 1 mM Ca2+; excited at 295 nm.
measured emission spectra of DREAM(64) and DREAM(160) both in the presence and
absence of Ca2+ (Figure 8.1A,B). Emission intensity decrease upon Ca2+ binding to both
DREAM(64) and DREAM(160), which is in agreement with previous studies. Then we
measured emission spectra of the DREAM(E186Q), a DREAM construct that is not
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expected to bind Ca2+ and other metals at EF-3 due to glutamate to glutamine mutation at
position 186, and DREAM(E234Q), a DREAM construct that is not anticipated to bind
Ca2+ at EF-4 due to glutamate to glutamine mutation at position 234 (Figure 8.1C,D). The
emission intensity decreases upon Ca2+ binding to DREAM(E186Q), a DREAM construct
with EF-3 inactive, but EF-4 active, suggesting Ca2+ binding to EF-4 could trigger
structural rearrangement that causes the decrease in emission intensity. Interestingly,
emission spectrum of DREAM(E234Q), DREAM construct with EF-4 inactive, but EF-3
inactive, is the same in the presence and absence of Ca2+, indicating binding of Ca2+ at EF4 might not cause Ca2+-triggered tertiary structural rearrangement. The emission study is
supported by Trp lifetime study (Figure 8.2A,B and Table 8.1). The lifetime of Trp 169 is
sensitive to structural rearrangement. The average lifetime of Trp169 in DREAM(64)
decreases from 3.8 ns to 3.1 ns upon Ca2+ binding. Like DREAM(64), the average lifetime
of Trp169 in DREAM(E186Q) decreases from 4.2 ns to 3.6 ns upon Ca2+ addition, but the
average lifetime of Trp169 in DREAM(E234Q) remains same (4.3 ns) upon Ca2+ addition,
which bolster finding of Trp emission study. To get insight about Ca2+ triggered secondary

Figure 8.2. Frequency-domain intensity decay of 20 µM DREAM(E186Q) (A) and
DREAM(E234Q) (B) in apo (square) and Ca2+ (circle) bound form. Solid symbols
represent phase delay; empty symbols represent modulation ratio. Solid lines
represent fitting of the data using a sum of three exponential decays model.
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structural rearrangement we measured far-UV CD spectra of all four DREAM constructs
(Figure 8.3A-D). We calculated percentage of -helix using online program K2D3 and
results show that Ca2+ binding causes ~ 6 increase in -helical content in DREAM(64)
and DREAM(E186Q) and ~ 10% increase in -helical content of DREAM(160) but helical content of DREAM(E234Q) remains same upon Ca2+ addition. Above far-UV CD
data is in agreement with the notion of Trp emission and Trp lifetime data.

Figure 8.3. Far-UV CD spectra of DREAM(64) (A), DREAM(160)
(B), DREAM(E186Q) (C), and DREAM(E234Q) (D) in the absence
and presence of 1mM Ca2+.
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Table 8.1: Fluorescence decay parameters of DREAM constructs in the presence and absence of metals.
Samples
τ1
τ2
τ3
f1
f2
f3
< τ>
1
2
3
2
(ns)
(ns)
(ns)
(%)
(%)
(%)
(ns)
(%)
(%)
(%)
ApoDREAM 0.24 ±
2.5 ±
7.1 ±
17.3 ± 45.4 ± 37.3 ± 75.1
19.2
5.9
3.8
1.5
0.03
0.1
0.3
0.8
3.0
0.3
(64)
2+
Ca DREAM 0.16 ±
1.9 ±
6.3 ±
22.0 ± 37.5 ± 40.5 ± 84.5
12.1
3.3
3.1
0.9
0.02
0.1
0.1
0.9
2.0
2.0
(64)
apoDREAM( 0.56 ±
2.5 ±
6.4 ±
7.5 ±
44.4 ± 49.1 ± 34.2
46.1
19.6
4.2
1.6
E186Q)
0.06
0.2
0.3
1.0
3.0
4.0
2+
Ca DREAM 0.48 ±
2.4 ±
6.2 ±
10.9 ± 49.4 ± 39.4 ± 45.3
41.9
12.8
3.6
1.4
(E186Q)
0.04
0.1
0.3
1.01
3.0
4.0
apoDREAM( 0.27 ±
2.6 ±
6.9 ±
8.6 ±
46.6 ± 44.7 ± 56.2
32.2
11.5
4.3
1.5
E234Q)
0.03
0.2
0.3
0.5
3.0
3.0
2+
Ca DREAM 0.27 ±
2.6 ±
6.9 ±
8.5 ±
48.4 ± 42.9 ± 56.5
32.6
10.8
4.3
1.9
(E234Q)
0.03
0.1
0.3
8.4
3.0
3.0
Recovered from Vinci analysis software using a sum of three discrete exponential decays. Phase and modulation errors were
set at ≤ 0.2° and ≤0.004, respectively. 1, 2, and 3 are lifetimes of the three discrete exponential decays; f1, f2and f3 represent
exponential decay fractions; 1, 2, and 3 are pre-exponential factors.
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8.2.2 Effects of EF-3 or EF-4 inactivation of DREAM on Its interaction with hydrophobic
molecule 1,8-ANS.
Hydrophobic molecule 1,8-ANS has been widely used for probing
hydrophobicity of protein surface as 1,8-ANS is almost non-fluorescence in solution but
fluorescence intensity increases by many-folds upon association with hydrophobic patches
of protein surface (Cardamone, Puri 1992). Our previous study has demonstrated that
DREAM is capable of binding 1,8-ANS in metal-free form but Ca2+ association to

Figure 8.4. Fluorescence emission of DREAM(64):1,8-ANS (A),
DREAM(160):1,8-ANS
(B),
DREAM(E186):1,8-ANS
(C),
and
DREAM(E234):1,8-ANS complexes in metal-free form and in the presence of 1 mM
Ca2+. Condition: 20 µM DREAM constructs, 20 µM 1,8-ANS, excited at 350 nm.
DREAM increases its affinity for 1,8-ANS. In this case, we investigated whether
inactivation of either EF-3 or EF-4 impacts 1,8-ANS (Gonzalez, Miksovska 2014). As a
control,

we

measured

emission

intensity

of

DREAM(64):1,8-ANS

and

DREAM(160):1,8-ANS complexes (Figure 8.4A,B) both in the presence Ca2+ and in
metal-free form and the result is consistent with previous studies; that is, the emission
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intensity of 1,8-ANS increases significantly upon binding to these protein constructs in
metal-free form and the emission intensity of both DREAM(64):1,8-ANS and
DREAM(160):1,8-ANS complexes are higher in the presence of Ca2+ compared with
corresponding metal-free form. Like above complexes, the emission intensity of
DREAM(E186Q):1,8-ANS and DREAM(E234Q):1,8-ANS complexes (Figure 8.4C,D)
increase significantly upon Ca2+ association compared with corresponding metal-free form,
suggesting binding of one Ca2+ in either EF-3 or EF-4 is good enough for increasing the
accessibility for 1,8-ANS binding site.
To support the above emission studies, we also measured the lifetime of the above
complexes in metal-free form and in the presence of Ca2+ (Figure 8.5A,B, Table 8.2).
Previously we showed that 1,8-ANS binds to two distinct binding sites on the DREAM
surface (Gonzalez, Miksovska 2014). Modulation-phase data for all complexes were best

Figure 8.5. Frequency-domain intensity decay of DREAM(E186Q):1,8-ANS
(A) and DREAM(E234Q):1,8-ANS (B) in apo (square) and Ca2+-bound form
(circle). Solid symbols represent phase delay; empty symbols represent
modulation ratio. Solid lines represent fitting of the data using a sum of three
exponential decays model.
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fitted by a three exponential decay model with 1,8-ANS lifetime fixed to 0.28 ns. Faster
lifetime τ1 could be attributed to 1,8-ANS binding to the partially solvent-exposed binding
site on DREAM, whereas longer lifetime τ2 can be assigned to 1,8-ANS binding to nonpolar solvent restricted binding site on DREAM. Inactivating EF-3 or EF-4 did not
significantly alter individual lifetimes, but 1 and 2 values are smaller in
DREAM(E186Q):1,8-ANS and DREAM(E234Q):1,8-ANS complexes both in the
presence of Ca2+ and in metal-free form compared with corresponding DREAM(64):1,8ANS (Table 8.2), suggesting that inactivating either EF-3 or EF-4 decreases DREAM
affinity for 1,8-ANS. Interestingly, the value of 2 did not change significantly upon Ca2+
binding to DREAM(E186Q):1,8-ANS and DREAM(E234Q):1,8-ANS complexes, but the
value of 2 increased by 2-folds upon Ca2+ binding to metal-free DREAM(64):1,8-ANS
(Table 8.2). It is possible that binding of one Ca2+ to DREAM(E186Q):1,8-ANS and
DREAM(E234Q):1,8-ANS complexes may not fully expose the hydrophobic cavities that
bind 1,8-ANS.
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Table 8.2: Fluorescence decay parameters of DREAM:1,8-ANS complexes.
DREAM:1,8-ANS
τ1
τ2
f1
f2
0
1
2
2
(ns)
(ns)
(%)
(%)
(%)
(%)
(%)
4.1 ± 0.1 16.9 ±
15.4 ±
83.0 ±
62.6
15.5
21.9
0.9
apoDREAM(64)
0.2
0.5
1.0
2+
4.3 ± 0.2 18.0 ±
9.7 ± 0.6 88.9 ±
40.4
16.9
42.7
0.9
Ca DREAM(64)
0.2
0.5
apoDREAM(E186Q)
3.5 ± 0.1 17.2 ±
12.3 ±
83.3 ±
68.9
13.0
18.1
1.5
0.1
0.4
0.4
Ca2+DREAM(E186Q)
3.7 ± 0.1 17.0 ±
10.1 ±
88.6 ±
60.7
13.5
25.8
1.2
0.1
0.8
0.5
apoDREAM(E234Q)
3.6 ± 0.1 16.1 ±
16.4 ±
75.3 ±
76.1
11.8
12.1
1.8
0.1
0.5
0.5
Ca2+DREAM(E234Q)
3.9 ± 0.1 16.7 ±
13.2 ±
82.7 ±
67.7
13.1
19.2
1.7
0.1
0.6
0.6
Recovered from Vinci analysis software using a sum of three discrete exponential decays with 1,8-ANS lifetime
fixed to 0.28 ns. Phase and modulation errors were set at ≤ 0.2° and ≤0.004, respectively. 0, 1, and 2 are
lifetimes of the three discrete exponential decays; f0, f1and f2 represent exponential decay fractions; 0, 1, and 2
are pre-exponential factors.
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8.2.3 Impact of EF-3 or EF-4 Inactivation of DREAM on Its Interaction with T-1 Domain
of Kv Channel.
Previous studies have demonstrated that KChIP1, a protein with high sequence
similarity with DREAM, interacts with the T-1 domain of Kv.4 channel through two contact
interfaces and this interaction has been shown to cause modulation of gating properties,
enhancement of surface expression, and facilitation of subunit assemblies of Kv4 channels
(Bourdeau, Laplante et al. 2011, Pioletti, Findeisen et al. 2006, Wang, Yan et al. 2007b,
Bahring, Dannenberg et al. 2001, Scannevin, Wang et al. 2004). Residues 1-20 (site-1) of
the T1 domain of Kv4 channel interacts with N- and C- terminal hydrophobic patches of
KChIP1. Residue 70-78 (site-2) of the T1 domain of Kv4 channel interacts with KChIP1
through both stacking and salt bridge interaction (Pioletti, Findeisen et al. 2006, Wang, Yan
et al. 2007a). Our previous result showed that DREAM interacts with site 1 (residues 2-22)
and site 2 (residues 70-90) of T-1 domain of the Kv channel (Azam, Miksovska 2018,
Azam, St Luis et al. 2019, Gonzalez, Pham et al. 2014). To investigate whether EF-3 or
EF-4 inactivation of DREAM modulates DREAM affinity for site 1 and site 2 of the T-1
domain of Kv channel, we titrated DREAM(E186Q) and DREAM(E234Q) into FITCtagged 0.5 μM site-1 and site-2 peptide (Figure 8.6A,B). Anisotropy value did not increase
upon the addition of saturation concentration DREAM(E186) or DREAM(E234Q) to site
1 peptide both in the presence and absence of Ca2+. As a control experiment, we added
corresponding wild-type DREAM(64) to site peptides both in the presence and absence
of Ca2+. In this case, anisotropy value increased significantly, especially in the presence of
Ca2+, which is similar to our previous study. Site 1 binds to N- and C- terminal hydrophobic
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Figure 8.6. Anisotropy change associated with Kv4.3 site-1 (residues 2-22) (A)
and Kv4.3 site- 2 (residues 70-90) (B) association with DREAM(E186Q) and
DREAM(E234Q) in the presence and absence of Ca2+.
patches on DREAM surface. We postulate that inactivating either EF-3 or EF-4 disturbs
big hydrophobic patches in the C-terminal of DREAM and subsequently prevents
interaction between DREAM and site-1. DREAM(E186Q) and DREAM(E234Q) addition
to site-2 show an increase in anisotropy, which is similar to wild-type DREAM(64)
addition site-2, suggesting inactivating either EF-3 or EF-4 may not modulate DREAM
interaction with site-2 of T-1 domain of Kv4 channels. The site-2 binding site is located at
the N-terminus of DREAM. Inactivating EF-3 or EF-4 at the C-terminus of DREAM may
likely not have impact on site-2 binding at the N-terminus.
8.3 Summary
In this study, we have shown that Ca2+ binding to EF-4 triggers secondary and
tertiary structural rearrangements of DREAM based on CD-data, Trp emission, and Trp
lifetime data. Inactivation either EF-3 or EF-4 decreases DREAM affinity for hydrophobic
molecule 1,8-ANS based on 1,8-ANS lifetime data. Lastly, inactivating EF-3 prevents
DREAM interaction with site-1 of the T-1 domain of K+ channel.
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9. CONCLUSIONS
Exposure to toxic metals such as Cd2+ and Pb2+ has been associated with
learning difficulties, IQ drop, and cognitive deficiencies in children and different
types of cancers and neurodegenerative diseases, but the molecular mechanism
through which these metals induces toxicity remains unexplored. DREAM is
expressed in the hippocampus, the part of the brain regulates memory consolidation
and learning. Cd2+ and Pb2+ have been shown to strongly impact the hippocampus
region. These metals also have been shown to bind to EF-hand of calmodulin (CaM)
and troponin C (TnC) with a higher affinity that physiological ligand Ca 2+. Binding
of these toxic metals modulates CaM interactions with downstream partners, which
is considered one of the possible mechanisms of Pb 2+-induced neurotoxicity.
Considering the facts that Pb2+ and Cd2+ impact hippocampus region and bind to EFhand protein and DREAM is an EF-hand protein and expressed in the hippocampus,
we investigated whether Cd2+ and Pb2+ bind to DREAM. In chapter 3, we
demonstrated the binding of Pb2+ to DREAM protein for the first time. We showed
that Pb2+ binds to EF-hand on DREAM with a higher affinity than Ca2+ and capable
of displacing Ca2+. Using fluorescence titration, we determined the dissociation
constant for Pb2+ binding to DREAM to be 20 ± 2 nM. Pb2+ association induces the
secondary and tertiary structural rearrangement of this protein that is analogous to
Ca2+ association as evidenced from Trp emission and circular dichroism data. Pb2+
binding exposes the hydrophobic patches of the DREAM and subsequently
facilitates the binding of hydrophobic molecule 1,8-ANS. From the fluorescence
titration, we determined that 1,8-ANS associates to DREAM with a 2-fold higher
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affinity in the presence of Pb2+ compared with the metal-free form. Isothermal
titration calorimetry experiments provided thermodynamics insight of the Pb2+ association
to DREAM. ITC data reveal two Pb2+ ions bind to DREAM protein with dissociation
constants 26 nM and 86 nM, respectively and binding of Pb2+ to DREAM is entropydriven as evidenced by positive enthalpy and positive entropy change. Most
interestingly, we demonstrated that the Pb2+ association alters DREAM interaction
with intracellular partners based on anisotropic titration of DREAM protein with
peptide-based model systems. More specifically, we determined that DREAM
interacts with Kv4.3(2–22) and Kv4.3(70–90) peptides of T-1 domain of Kv channel with
about 7-fold and 50-fold higher affinity, respectively, in the presence of Pb2+, compared
with the corresponding apo-form. Considering the implication of Kv channels in
hippocampus-dependent memory and learning processes, Kv channel:KChIP complexes
may rerpesent molecular target contributing to Pb2+ induced memory and learning
deficiencies. Also, DREAM interacts with helix 9 of presenilin-1 (PS1HL9) with about 70
times higher affinity than correspoding metal-free form. Several studies demonstrated that
an early life exposure to Pb2+ promotes developmental reprogramming of APP gene
expression, leading to an augmented expression of amyloid precursor protein during
adulthood. The interaction between Pb2+-bound DREAM and PS1HL9 observed here
suggest that elevated concentrations of Pb2+ may directly impact the proteolytic processing
of the β-amyloid precursor protein. Considering high sequence identity of the C-terminal
domain of neuronal calcium sensors and significant amount of Pb2+ in the brain (0.52–4
ppm) due to occupational and environmental exposure to the Pb2+, especially in the

173

hippocampus, other members of NCS family are likely to bind Pb2+ with higher affinity
than that for Ca2+ and be involved in Pb2+-induced neurotoxicity.
In chapter 4, we demonstrated Cd2+ binding to DREAM. We show Cd2+ binding
triggers secondary and tertiary structural rearrangement of the DREAM based on
Trp emission and CD spectra. From the emission and CD spectra of DREAM protein
in which either EF-3 or EF-4 is inactivated, we found that Cd2+ binding at EF-4
could trigger structural rearrangement of DREAM. We determined that Cd2+ binds
to DREAM with a dissociation constant 89 ± 10 nM, which is about 5-times weaker
than Pb2+ binding to DREAM. Interestingly, although Cd2+ ion has similar ionic radii
and charge/radius ratio values as Ca2+, the association of Cd2+ to EF-3 and EF-4
triggers a conformational transition that is somewhat restricted compared to that
determined for the binding of the physiological ligand, Ca 2+. This is substantiated
by 1,8-ANS emission data as well as lower affinity constants for binding of peptides
that mimic physiological effector proteins presenilin and T1 domain of Kv channels.
Isothermal titration calorimetry data unveiled that Cd2+ association with DREAM is
accompanied with a positive change in entropy and enthalpy, suggesting the reaction is
entropy-driven. Considering high sequence similarity of DREAM with other NCS proteins,
Cd2+ could bind to other NCS proteins and these interactions could provide insight into the
molecular basis of neurotoxicity.
In chapter 5, we determined Li+ binding to DREAM. Although Li+-based compounds
have been used as a first line therapy for the treatment of severe mental disorders for more
than six decades and have a wide range of applications in psychopharmacology, the
molecular mechanism of Li+ action remains largely unknown. Inhibitions of inositol

174

monophosphatase (IMPase) and glycogen synthase kinase-3 beta (GSK-3β) were proposed
as molecular mechanisms of Li+ action with Li+ inhibiting IMPase by displacing the native
cofactor Mg2+. Recent in vivo and in cellular studies demonstrated that chronic Li+
administration provides a protective effect against neurodegenerative diseases including
Alzheimer, Parkinson and Huntington disease. However, the exact mechanism through
which Li+ exerts its therapeutic action remains an active area of research. We report that
neuroprotective agent Li+ binds to DREAM with an equilibrium dissociation constant of
34 ± 4 μM and impacts DREAM structural and dynamic properties in a similar manner as
observed for its physiological ligand, Ca2+. The results of fluorescence spectroscopy and
molecular dynamics are consistent with Li+ binding at the chelating loop of the EF-hands.
In the Li+ bound form, DREAM association to peptides mimicking DREAM binding sites
in voltage-gated potassium channel is enhanced compared to the apoprotein, whereas
DREAM affinity for presenilin binding site, helix-9, is impeded. The reduced affinity of
Li+DREAM for helix-9 compared with Ca2+DREAM is in line with in vivo results showing
that Li+ administration decreases levels of soluble Aβ42 in transgenic mouse model of
Alzheimer’s disease. These results suggest that DREAM and possibly other members of
neuronal calcium sensor family belong to Li+ intracellular targets and interactions between
Li+ and NCS provide a molecular basis for Li+ neuroprotective action.
In chapter 6, we investigated whether toxic metals As5+, Hg2+, and Mn2+ and other
alkaline metals such as Ba2+ and Sr2+ bind to DREAM. Based on tryptophan emission and
1,8-emission study we conclude that either As5+, Hg2+, Mn2+, Ba2+, or Sr2+ does not bind
to DREAM or binding of As5+, Hg2+, Mn2+, Ba2+, or Sr2+ does not trigger structural
rearrangements.
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In chapter 7, we investigated impact of Lys87 to Ala mutation on DREAM secondary
and tertiary structures and interaction with intracellular partners. Accelerated molecular
dynamics data indicate the presence of a salt bridge between Lys87 and Asp 165 that
couples the loop between helix-1 and helix-2 in the N- terminal domain with the EF-3 in
the C- terminal domain We postulated that the salt bridge involved in the propagation of
calcium-triggered structural changes between the C- terminal and N- terminal domain. To
determine the contribution of Lys87 to the interdomain communication, we mutated Lys87
to Ala in order to break the salt bridge and investigated the impact of the mutation on
DREAM secondary and tertiary structures and DREAM interactions with interacting
partners. Our data reveal that the emission maximum of Trp169 in DREAM(K87A) is 5
nm red-shifted compared with corresponding wild-type protein, suggesting Trp169 is more
solvent exposed in DREAM(K87A). The increase in solvent accessibility can be explained
by the fact that the absence of salt bridge destabilizes the protein structure. Also disrupting
the interdomain coummunication by mutating Lys87 to Ala prevents DREAM interaction
with PS1HL9 and site-1 and site-2 peptides of the T-1 domain of Kv channel. This result
is consistent with the notion of 1,8-ANS lifetime data where DREAM shows a weaker
affinity for hydrophobic molecule 1,8-ANS.
In chapter 8, we mutated glutamate residue at 12th position of EF-3 (DREAM(E186Q))
or EF-4 (DREAM(E234Q)) to glutamine for destroying Ca2+ binding properties of these
EF-hands and investigated impact of mutations on Ca2+-triggered secondary and tertiary
structural rearrangements of the protein and Ca2+-induced modulation of DREAM
interaction with T-1 domain of Kv channel. On the basis of CD, Trp emission, and 1,8ANS emission data, we conclude that Ca2+ binding in EF-4 causes secondary and tertiary
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structural rearrangement of the proteins. We also demonstrated that EF-3 or EF-4
inactivation inhibits DREAM interaction with Kv4.3(2–22) peptides of T-1 domain of Kv
channel, but EF-3 or EF-4 inactivation doesn’t impact DREAM interaction with Kv4.3(70–
90) peptides of T-1 domain of Kv channel. Kv4.3(2–22) binds to N- and C- terminal
hydrophobic patches on DREAM surface; inactivating either EF-3 or EF-4 might disturb
big hydrophobic patches in the C-terminal of DREAM and subsequently prevents
interaction between DREAM and Kv4.3(2–22). Kv4.3(70–90) binding site is located at the
N-terminus of DREAM. Inactivating EF-3 or EF-4 at the C-terminus of DREAM may
likely not have impact on Kv4.3(70–90) binding at the N-terminus.

177

LIST OF REFERENCES
ABD RASHID, N., HAPIDIN, H., ABDULLAH, H., ISMAIL, Z. and LONG, I., 2017.
Nicotine‐prevented learning and memory impairment in REM sleep‐deprived rat is
modulated by DREAM protein in the hippocampus. Brain and behavior, 7(6), pp. e00704.
AMES, J.B. and LIM, S., 2012. Molecular structure and target recognition of neuronal
calcium sensor proteins. Biochimica et Biophysica Acta (BBA)-General Subjects, 1820(8),
pp. 1205-1213.
AMES, J.B., TANAKA, T., STRYER, L. and IKURA, M., 1996. Portrait of a myristoyl
switch protein. Current opinion in structural biology, 6(4), pp. 432-438.
AN, W.F., BOWLBY, M.R., BETTY, M., CAO, J., LING, H., MENDOZA, G., HINSON,
J.W., MATTSSON, K.I., STRASSLE, B.W. and TRIMMER, J.S., 2000. Modulation of Atype potassium channels by a family of calcium sensors. Nature, 403(6769), pp. 553-556.
ANDERSSON, A., FORSEN, S., THULIN, E. and VOGEL, J.J., 1983. Cadmium-113
nuclear magnetic resonance studies of proteolytic fragments of calmodulin: assignment of
strong and weak cation binding sites. Biochemistry, 22(10), pp. 2309-2313.
ARAVIND, P., CHANDRA, K., REDDY, P.P., JEROMIN, A., CHARY, K. and
SHARMA, Y., 2008. Regulatory and structural EF-hand motifs of neuronal calcium
sensor-1: Mg 2 modulates Ca 2 binding, Ca 2 -induced conformational changes, and
equilibrium unfolding transitions. Journal of molecular biology, 376(4), pp. 1100-1115.
ARCHIBALD, F.S. and TYREE, C., 1987. Manganese poisoning and the attack of trivalent
manganese upon catecholamines. Archives of Biochemistry and Biophysics, 256(2), pp.
638-650.
ARGOS, M., KALRA, T., RATHOUZ, P.J., CHEN, Y., PIERCE, B., PARVEZ, F.,
ISLAM, T., AHMED, A., RAKIBUZ-ZAMAN, M. and HASAN, R., 2010. Arsenic
exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh
(HEALS): a prospective cohort study. The Lancet, 376(9737), pp. 252-258.
AZAM, S. and MIKSOVSKA, J., 2018. Pb2 Binds to DREAM and Modulates Its
Interactions with Binding Partners: a Link between Neuronal Calcium Sensors and Pb2
Neurotoxicity. ACS chemical neuroscience, 10 (3), 1263–1272 .
AZAM, S., ST LUIS, G. and MIKSOVSKA, J., 2019. Cadmium association to DREAM
promotes DREAM interactions with intracellular partners in a similar manner as its
physiological ligand, calcium. Metallomics, 10.1039/C9MT00059C .

178

BÄHRE, H., DANKER, K.Y., STASCH, J., KAEVER, V. and SEIFERT, R., 2014.
Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells. Biochemical and
biophysical research communications, 443(4), pp. 1195-1199.
BAHRING, R., DANNENBERG, J., PETERS, H.C., LEICHER, T., PONGS, O. and
ISBRANDT, D., 2001. Conserved Kv4 N-terminal domain critical for effects of Kv
channel-interacting protein 2.2 on channel expression and gating. The Journal of biological
chemistry, 276(26), pp. 23888-23894.
BARRY, P.S. and MOSSMAN, D.B., 1970. Lead concentrations in human tissues. British
journal of industrial medicine, 27(4), pp. 339-351.
BASHA, M.R., MURALI, M., SIDDIQI, H.K., GHOSAL, K., SIDDIQI, O.K.,
LASHUEL, H.A., GE, Y.W., LAHIRI, D.K. and ZAWIA, N.H., 2005. Lead (Pb) exposure
and its effect on APP proteolysis and Abeta aggregation. FASEB journal : official
publication of the Federation of American Societies for Experimental Biology, 19(14), pp.
2083-2084.
BASHA, M.R., WEI, W., BAKHEET, S.A., BENITEZ, N., SIDDIQI, H.K., GE, Y.W.,
LAHIRI, D.K. and ZAWIA, N.H., 2005. The fetal basis of amyloidogenesis: exposure to
lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging
brain. The Journal of neuroscience : the official journal of the Society for Neuroscience,
25(4), pp. 823-829.
BERRIDGE, M.J., BOOTMAN, M.D. and RODERICK, H.L., 2003. Calcium: calcium
signalling: dynamics, homeostasis and remodelling. Nature reviews Molecular cell
biology, 4(7), pp. 517.
BERRIDGE, M.J., LIPP, P. and BOOTMAN, M.D., 2000. The versatility and universality
of calcium signalling. Nature reviews Molecular cell biology, 1(1), pp. 11.
BEZPROZVANNY, I., 2007. Inositol 1, 4, 5-tripshosphate receptor, calcium signalling
and Huntington’s disease. Calcium Signalling and Disease. Springer, pp. 323-335.
BEZPROZVANNY, I., 2009. Calcium signaling and neurodegenerative diseases. Trends
in molecular medicine, 15(3), pp. 89-100.
BLOCK, C., FREYERMUTH, S., BEYERSMANN, D. and MALVIYA, A., 1992. Role of
cadmium in activating nuclear protein kinase C and the enzyme binding to nuclear protein.
Journal of Biological Chemistry, 267(28), pp. 19824-19828.
BOECKEL, G.R. and EHRLICH, B.E., 2018. NCS-1 is a regulator of calcium signaling in
health and disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research,
1865,11, 1660-1667 .

179

BOLSHAKOV, V.Y. and SIEGELBAUM, S.A., 1994. Postsynaptic induction and
presynaptic expression of hippocampal long-term depression. Science (New York, N.Y.),
264(5162), pp. 1148-1152.
BOURDEAU, M., LAPLANTE, I., LAURENT, C. and LACAILLE, J., 2011. KChIP1
modulation of Kv4. 3-mediated A-type K currents and repetitive firing in hippocampal
interneurons. Neuroscience, 176, pp. 173-187.
BRANCO, V., CANÁRIO, J., LU, J., HOLMGREN, A. and CARVALHO, C., 2012.
Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione
peroxidase. Free Radical Biology and Medicine, 52(4), pp. 781-793.
BRAUNEWELL, K. and GUNDELFINGER, E.D., 1999. Intracellular neuronal calcium
sensor proteins: a family of EF-hand calcium-binding proteins in search of a function. Cell
and tissue research, 295(1), pp. 1-12.
BRAUNEWELL, K. and SZANTO, A.J.K., 2009. Visinin-like proteins (VSNLs):
interaction partners and emerging functions in signal transduction of a subfamily of
neuronal Ca2 -sensor proteins. Cell and tissue research, 335(2), pp. 301-316.
BRINI, M., CALÌ, T., OTTOLINI, D. and CARAFOLI, E., 2014. Neuronal calcium
signaling: function and dysfunction. Cellular and molecular life sciences, 71(15), pp.
2787-2814.
BROPHY, M.B. and NOLAN, E.M., 2015. Manganese and microbial pathogenesis:
sequestration by the mammalian immune system and utilization by microorganisms. ACS
chemical biology, 10(3), pp. 641-651.
BROWN, K.M. and TRACY, D.K., 2013. Lithium: the pharmacodynamic actions of the
amazing ion. Therapeutic advances in psychopharmacology, 3(3), pp. 163-176.
BURGOYNE, R.D., 2007. Neuronal calcium sensor proteins: generating diversity in
neuronal Ca2 signalling. Nature Reviews Neuroscience, 8(3), pp. 182-193.
BURGOYNE, R.D. and WEISS, J.L., 2001. The neuronal calcium sensor family of Ca2+binding proteins. The Biochemical journal, 353(Pt 1), pp. 1-12.
BUXBAUM, J.D., CHOI, E., LUO, Y., LILLIEHOOK, C., CROWLEY, A.C.,
MERRIAM, D.E. and WASCO, W., 1998. Calsenilin: a calcium-binding protein that
interacts with the presenilins and regulates the levels of a presenilin fragment. Nature
medicine, 4(10), pp. 1177-1181.
CADE, J.F., 1949. Lithium salts in the treatment of psychotic excitement. Medical journal
of Australia, 2(10), pp. 349-352.

180

CALLSEN, B., ISBRANDT, D., SAUTER, K., HARTMANN, L.S., PONGS, O. and
BÄHRING, R., 2005. Contribution of N‐and C‐terminal channel domains to Kv channel
interacting proteins in a mammalian cell line. The Journal of physiology, 568(2), pp. 397412.
CALVERT, P.D., KLENCHIN, V.A. and BOWNDS, M.D., 1995. Rhodopsin kinase
inhibition by recoverin. Function of recoverin myristoylation. The Journal of biological
chemistry, 270(41), pp. 24127-24129.
CANFIELD, R.L., HENDERSON JR, C.R., CORY-SLECHTA, D.A., COX, C., JUSKO,
T.A. and LANPHEAR, B.P., 2003. Intellectual impairment in children with blood lead
concentrations below 10 μg per deciliter. New England journal of medicine, 348(16), pp.
1517-1526.
CAO, Y., CHEN, A., RADCLIFFE, J., DIETRICH, K.N., JONES, R.L., CALDWELL, K.
and ROGAN, W.J., 2009. Postnatal cadmium exposure, neurodevelopment, and blood
pressure in children at 2, 5, and 7 years of age. Environmental health perspectives, 117(10),
pp. 1580-1586.
CAPEL, I.D., PINNOCK, M.H., DORRELL, H.M., WILLIAMS, D.C. and GRANT, E.C.,
1981. Comparison of concentrations of some trace, bulk, and toxic metals in the hair of
normal and dyslexic children. Clinical chemistry, 27(6), pp. 879-881.
CARAFOLI, E., SANTELLA, L., BRANCA, D. and BRINI, M., 2001. Generation,
control, and processing of cellular calcium signals. Critical reviews in biochemistry and
molecular biology, 36(2), pp. 107-260.
CARDAMONE, M. and PURI, N.K., 1992. Spectrofluorimetric assessment of the surface
hydrophobicity of proteins. The Biochemical journal, 282 (Pt 2), pp. 589-593.
CAROCCI, A., ROVITO, N., SINICROPI, M.S. and GENCHI, G., 2014. Mercury toxicity
and neurodegenerative effects. Reviews of environmental contamination and toxicology.
Springer, pp. 1-18.
CARRION, A.M., LINK, W.A., LEDO, F., MELLSTRÖM, B. and NARANJO, J.R., 1999.
DREAM is a Ca2&plus;-regulated transcriptional repressor. Nature, 398(6722), pp. 80-84.
CARRION, A.M., MELLSTROM, B. and NARANJO, J.R., 1998. Protein kinase Adependent derepression of the human prodynorphin gene via differential binding to an
intragenic silencer element. Molecular and cellular biology, 18(12), pp. 6921-6929.
CARVALHO, C.M., CHEW, E.H., HASHEMY, S.I., LU, J. and HOLMGREN, A., 2008.
Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity.
The Journal of biological chemistry, 283(18), pp. 11913-11923.

181

CHANG, K.N., LEE, T.C., TAM, M.F., CHEN, Y.C., LEE, L.W., LEE, S.Y., LIN, P.J.
and HUANG, R.N., 2003. Identification of galectin I and thioredoxin peroxidase II as two
arsenic-binding proteins in Chinese hamster ovary cells. The Biochemical journal, 371(Pt
2), pp. 495-503.
CHAO, S.H., BU, C.H. and CHEUNG, W.Y., 1995. Stimulation of myosin light-chain
kinase by Cd2 and Pb2. Archives of Toxicology, 69(3), pp. 197-203.
CHAO, S.L., MOSS, J.M. and HARRY, G.J., 2007. Lead‐induced alterations of apoptosis
and neurotrophic factor mRNA in the developing rat cortex, hippocampus, and cerebellum.
Journal of Biochemical and Molecular Toxicology, 21(5), pp. 265-272.
CHEN, C., WANG, S., CHIOU, J., TSENG, C., CHIOU, H., HSUEH, Y., CHEN, S., WU,
M. and LAI, M., 2007. Arsenic and diabetes and hypertension in human populations: a
review. Toxicology and applied pharmacology, 222(3), pp. 298-304.
CHEN, Y., GRAZIANO, J.H., PARVEZ, F., LIU, M., SLAVKOVICH, V., KALRA, T.,
ARGOS, M., ISLAM, T., AHMED, A., RAKIBUZ-ZAMAN, M., HASAN, R., SARWAR,
G., LEVY, D., VAN GEEN, A. and AHSAN, H., 2011. Arsenic exposure from drinking
water and mortality from cardiovascular disease in Bangladesh: prospective cohort study.
BMJ (Clinical research ed.), 342, pp. d2431.
CHENG, H.M., PITCHER, G.M., LAVIOLETTE, S.R., WHISHAW, I.Q., TONG, K.I.,
KOCKERITZ, L.K., WADA, T., JOZA, N.A., CRACKOWER, M. and GONCALVES, J.,
2002. DREAM is a critical transcriptional repressor for pain modulation. Cell, 108(1), pp.
31-43.
CHOONG, G., LIU, Y. and TEMPLETON, D.M., 2014. Interplay of calcium and cadmium
in mediating cadmium toxicity. Chemico-biological interactions, 211, pp. 54-65.
CHOUCHANE, S. and SNOW, E.T., 2001. In vitro effect of arsenical compounds on
glutathione-related enzymes. Chemical research in toxicology, 14(5), pp. 517-522.
CHRISTIE, B.R., MAGEE, J.C. and JOHNSTON, D., 1996. Dendritic calcium channels
and hippocampal long‐term depression. Hippocampus, 6(1), pp. 17-23.
CLAPHAM, D.E., 2007. Calcium signaling. Cell, 131(6), pp. 1047-1058.
CLARKSON, T.W. and MAGOS, L., 2006. The toxicology of mercury and its chemical
compounds. Critical reviews in toxicology, 36(8), pp. 609-662.
CLARKSON, T.W., 2002. The three modern faces of mercury. Environmental health
perspectives, 110 Suppl 1, pp. 11-23.

182

COLLINS, J.H., 1974. Homology of myosin light chains, troponin-C and parvalbumins
deduced from comparison of their amino acid sequences. Biochemical and biophysical
research communications, 58(1), pp. 301-308.
COLLINS, J.H., POTTER, J.D., HORN, M.J., WILSHIRE, G. and JACKMAN, N., 1973.
The amino acid sequence of rabbit skeletal muscle troponin C: Gene replication and
homology with calcium‐binding proteins from carp and hake muscle. FEBS letters, 36(3),
pp. 268-272.
COSTIGAN, M. and WOOLF, C.J., 2002. No DREAM, no pain: closing the spinal gate.
Cell, 108(3), pp. 297-300.
CRABTREE, M.D. and SHAMMAS, S.L., 2018. Stopped-Flow Kinetic Techniques for
Studying Binding Reactions of Intrinsically Disordered Proteins. Methods in enzymology,
611, pp. 423-457.
DAMO, S.M., KEHL-FIE, T.E., SUGITANI, N., HOLT, M.E., RATHI, S., MURPHY,
W.J., ZHANG, Y., BETZ, C., HENCH, L., FRITZ, G., SKAAR, E.P. and CHAZIN, W.J.,
2013. Molecular basis for manganese sequestration by calprotectin and roles in the innate
immune response to invading bacterial pathogens. Proceedings of the National Academy
of Sciences of the United States of America, 110(10), pp. 3841-3846.
DE FERRARI, G., CHACON, M., BARRIA, M., GARRIDO, J., GODOY, J.,
OLIVARES, G., REYES, A., ALVAREZ, A., BRONFMAN, M. and INESTROSA, N.,
2003. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments
induced by β-amyloid fibrils. Molecular psychiatry, 8(2), pp. 195.
DEIBLER, K. and BASU, P., 2013. Continuing issues with lead: recent advances in
detection. European journal of inorganic chemistry, 2013(7), pp. 1086-1096.
DIZHOOR, A.M., LOWE, D.G., OLSHEVSKAYA, E.V., LAURA, R.P. and HURLEY,
J.B., 1994. The human photoreceptor membrane guanylyl cyclase, RetGC, is present in
outer segments and is regulated by calcium and a soluble activator. Neuron, 12(6), pp.
1345-1352.
DIZHOOR, A.M., RAY, S., KUMAR, S., NIEMI, G., SPENCER, M., BROLLEY, D.,
WALSH, K.A., PHILIPOV, P.P., HURLEY, J.B. and STRYER, L., 1991. Recoverin: a
calcium sensitive activator of retinal rod guanylate cyclase. Science (New York, N.Y.),
251(4996), pp. 915-918.
D'ONOFRIO, S., HYDE, J. and GARCIA‐RILL, E., 2017. Interaction between neuronal
calcium sensor protein 1 and lithium in pedunculopontine neurons. Physiological reports,
5(7),.

183

D'ONOFRIO, S., KEZUNOVIC, N., HYDE, J.R., LUSTER, B., MESSIAS, E., URBANO,
F.J. and GARCIA-RILL, E., 2015. Modulation of gamma oscillations in the
pedunculopontine nucleus by neuronal calcium sensor protein-1: relevance to
schizophrenia and bipolar disorder. Journal of neurophysiology, 113(3), pp. 709-719.
DOYLE, D., 2009. Notoriety to respectability: a short history of arsenic prior to its present
day use in haematology. British journal of haematology, 145(3), pp. 309-317.
DUDEV, T., MAZMANIAN, K. and LIM, C., 2018. Competition between Li and Na in
sodium transporters and receptors: Which Na -Binding sites are “therapeutic” Li targets?
Chemical Science, 9(17), pp. 4093-4103.
EDINGTON, S.C., GONZALEZ, A., MIDDENDORF, T.R., HALLING, D.B.,
ALDRICH, R.W. and BAIZ, C.R., 2018. Coordination to lanthanide ions distorts binding
site conformation in calmodulin. Proceedings of the National Academy of Sciences of the
United States of America, 115(14), pp. E3126-E3134.
ELLIS, P.D., STRANG, P. and POTTER, J.D., 1984. Cadmium-substituted skeletal
troponin C. Cadmium-113 NMR spectroscopy and metal binding investigations. The
Journal of biological chemistry, 259(16), pp. 10348-10356.
EL‐MARAGHY, S.A., GAD, M.Z., FAHIM, A.T. and HAMDY, M.A., 2001. Effect of
cadmium and aluminum intake on the antioxidant status and lipid peroxidation in rat
tissues. Journal of Biochemical and Molecular Toxicology, 15(4), pp. 207-214.
ENGEL, T., GOÑI‐OLIVER, P., LUCAS, J.J., AVILA, J. and HERNÁNDEZ, F., 2006.
Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents
tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed
neurofibrillary tangles do not revert. Journal of neurochemistry, 99(6), pp. 1445-1455.
ESSEN, L., PERISIC, O., CHEUNG, R., KATAN, M. and WILLIAMS, R.L., 1996.
Crystal structure of a mammalian phosphoinositide-specific phospholipase Cδ. Nature,
380(6575), pp. 595.
FLAHERTY, K.M., ZOZULYA, S., STRYER, L. and MCKAY, D.B., 1993. Threedimensional structure of recoverin, a calcium sensor in vision. Cell, 75(4), pp. 709-716.
FONTÁN-LOZANO, Á., ROMERO-GRANADOS, R., DEL-POZO-MARTÍN, Y.,
SUÁREZ-PEREIRA, I., DELGADO-GARCÍA, J.M., PENNINGER, J.M. and CARRIÓN,
Á.M., 2009. Lack of DREAM protein enhances learning and memory and slows brain
aging. Current Biology, 19(1), pp. 54-60.
FORLENZA, O.V., DE-PAULA, VANESSA DE JESUS RODRIGUES and DINIZ, B.,
2014. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s

184

disease and related neurodegenerative disorders. ACS chemical neuroscience, 5(6), pp.
443-450.
FORSÉN, S., THULIN, E., DRAKENBERG, T., KREBS, J. and SEAMON, K., 1980. A
113Cd NMR study of calmodulin and its interaction with calcium, magnesium and
trifluoperazine. FEBS letters, 117(1-2), pp. 189-194.
FRIEDMAN, R., 2014. Structural and computational insights into the versatility of
cadmium binding to proteins. Dalton Transactions, 43(7), pp. 2878-2887.
FULCHER, L.M., 2015. Thermodynamic and spectroscopic studies of Cd²⁺ binding to the
regulatory domain and full length human cardiac troponin C (HcTnC): elucidating
plausible Cd²⁺ binding sites.
GABBIANI, G., BAIC, D. and DEZIEL, C., 1967. Toxicity of cadmium for the central
nervous system. Experimental neurology, 18(2), pp. 154-160.
GEORGE, S.E., SU, Z., FAN, D. and MEANS, A.R., 1993. Calmodulin-cardiac troponin
C chimeras. Effects of domain exchange on calcium binding and enzyme activation. The
Journal of biological chemistry, 268(33), pp. 25213-25220.
GERKE, V. and MOSS, S.E., 2002. Annexins: from structure to function. Physiological
Reviews, 82(2), pp. 331-371.
GIFFORD, J.L., WALSH, M.P. and VOGEL, H.J., 2007. Structures and metal-ion-binding
properties of the Ca2+-binding helix-loop-helix EF-hand motifs. The Biochemical journal,
405(2), pp. 199-221.
GILSTON, B.A., SKAAR, E.P. and CHAZIN, W.J., 2016. Binding of transition metals to
S100 proteins. Science China Life Sciences, 59(8), pp. 792-801.
GOHARA, D.W. and DI CERA, E., 2016. Molecular Mechanisms of Enzyme Activation
by Monovalent Cations. The Journal of biological chemistry, 291(40), pp. 20840-20848.
GOLDSTEIN, G.W. and AR, D., 1983. Lead activates calmodulin sensitive processes. Life
Sciences, 33(10), pp. 1001-1006.
GONZALEZ, W.G., ARANGO, A.S. and MIKSOVSKA, J., 2015. Amphiphilic Residues
29–44 of DREAM N-Termini Mediate Calmodulin: DREAM Complex Formation.
Biochemistry, 54(28), pp. 4391-4403.
GONZALEZ, W.G. and MIKSOVSKA, J., 2014. Application of ANS fluorescent probes
to identify hydrophobic sites on the surface of DREAM. Biochimica Et Biophysica Acta
(BBA)-Proteins and Proteomics, 1844(9), pp. 1472-1480.

185

GONZALEZ, W.G., PHAM, K. and MIKSOVSKA, J., 2014. Modulation of the voltagegated potassium channel (Kv4.3) and the auxiliary protein (KChIP3) interactions by the
current activator NS5806. The Journal of biological chemistry, 289(46), pp. 32201-32213.
GONZALEZ, W.G., RAMOS, V., DIAZ, M., GARABEDIAN, A., MOLANOAREVALO, J.C., FERNANDEZ-LIMA, F. and MIKSOVSKA, J., 2016. Characterization
of the Photophysical, Thermodynamic, and Structural Properties of the Terbium(III)DREAM Complex. Biochemistry, 55(12), pp. 1873-1886.
GORKHALI, R., HUANG, K., KIRBERGER, M. and YANG, J.J., 2016. Defining
potential roles of Pb 2 in neurotoxicity from a calciomics approach. Metallomics, 8(6), pp.
563-578.
GRABAREK, Z., 2006. Structural basis for diversity of the EF-hand calcium-binding
proteins. Journal of Molecular Biology, 359(3), pp. 509-525.
GRANDJEAN, P., 1978. Regional distribution of lead in human brains. Toxicology letters,
2(1), pp. 65-69.
GROVER, L.M. and TEYLER, T.J., 1990. Two components of long-term potentiation
induced by different patterns of afferent activation. Nature, 347(6292), pp. 477.
GU, C. and COOPER, D.M., 2000. Ca(2+), Sr(2+), and Ba(2+) identify distinct regulatory
sites on adenylyl cyclase (AC) types VI and VIII and consolidate the apposition of
capacitative cation entry channels and Ca(2+)-sensitive ACs. The Journal of biological
chemistry, 275(10), pp. 6980-6986.
GUILARTE, T.R., 2010. APLP1, Alzheimer's-like pathology and neurodegeneration in the
frontal cortex of manganese-exposed non-human primates. Neurotoxicology, 31(5), pp.
572-574.
GUNTER, T.E., GAVIN, C.E., ASCHNER, M. and GUNTER, K.K., 2006. Speciation of
manganese in cells and mitochondria: a search for the proximal cause of manganese
neurotoxicity. Neurotoxicology, 27(5), pp. 765-776.
HABERMANN, E., CROWELL, K. and JANICKI, P., 1983. Lead and other metals can
substitute for Ca 2 in calmodulin. Archives of Toxicology, 54(1), pp. 61-70.
HAIMOVICH, A., ELIAV, U. and GOLDBOURT, A., 2012. Determination of the lithium
binding site in inositol monophosphatase, the putative target for lithium therapy, by magicangle-spinning solid-state NMR. Journal of the American Chemical Society, 134(12), pp.
5647-5651.

186

HALLCHER, L.M. and SHERMAN, W.R., 1980. The effects of lithium ion and other
agents on the activity of myo-inositol-1-phosphatase from bovine brain. The Journal of
biological chemistry, 255(22), pp. 10896-10901.
HANDLEY, M.T., LIAN, L., HAYNES, L.P. and BURGOYNE, R.D., 2010. Structural
and functional deficits in a neuronal calcium sensor-1 mutant identified in a case of autistic
spectrum disorder. PloS one, 5(5), pp. e10534.
HARTWIG, A., BLESSING, H., SCHWERDTLE, T. and WALTER, I., 2003. Modulation
of DNA repair processes by arsenic and selenium compounds. Toxicology, 193(1-2), pp.
161-169.
HARWOOD, A., 2005. Lithium and bipolar mood disorder: the inositol-depletion
hypothesis revisited. Molecular psychiatry, 10(1), pp. 117.
HAYNES, L.P., SHERWOOD, M.W., DOLMAN, N.J. and BURGOYNE, R.D., 2007.
Specificity, Promiscuity and Localization of ARF Protein Interactions with NCS‐1 and
Phosphatidylinositol‐4 Kinase‐IIIβ. Traffic, 8(8), pp. 1080-1092.
HENZL, M.T., LARSON, J.D. and AGAH, S., 2004a. Influence of monovalent cation
identity on parvalbumin divalent ion-binding properties. Biochemistry, 43(10), pp. 27472763.
HENZL, M.T., LARSON, J.D. and AGAH, S., 2004b. Influence of monovalent cation
identity on parvalbumin divalent ion-binding properties. Biochemistry, 43(10), pp. 27472763.
HOLMQVIST, M.H., CAO, J., HERNANDEZ-PINEDA, R., JACOBSON, M.D.,
CARROLL, K.I., SUNG, M.A., BETTY, M., GE, P., GILBRIDE, K.J., BROWN, M.E.,
JURMAN, M.E., LAWSON, D., SILOS-SANTIAGO, I., XIE, Y., COVARRUBIAS, M.,
RHODES, K.J., DISTEFANO, P.S. and AN, W.F., 2002. Elimination of fast inactivation
in Kv4 A-type potassium channels by an auxiliary subunit domain. Proceedings of the
National Academy of Sciences of the United States of America, 99(2), pp. 1035-1040.
HUANG, H., BIHAQI, S.W., CUI, L. and ZAWIA, N.H., 2011. In vitro Pb exposure
disturbs the balance between Aβ production and elimination: the role of AβPP and
neprilysin. Neurotoxicology, 32(3), pp. 300-306.
HUGHES, M.F., 2002. Arsenic toxicity and potential mechanisms of action. Toxicology
letters, 133(1), pp. 1-16.
HUGHES, R.E., BRZOVIC, P.S., KLEVIT, R.E. and HURLEY, J.B., 1995. Calciumdependent solvation of the myristoyl group of recoverin. Biochemistry, 34(36), pp. 1141011416.

187

HUMPHREY, W., DALKE, A. and SCHULTEN, K., 1996. VMD: visual molecular
dynamics. Journal of Molecular Graphics, 14(1), pp. 33-38.
IARC WORKING GROUP ON THE EVALUATION OF THE CARCINOGENIC RISK
OF CHEMICALS TO HUMANS, 1993. Beryllium, cadmium, mercury, and exposures in
the glass manufacturing industry. International Agency for Research on Cancer.
IMPEY, S., MARK, M., VILLACRES, E.C., POSER, S., CHAVKIN, C. and STORM,
D.R., 1996. Induction of CRE-mediated gene expression by stimuli that generate longlasting LTP in area CA1 of the hippocampus. Neuron, 16(5), pp. 973-982.
IPCS, W., 1992. Enviropnmental Health Criteria 134. Cadmium, 52–130. World Health
Organization, Geneva, .
JAIN, C. and ALI, I., 2000. Arsenic: occurrence, toxicity and speciation techniques. Water
research, 34(17), pp. 4304-4312.
JALILEHVAND, F., SPÅNGBERG, D., LINDQVIST-REIS, P., HERMANSSON, K.,
PERSSON, I. and SANDSTRÖM, M., 2001. Hydration of the calcium ion. An EXAFS,
large-angle X-ray scattering, and molecular dynamics simulation study. Journal of the
American Chemical Society, 123(3), pp. 431-441.
JAN, A.T., ALI, A. and HAQ, Q., 2011. Glutathione as an antioxidant in inorganic mercury
induced nephrotoxicity. Journal of postgraduate medicine, 57(1), pp. 72-77.
JÄRUP, L. and ÅKESSON, A., 2009. Current status of cadmium as an environmental
health problem. Toxicology and applied pharmacology, 238(3), pp. 201-208.
JEANNE, M., LALLEMAND-BREITENBACH, V., FERHI, O., KOKEN, M., LE BRAS,
M., DUFFORT, S., PERES, L., BERTHIER, C., SOILIHI, H. and RAUGHT, B., 2010.
PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
Cancer cell, 18(1), pp. 88-98.
JESU JAYA SUDAN, R. and SUDANDIRADOSS, C., 2012. Pattern prediction and
coordination geometry analysis from cadmium‐binding proteins: a computational
approach. Acta Crystallographica Section D, 68(10), pp. 1346-1358.
JIN, T., LU, J. and NORDBERG, M., 1998. Toxicokinetics and biochemistry of cadmium
with special emphasis on the role of metallothionein. Neurotoxicology, 19(4-5), pp. 529535.
JO, D., JANG, J., KIM, B., LUNDKVIST, J. and JUNG, Y., 2005. Overexpression of
calsenilin enhances γ-secretase activity. Neuroscience letters, 378(1), pp. 59-64.

188

JO, S., KIM, T., IYER, V.G. and IM, W., 2008. CHARMM‐GUI: a web‐based graphical
user interface for CHARMM. Journal of computational chemistry, 29(11), pp. 1859-1865.
JOHNSON, S., 2001. Gradual micronutrient accumulation and depletion in Alzheimer’s
disease. Medical hypotheses, 56(6), pp. 595-597.
JOSEPH, P., MUCHNOK, T.K., KLISHIS, M.L., ROBERTS, J.R., ANTONINI, J.M.,
WHONG, W. and ONG, T., 2001. Cadmium-induced cell transformation and
tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc
proto-oncogenes: role of cellular calcium and reactive oxygen species. Toxicological
sciences, 61(2), pp. 295-303.
KANTER, M., UNSAL, C., AKTAS, C. and ERBOGA, M., 2016. Neuroprotective effect
of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in
hippocampus. Toxicology and industrial health, 32(3), pp. 541-550.
KAWAMOTO, E.M., VIVAR, C. and CAMANDOLA, S., 2012. Physiology and
pathology of calcium signaling in the brain. Frontiers in pharmacology, 3, pp. 61.
KERN, M., WISNIEWSKI, M., CABELL, L. and AUDESIRK, G., 2000. Inorganic lead
and calcium interact positively in activation of calmodulin. Neurotoxicology, 21(3), pp.
353-363.
KHROMOVA, V. and MYSHKIN, A., 2000. Coagulation of bovine methemoglobin
mercurated at reactive sulfur in the presence of ligands with a high affinity for Hg (II).
Russian Journal of General Chemistry, 70(4), pp. 635-639.
KIRBERGER, M., WONG, H.C., JIANG, J. and YANG, J.J., 2013. Metal toxicity and
opportunistic binding of Pb 2 in proteins. Journal of inorganic biochemistry, 125, pp. 4049.
KIRBERGER, M. and YANG, J.J., 2008. Structural differences between Pb 2 -and Ca 2 binding sites in proteins: implications with respect to toxicity. Journal of inorganic
biochemistry, 102(10), pp. 1901-1909.
KITCHIN, K.T. and WALLACE, K., 2005. Arsenite binding to synthetic peptides based
on the Zn finger region and the estrogen binding region of the human estrogen receptor-α.
Toxicology and applied pharmacology, 206(1), pp. 66-72.
KOH, P.O., UNDIE, A.S., KABBANI, N., LEVENSON, R., GOLDMAN-RAKIC, P.S.
and LIDOW, M.S., 2003. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the
prefrontal cortex of schizophrenic and bipolar patients. Proceedings of the National
Academy of Sciences of the United States of America, 100(1), pp. 313-317.

189

KONYAEVA, V. and MYSHKIN, A., 1998a. Effect of weak chemical actions on
coagulation of oxyhemoglobin mercurated at reactive sulfur. III. Effects of EDTA and
Thiourea. Russian journal of general chemistry, 68(4), pp. 643-649.
KONYAEVA, V. and MYSHKIN, A., 1998b. Effect of weak chemical actions on
coagulation of oxyhemoglobin mercurated at reactive sulfur. III. Effects of EDTA and
Thiourea. Russian journal of general chemistry, 68(4), pp. 643-649.
KONYAEVA, V. and MYSHKIN, A., 1998c. Effect of weak chemical interactions on
coagulation of oxyhemoglobin mercurated at reactive sulfur. I. Influence of Tris
(hydroxymethyl) aminomethane. Russian journal of general chemistry, 68(4), pp. 630-636.
KRETSINGER, R.H. and NOCKOLDS, C.E., 1973. Carp muscle calcium-binding protein.
II. Structure determination and general description. The Journal of biological chemistry,
248(9), pp. 3313-3326.
KUMAR, R., AGARWAL, A.K. and SETH, P.K., 1996. Oxidative stress-mediated
neurotoxicity of cadmium. Toxicology letters, 89(1), pp. 65-69.
KUMAR, S., AHMAD, E., KUMAR, S., KHAN, R.H. and GOURINATH, S., 2012.
Flexibility of EF-hand motifs: structural and thermodynamic studies of Calcium Binding
Protein-1 from Entamoeba histolytica with Pb 2 , Ba 2 , and Sr 2. BMC biophysics, 5(1),
pp. 15.
KUNJILWAR, K., QIAN, Y. and PFAFFINGER, P.J., 2013. Functional stoichiometry
underlying KC h IP regulation of Kv4. 2 functional expression. Journal of neurochemistry,
126(4), pp. 462-472.
KURSULA, P. and MAJAVA, V., 2007. A structural insight into lead neurotoxicity and
calmodulin activation by heavy metals. Acta Crystallographica Section F: Structural
Biology and Crystallization Communications, 63(8), pp. 653-656.
LAFUENTE, A., FENÁNDEZ-REY, E., SEARA, R., PÉREZ-LORENZO, M. and
ESQUIFINO, A., 2001. Alternate cadmium exposure differentially affects amino acid
metabolism within the hypothalamus, median eminence, striatum and prefrontal cortex of
male rats. Neurochemistry international, 39(3), pp. 187-192.
LAFUENTE, A., GONZALEZ-CARRACEDO, A., ROMERO, A. and ESQUIFINO, A.,
2003. Effect of cadmium on 24-h variations in hypothalamic dopamine and serotonin
metabolism in adult male rats. Experimental brain research, 149(2), pp. 200-206.
LAKHIN, A., EFREMOVA, A., MAKAROVA, I., GRISHINA, E., SHRAM, S.,
TARANTUL, V. and GENING, L., 2013. Effect of Mn (II) on error-prone DNA
polymerase iota activity in extracts from human normal and tumor cells. Molecular
Genetics, Microbiology and Virology, 28(1), pp. 1-7.

190

LAKHIN, A., TARANTUL, V. and GENING, L., 2014. Manganese-induced infidelity of
DNA synthesis as a possible cause of manganism. Molecular Genetics, Microbiology and
Virology, 29(1), pp. 16-22.
LEDO, F., KREMER, L., MELLSTROM, B. and NARANJO, J.R., 2002. Ca2+-dependent
block of CREB-CBP transcription by repressor DREAM. The EMBO journal, 21(17), pp.
4583-4592.
LEROY, K., ANDO, K., HÉRAUD, C., YILMAZ, Z., AUTHELET, M., BOEYNAEMS,
J., BUÉE, L., DE DECKER, R. and BRION, J., 2010. Lithium treatment arrests the
development of neurofibrillary tangles in mutant tau transgenic mice with advanced
neurofibrillary pathology. Journal of Alzheimer's Disease, 19(2), pp. 705-719.
LI, X., LV, Y., YU, S., ZHAO, H. and YAO, L., 2012. The effect of cadmium on Aβ levels
in APP/PS1 transgenic mice. Experimental and therapeutic medicine, 4(1), pp. 125-130.
LIANG, P., WANG, H., CHEN, H., CUI, Y., GU, L., CHAI, J. and WANG, K., 2009.
Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation. The Journal of
biological chemistry, 284(8), pp. 4960-4967.
LIM, S., DIZHOOR, A. and AMES, J., 2014. Structural diversity of neuronal calcium
sensor proteins and insights for activation of retinal guanylyl cyclase by GCAP1. Frontiers
in molecular neuroscience, 7, pp. 19.
LIM, S., PESHENKO, I., DIZHOOR, A. and AMES, J.B., 2009. Effects of Ca2 , Mg2 ,
and myristoylation on guanylyl cyclase activating protein 1 structure and stability.
Biochemistry, 48(5), pp. 850-862.
LIM, D., FEDRIZZI, L., TARTARI, M., ZUCCATO, C., CATTANEO, E., BRINI, M. and
CARAFOLI, E., 2008. Calcium homeostasis and mitochondrial dysfunction in striatal
neurons of Huntington disease. The Journal of biological chemistry, 283(9), pp. 57805789.
LIN, C., HUANG, C., CHEN, W., CHANG, Y., DING, W., LIN, M., WU, S. and HUANG,
R., 2006. Characterization of the interaction of galectin-1 with sodium arsenite. Chemical
research in toxicology, 19(3), pp. 469-474.
LISS, B., FRANZ, O., SEWING, S., BRUNS, R., NEUHOFF, H. and ROEPER, J., 2001.
Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and
KChip3.1 transcription. The EMBO journal, 20(20), pp. 5715-5724.
LONG, G.J., ROSEN, J.F. and SCHANNE, F.A., 1994. Lead activation of protein kinase
C from rat brain. Determination of free calcium, lead, and zinc by 19F NMR. The Journal
of biological chemistry, 269(2), pp. 834-837.

191

LOPEZ, E., ARCE, C., OSET-GASQUE, M., CANADAS, S. and GONZALEZ, M., 2006.
Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical
neurons in culture. Free Radical Biology and Medicine, 40(6), pp. 940-951.
LOPEZ, E., FIGUEROA, S., OSET‐GASQUE, M. and GONZALEZ, M., 2003. Apoptosis
and necrosis: two distinct events induced by cadmium in cortical neurons in culture. British
journal of pharmacology, 138(5), pp. 901-911.
LOUIS‐JEUNE, C., ANDRADE‐NAVARRO, M.A. and PEREZ‐IRATXETA, C., 2012.
Prediction of protein secondary structure from circular dichroism using theoretically
derived spectra. Proteins: Structure, Function, and Bioinformatics, 80(2), pp. 374-381.
LU, J., CHEW, E.H. and HOLMGREN, A., 2007. Targeting thioredoxin reductase is a
basis for cancer therapy by arsenic trioxide. Proceedings of the National Academy of
Sciences of the United States of America, 104(30), pp. 12288-12293.
LUCCHINI, R., PLACIDI, D., CAGNA, G., FEDRIGHI, C., OPPINI, M., PELI, M. and
ZONI, S., 2017. Manganese and developmental neurotoxicity. Neurotoxicity of Metals.
Springer, pp. 13-34.
LUGO, J.N., BREWSTER, A.L., SPENCER, C.M. and ANDERSON, A.E., 2012. Kv4.2
knockout mice have hippocampal-dependent learning and memory deficits. Learning &
memory (Cold Spring Harbor, N.Y.), 19(5), pp. 182-189.
LUSIN, J.D., VANAROTTI, M., LI, C., VALIVETI, A. and AMES, J.B., 2008. NMR
structure of DREAM: Implications for Ca2 -dependent DNA binding and protein
dimerization. Biochemistry, 47(8), pp. 2252-2264.
MAKINO, C.L., DODD, R.L., CHEN, J., BURNS, M.E., ROCA, A., SIMON, M.I. and
BAYLOR, D.A., 2004. Recoverin regulates light-dependent phosphodiesterase activity in
retinal rods. The Journal of general physiology, 123(6), pp. 729-741.
MANCA, D., RICARD, A.C., TROTTIER, B. and CHEVALIER, G., 1991. Studies on
lipid peroxidation in rat tissues following administration of low and moderate doses of
cadmium chloride. Toxicology, 67(3), pp. 303-323.
MARCUS, Y., 1991. Thermodynamics of solvation of ions. Part 5.—Gibbs free energy of
hydration at 298.15 K. Journal of the Chemical Society, Faraday Transactions, 87(18), pp.
2995-2999.
MARKOVAC, J. and GOLDSTEIN, G.W., 1988. Picomolar concentrations of lead
stimulate brain protein kinase C. Nature, 334(6177), pp. 71-73.

192

MARLOWE, M., ERRERA, J. and JACOBS, J., 1983. Increased lead and cadmium
burdens among mentally retarded children and children with borderline intelligence.
American Journal of Mental Deficiency, 87(5), 477-483.
MARMOL, F., 2008. Lithium: bipolar disorder and neurodegenerative diseases Possible
cellular mechanisms of the therapeutic effects of lithium. Progress in NeuroPsychopharmacology and Biological Psychiatry, 32(8), pp. 1761-1771.
MARTINEZ-FINLEY, E.J., GAVIN, C.E., ASCHNER, M. and GUNTER, T.E., 2013.
Manganese neurotoxicity and the role of reactive oxygen species. Free radical biology and
medicine, 62, pp. 65-75.
MASON, L.H., HARP, J.P. and HAN, D.Y., 2014. Pb neurotoxicity: neuropsychological
effects of lead toxicity. BioMed research international, 2014, pp. 840547.
MATTSON, M.P., 2007. Calcium and neurodegeneration. Aging cell, 6(3), pp. 337-350.
MATTSON, M.P., 2004. Pathways towards and away from Alzheimer's disease. Nature,
430(7000), pp. 631.
MAZZEI, G.J., GIRARD, P.R. and KUO, J., 1984. Environmental pollutant Cd2
biphasically and differentially regulates myosin light chain kinase and phospholipid/Ca2 ‐
dependent protein kinase. FEBS letters, 173(1), pp. 124-128.
MCCUE, H.V., HAYNES, L.P. and BURGOYNE, R.D., 2010. The diversity of calcium
sensor proteins in the regulation of neuronal function. Cold Spring Harbor perspectives in
biology, 2(8), pp. a004085.
MCNEIL, A.K., RESCHER, U., GERKE, V. and MCNEIL, P.L., 2006. Requirement for
annexin A1 in plasma membrane repair. The Journal of biological chemistry, 281(46), pp.
35202-35207.
MÉNDEZ-ARMENTA, M. and RIOS, C., 2007. Cadmium neurotoxicity. Environmental
toxicology and pharmacology, 23(3), pp. 350-358.
MÉNDEZ-ARMENTA, M., VILLEDA-HERNÁNDEZ, J., BARROSO-MOGUEL, R.,
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